INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1524, 'US Military Doctors Blow The Whistle on Miscarriages, Cancers, Embolism, Death from CoV-19 Vaccines', 'https://drrobertyoung.com/us-military-doctors-blow-the-whistle-on-miscarriages-cancers-embolism-death-from-cov-19-vaccines/', 'US Military Doctors Whistleblow on 300% Increase in Soldier Miscarriages & Cancer Over 5-Year Average in 2021 Post COVID-Vaccines; Dr. Jessica Rose Estimates Over 172,000 American Miscarriages from CDC VAERS Data\nAt a senate hearing for Senator Ron Johnson on Monday January 24, 2022, Lawyer Thomas Renz, attorney for America’s Frontline Doctors revealed that three military doctors have come forward to whistleblow on excessive numbers of miscarriages, infertility diagnoses, cancer diagnoses, Bell’s palsy, myocardial infarctions and other serious ailments among previously fit and healthy soldiers who lined up for the dubious COVID-19 injections.\nThese reports come from diagnosis codes recorded at the DMED database–Defense Medical Epidemiology Database–for insurance purposes, which were investigated by the military physicians on seeing an increase in cases they were seeing clinically.\n“ According to Renz, it was the actual clinical experience of the three named doctors and several unnamed doctors that led them to investigate DMED, and their discoveries reflected their experience treating patients with ailments extremely unusual to healthy, young soldiers since the rollout of the vaccines.\n“ I have spoken to one of the whistleblowers who attests to being gravely concerned with seeing young soldiers with sudden metastatic cancers, auto-immune diseases, and heart and circulatory disorders that have caused many soldiers to drop out of various training programs. “These doctors were motivated to explore DMED data due to the numbers of case increases they were seeing empirically,” said the whistleblower, who served in the military for many years.”\n–Daniel Horowitz, https://www.theblaze.com/op-ed/horowitz-whistleblowers-share-dod-medical-data-that-blows-vaccine-safety-debate-wide-open\n“Aside from the spike in miscarriage diagnoses (ICD code O03 for spontaneous abortions), there was an almost 300% increase in cancer diagnoses (from a five-year average of 38,700 per year to 114,645 in the first 11 months of 2021). There was also a 1,000% increase in diagnosis codes for neurological issues , which increased from a baseline average of 82,000 to 863,000!\nSome other numbers he did not mention at the hearing but gave to me in the interview are the following:\n1. Myocardial infarction –269% increase\n2. Bell’s palsy – 291% increase\n3. Congenital malformations (for children of military personnel) – 156% increase\n4. Female infertility – 471% increase\n5. Pulmonary embolisms – 467% increase.”\nExcerpt from the hearing below:\n“Our Soldiers Are Being Experimented On, Injured and Sometimes Killed by CoV-19 Vaccines” Lawyer Renz\nCDC VAERS data is known to be under-reported from 10 to 100 times, as indeed all databases recording adverse events to the vaccines. But the fact that women in large numbers are experiencing menstruation problems, fertility problems, early miscarriages or spontaneous abortions post-COVID-vaccine is well-known now in true-media circles reporting on the adverse event reports in these public databases (CDC VAERS, WHO’S VigiAccess, EU’s Eudravigilance, UK’s Yellow Card Scheme) as well as from social media posts, covered earlier here in detail at:\nNews Report 4 | High Signal of Harm from COVID Vaccines for Pregnant Women and News Report 3 | They’re Playing Russian Roulette with Child COVID Vaccines | 12 Primary Reasons Not to Inject Your Child as well as other reports and articles.\nNews Report 4 | High Signal of Harm from COVID Vaccines for Pregnant Women\nLieutenant Colonel Dr. Theresa Long , aviation surgeon and one of the military whistleblowers along with Dr. Samuel Sigoloff and Peter Chambers had testified earlier to Senator Ron Johnson about vaccine injuries in the military , featured here earlier:\nDr. Long’s affidavit was published earlier in that article and can be read here: Affidavit of LTC. Theresa Long, MD…\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nScanning & Transmission Electron Microscopy Reveals Graphene Oxide in CoV-19 Vaccines\nPhase Contrast, Dark Field, Bright Field Microscopy, Transmission and Scanning Electron Microscopy and Energy-Dispersive X-ray Spectroscopy Reveal the Ingredients in the CoV-19 Vaccines!\nTo learn about the specific nondisclosed contents of these so-called vaccines go to the following link:\nhttps://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nhttps://www.bitchute.com/video/jnpG3weGmOui/\nhttps://www.bitchute.com/video/0wrX2Mwfrx4Z/\nLatest Interviews with Robert O. Young MSc, DSc, PhD, Naturopathic Practitioner\nhttps://clouthub.com/c/31f7f14d-de46-4cdc-bb20-8b50a9c2bcc9\nhttps://www.drrobertyoung.com/post/from-corona-to-cancer', '[-0.07105828821659088, -0.028205091133713722, -0.023812420666217804, 0.018119055777788162, -0.03831856697797775, -0.023972641676664352, 0.02562939189374447, 0.10657995939254761, -0.015889199450612068, 0.06735993921756744, -0.034137800335884094, 0.10086934268474579, 0.03309458866715431, 0.02081245929002762, -0.04702369496226311, 0.02948042005300522, 0.0053352718241512775, -0.02539917826652527, -0.001981015084311366, 0.028267404064536095, -0.06321903318166733, 0.06201261281967163, 0.09497728198766708, 0.0929914191365242, 0.03878142684698105, -0.03961234167218208, -0.05317458137869835, -0.00694579491391778, -0.07319803535938263, 0.0495016984641552, 0.04285414516925812, 0.0014505949802696705, -0.02266879566013813, -0.030804041773080826, 0.021558869630098343, 0.009728386066854, 0.03426964953541756, 0.057644426822662354, 0.0025856834836304188, 0.04892382770776749, 0.031178221106529236, -0.05541776865720749, 0.037035416811704636, 0.06605099141597748, 0.01764732412993908, -0.036249056458473206, -0.11991328746080399, 0.009228793904185295, 0.030183739960193634, 0.10118812322616577, -0.043883539736270905, -0.07430225610733032, 0.05117423087358475, 0.01089533232152462, 0.010830529034137726, -0.16003844141960144, -0.03300924599170685, 0.012976226396858692, -0.05719611793756485, -0.00689536239951849, -0.05729048699140549, -0.012489103712141514, 0.05595705285668373, -0.007786458358168602, -0.056928034871816635, 0.05957157164812088, 0.061118241399526596, -0.08006226271390915, 0.050769902765750885, 0.045427270233631134, 0.05650024861097336, 0.07494775205850601, -0.0162940863519907, 0.13616573810577393, -0.08037375658750534, 0.020653951913118362, 0.11727330833673477, 0.09385108202695847, 0.08451668173074722, -0.10891836136579514, 0.04584082216024399, 0.021825172007083893, 0.020574625581502914, 0.004642713349312544, -0.004812539089471102, -0.037004102021455765, 0.004015932325273752, 0.006224361713975668, -0.011140024289488792, 0.03456105291843414, 0.002420558361336589, -0.056881919503211975, 0.02959953434765339, 0.07700572162866592, -0.013208972290158272, 0.06890936195850372, -0.021559663116931915, -0.019388459622859955, -0.055210914462804794, -0.001486217137426138, -0.056701891124248505, -0.07388752698898315, -0.032470282167196274, 0.0197304654866457, -0.02963787503540516, 0.014007764868438244, -0.07411538064479828, -0.079062320291996, -0.05978693440556526, 0.0033275035675615072, 0.01721908524632454, 0.1035064160823822, -0.028567371889948845, -0.005220779683440924, -0.047401607036590576, 0.10383531451225281, -0.014192305505275726, -0.031721826642751694, 0.0324571430683136, 0.047609347850084305, -0.026823805645108223, -0.027205124497413635, -0.05624550208449364, -0.000538611551746726, 0.08998998254537582, 0.006494664121419191, 0.027734600007534027, 5.024705703887563e-33, 0.08659332245588303, -0.04827721416950226, 0.10657381266355515, 0.08379222452640533, -0.03741084784269333, 0.0643928200006485, 0.010973414406180382, -0.060687195509672165, 0.02373928762972355, -0.04142102971673012, -0.06248890236020088, -0.02255493588745594, 0.10903225094079971, 0.021711312234401703, -0.11072437465190887, 0.02030494436621666, -0.06293406337499619, 0.005976106505841017, -0.05203135311603546, 0.029994266107678413, 0.010313679464161396, 0.015361912548542023, -0.032308656722307205, 0.022557007148861885, 0.03823180869221687, 0.006588649470359087, -0.04883947595953941, 0.09126155078411102, 0.057507194578647614, 0.011603029444813728, -0.06197771802544594, -0.0032070637680590153, 0.12452492862939835, -0.04893166571855545, 0.007693955209106207, 0.0035405245143920183, 0.003295743837952614, -0.010437729768455029, -0.028986742720007896, 0.07004440575838089, 0.07432590425014496, 0.024475226178765297, -0.06645922362804413, -0.009309818036854267, 0.02037629298865795, -0.08631215244531631, -0.04897595942020416, -0.13851214945316315, -0.10677891224622726, -0.01416995469480753, 0.020563077181577682, 0.04488871991634369, 0.0005423436523415148, -0.019654320552945137, 0.033015452325344086, 0.004366559907793999, 0.005361116956919432, 0.005520974285900593, 0.028036992996931076, -0.0393281988799572, 0.057915739715099335, -0.0014482932165265083, 0.011835276149213314, 0.01577376201748848, -0.10389155149459839, -0.06512819230556488, -0.0549246184527874, -0.0893041342496872, -0.08523932844400406, 0.04302944988012314, -0.020516669377684593, 0.00271034799516201, -0.06155749782919884, -0.0920555517077446, -0.06840410828590393, -0.0006238091154955328, 0.01776147447526455, 0.008479178883135319, 0.041035037487745285, -0.07422333210706711, -0.019391821697354317, -0.017122281715273857, -0.004191581159830093, 0.11792705953121185, -0.054291751235723495, -0.010500774718821049, -0.051572635769844055, -0.02664770558476448, -0.08406894654035568, -0.02449849247932434, -0.016720987856388092, 0.039296746253967285, 0.03374871984124184, -0.026760702952742577, -0.00921565480530262, -7.666228119913436e-33, -0.12869440019130707, 0.07117307931184769, -0.009419095702469349, 0.026401925832033157, 0.03176549822092056, 0.0007384269265457988, 0.11224132776260376, 0.017040638253092766, 0.025898216292262077, -0.05134175717830658, 0.05030600354075432, -0.036127205938100815, -0.04392348974943161, 0.040037769824266434, -0.1010783314704895, 0.04564722254872322, -0.03640320524573326, -1.0709031812439207e-05, -0.014961382374167442, -0.00198938837274909, 0.06861108541488647, 0.0861504003405571, 0.01589467190206051, -0.011515338905155659, -0.014622753486037254, 0.02763802371919155, 0.05338059738278389, 0.010464755818247795, 0.024599580094218254, -0.05352017655968666, 0.0027888815384358168, 0.026436474174261093, -0.0015038424171507359, 0.043675389140844345, 0.04566511884331703, -0.0006894793477840722, 0.0014434902695938945, -0.006044103763997555, -0.03222627192735672, -0.07733678817749023, -0.003968662116676569, -0.013949057087302208, -0.08178634196519852, 0.012028289958834648, -0.04058847576379776, -0.010077531449496746, 0.04663015902042389, -0.022071585059165955, 0.06538882106542587, -0.005766425281763077, -0.071049265563488, -0.0743522122502327, -0.054148346185684204, 0.12788623571395874, -0.06361915916204453, -0.020984463393688202, -0.05241098254919052, -0.08137798309326172, 0.01403079554438591, 0.09128735214471817, -0.023107001557946205, -0.007909887470304966, -0.028277965262532234, -0.029905201867222786, -0.016455652192234993, 0.02779405191540718, 0.030435781925916672, -0.021482685580849648, 0.04921973869204521, -0.02646259032189846, 0.03593302518129349, -0.10157939046621323, -0.08914462476968765, -0.06624309718608856, 0.02212481200695038, -0.007542503532022238, -0.06182966008782387, -0.036811042577028275, -0.056368689984083176, 0.0671820193529129, 0.022419041022658348, -0.127869114279747, 0.021324384957551956, 0.07639351487159729, -0.03819062560796738, 0.01910075917840004, 0.001589982071891427, -0.020302191376686096, -0.04186172038316727, 0.047000717371702194, -0.07964565604925156, -0.06834864616394043, -0.03619049862027168, -0.03346487879753113, -0.03351129591464996, -5.398226576858178e-08, 0.006429310888051987, 0.01990078203380108, -0.012815277092158794, 0.024635611101984978, -0.04313172027468681, -0.12265680730342865, -0.029286513105034828, 0.04695158824324608, 0.010954462923109531, 0.03996024280786514, 0.04130944982171059, 0.056052062660455704, -0.012129174545407295, -0.03805151954293251, 0.05415446311235428, 0.023919332772493362, -0.08553357422351837, 0.07768837362527847, -0.03423508256673813, -0.02511834166944027, -0.029710549861192703, -0.014791186898946762, -0.031769003719091415, -0.01447879709303379, -0.005576229188591242, 0.06920384615659714, -0.020276635885238647, 0.04033847898244858, -0.013947511091828346, -0.01615118607878685, -0.05076053366065025, 0.006100619211792946, 0.07664519548416138, 0.01069586630910635, -0.05151575803756714, -0.04747004806995392, 0.016136812046170235, -0.01508121658116579, 0.01979546807706356, -0.007136944681406021, 0.008331560529768467, 0.017943255603313446, 0.037301406264305115, 0.03194460645318031, 0.01692277193069458, -0.029436474665999413, -0.0203276164829731, 0.04904015362262726, -0.022688735276460648, 0.0013350408989936113, 0.015879837796092033, -0.012905503623187542, -0.0157012976706028, 0.05349056422710419, 0.015323938801884651, 0.12171322852373123, 0.00894877128303051, -0.027871865779161453, 0.013268444687128067, -0.017120666801929474, -0.007803126238286495, -0.07099411636590958, 0.01848084293305874, 0.016580671072006226]'),
(1525, 'The Harvard Lectures – ‘Towards the Ethics of Healing’', 'https://drrobertyoung.com/the-harvard-lectures-towards-the-ethics-of-healing/', 'The following links are a resource that will help you in your education on my New Biology – A New Way of Living, Eating and Thinking\nThe Harvard Lectures – ‘Towards the Ethics of Healing’ begins the debate on human health and how we should treat any sickness and disease.\n2. Dr. Robert O Young’s Harvard Lecture – Towards the Ethics of Healing – Part 2 of 3 – The Law of Change – https://youtu.be/J7NJql-jwVQ –\n3. Dr. Robert O Young’s Harvard Lecture – Towards the Ethics of Healing – Part 3 of 3 – The Harvard Lecture – Part 3 – The New Biology – https://youtu.be/6I1E2C8os_Q\nTo learn more about the life and 40 year career of Dr. Young go to: www.drrobertyoung.com and/or www.phmiracleproducts.com Education and pH Miracle retreats: www.phmiracleretreat.com\nRobert O Young MSc, DSc, PhD, Naturopathic Practitioner\nPS My latest interview on The New Biology with Dr. Tenpenny –\nhttps://clouthub.com/v/dbf1300a-2395-45d2-b8c8-c377b1fd4109', '[-0.012691035866737366, -0.028362218290567398, 0.021726176142692566, 0.01732086017727852, -0.006388732697814703, 0.007807327434420586, -0.04639251530170441, 0.05840541794896126, -0.021250039339065552, -0.0029728254303336143, 0.008142216131091118, 0.09729082882404327, -0.10869457572698593, 0.034394536167383194, -0.062416933476924896, 0.014829999767243862, -0.02466350421309471, 0.060935333371162415, -0.0457000695168972, 0.03894257918000221, -0.006676840130239725, 0.03258240595459938, 0.10354586690664291, -0.0003364799777045846, -0.05378849804401398, -0.03769838809967041, 0.05400616675615311, -0.08065801113843918, -0.03669796884059906, -0.040366485714912415, 0.05197435989975929, 0.01780793070793152, -0.005252189002931118, -0.02254435233771801, -0.003129594260826707, -0.012673129327595234, 0.026133567094802856, 0.03477680683135986, -0.033197950571775436, 0.07327193766832352, -0.006921459920704365, -0.039807241410017014, -0.000593336415477097, -0.004112659487873316, 0.0030146825592964888, -0.07498833537101746, -0.03352474793791771, -0.025698592886328697, 0.051057275384664536, 0.006927494890987873, -0.12351769208908081, -0.0792599469423294, -0.06054426357150078, -0.03618832305073738, 0.005820919293910265, 0.02142692543566227, -0.05113406479358673, -0.02477913163602352, -0.11581975221633911, -0.046981509774923325, 0.0362827405333519, -0.019184768199920654, 0.005078309681266546, 0.05920889973640442, -0.042755287140607834, -0.03595110401511192, 0.022310307249426842, 0.07125930488109589, 0.010302110575139523, -0.01628013141453266, -0.05633554607629776, -0.06314786523580551, -0.008296250365674496, -0.025099581107497215, 0.027502238750457764, 0.03088105469942093, 0.01354790385812521, 0.035268139094114304, -0.03193187713623047, -0.017219681292772293, 0.10472191870212555, 0.05485260859131813, 0.05881263688206673, -0.004912582691758871, -0.06047240272164345, -0.06352618336677551, 0.009261565282940865, 0.010141137056052685, -0.013790265657007694, 0.05824203044176102, 0.03790169209241867, 0.01143889781087637, -0.023190300911664963, 0.059981267899274826, 0.01718861795961857, 0.07277694344520569, -0.07156461477279663, -0.01764637604355812, -0.024079574272036552, 0.018868442624807358, -0.021781057119369507, 0.0037738648243248463, -0.00769920414313674, 0.03716647997498512, 0.007277473341673613, 0.012571968138217926, -0.039825502783060074, -0.056605011224746704, 0.06350154429674149, -0.002175066852942109, 0.04134736582636833, 0.10999099910259247, -0.05564940720796585, 0.026243552565574646, 0.10563058406114578, 0.02969571389257908, -0.0026485079433768988, -0.0038021171931177378, 0.07656659930944443, -0.05947074666619301, -0.008204489015042782, -0.061809245496988297, -0.0025106577668339014, -0.05037921667098999, -0.03615786135196686, -0.01966974511742592, -0.015954414382576942, -3.919447140526907e-35, 0.07227210700511932, 0.039867814630270004, 0.04715394228696823, 0.033248525112867355, 0.010167053900659084, 0.0814095139503479, 0.047760747373104095, 0.009934121742844582, -0.03227464109659195, -0.09685460478067398, 0.057592883706092834, -0.015085259452462196, 0.0454198494553566, -0.024496937170624733, -0.1397162824869156, -0.0569022037088871, -0.10361290723085403, -0.011116829700767994, 0.061824873089790344, 0.026786591857671738, -0.024646073579788208, 0.026597948744893074, -0.053276482969522476, 0.012212101370096207, -0.008990148082375526, -0.02642868086695671, -0.004251999314874411, -0.02266053855419159, 0.09325727075338364, 0.0032023033127188683, -0.07727949321269989, -0.009982756339013577, -0.07079330831766129, -0.05574924126267433, -8.980226266430691e-05, 0.017224080860614777, -0.0013663917779922485, -0.04419730603694916, 0.03286486491560936, -0.1049765944480896, 0.007210572715848684, -0.0033465507440268993, 0.029847048223018646, 0.004481054842472076, 0.04446656256914139, 0.03638441488146782, 0.015085523016750813, -0.03007422760128975, 0.036443039774894714, -0.016220008954405785, -0.051476042717695236, -0.051483556628227234, 0.0035384364891797304, -0.0843106284737587, -0.0011296290904283524, -0.04676976054906845, -0.07128161936998367, 0.05541209504008293, -0.06969566643238068, 0.006280009634792805, 0.09459687024354935, 0.0539146363735199, -0.055132247507572174, -0.030772075057029724, -0.059002071619033813, 0.00706502515822649, -0.08011560887098312, -0.09691314399242401, 0.061237819492816925, 0.0015152825508266687, -0.05704346299171448, 0.01884857751429081, -0.015007182955741882, 0.004723000340163708, -0.010451122187077999, -0.0018072413513436913, -0.021077226847410202, -0.0963028222322464, -0.04842953011393547, -0.002499989001080394, 0.026954665780067444, 0.09006637334823608, -0.08488702028989792, 0.08212152123451233, 0.004882239270955324, -0.03131198510527611, -0.007015027571469545, 0.0019113364396616817, 0.06756816059350967, 0.0180659219622612, 0.054050512611866, -0.06541001051664352, 0.03995319828391075, 0.032064422965049744, -0.033978141844272614, -3.618954417600252e-33, 0.0800618827342987, -0.013733978383243084, 0.005007904022932053, 0.055531371384859085, 0.10382353514432907, -0.009785299189388752, 0.00045969997881911695, 0.09872975945472717, 0.06187649071216583, -0.09665021300315857, -0.00178874796256423, 0.031592756509780884, -0.005397984758019447, -0.007865394465625286, -0.10721220076084137, -0.04343149811029434, -0.08834157884120941, 0.04608088731765747, -0.10849492996931076, -0.0004959063953720033, 0.01864684373140335, 0.16374604403972626, -0.04331694170832634, 0.015592432580888271, -0.00473766541108489, 0.06046357378363609, 0.09835755079984665, 0.0809737890958786, -0.006923670880496502, 0.0051183514297008514, 0.0874265506863594, 0.08508116006851196, -0.025466669350862503, 0.022871967405080795, -0.043011583387851715, 0.07803156971931458, -0.0010890940902754664, -0.06165643036365509, 0.017605064436793327, -0.08491428196430206, 0.1315794140100479, -0.08379427343606949, -0.03342069685459137, -0.09159456193447113, 0.05403832718729973, 0.05878819525241852, -0.06560417264699936, 0.05066251754760742, 0.010923776775598526, 0.03711409494280815, 0.029096679762005806, 0.00039987696800380945, -0.0039993892423808575, 0.008700855076313019, 0.0759650468826294, -0.016941368579864502, 0.03475093096494675, -0.06723129749298096, 0.023736491799354553, -0.022189442068338394, -0.051247283816337585, 0.03206399083137512, -0.03656983748078346, 0.02121337503194809, -0.06958833336830139, -0.012898217886686325, 0.04156781733036041, 0.0478174053132534, -0.05275843292474747, 0.03654571995139122, -0.08655866980552673, 0.025793641805648804, -0.0043317717500030994, -0.05921827629208565, 0.02729506976902485, 0.017007943242788315, -0.09383521974086761, -0.06383652985095978, -0.05260522663593292, 0.04238836467266083, -0.06932739168405533, -0.16025927662849426, 0.010720797814428806, 0.050405535846948624, -0.029022661969065666, 0.03739994019269943, 0.027748560532927513, -0.0012525897473096848, -0.02947290800511837, 0.04517446458339691, -0.054201193153858185, -0.03992246836423874, -0.0758739709854126, -0.030440961942076683, 0.03692008927464485, -5.5438679424923976e-08, 0.140217125415802, -0.050739653408527374, 0.005011854227632284, -0.0034088403917849064, -0.022039758041501045, -0.023171959444880486, -0.05461226403713226, 0.002268678741529584, -0.01783430017530918, 0.1257091611623764, -0.053474921733140945, 0.04791425168514252, 0.018233180046081543, 0.06744804233312607, 0.05257618799805641, -0.0019122821977362037, 0.01713017374277115, -0.013946535997092724, -0.0020828223787248135, -0.08569909632205963, 0.005383873824030161, 0.01443781703710556, 0.060681141912937164, 0.0010117398342117667, 0.010631473734974861, -0.010486348532140255, 0.022606201469898224, -0.013023276813328266, -0.05132611095905304, -0.07373057305812836, 0.03886335715651512, 0.051656100898981094, 0.019221492111682892, 0.03865586966276169, -0.0158479455858469, -0.10950623452663422, -0.009202789515256882, -0.07682555913925171, 0.05736285448074341, 0.03496399149298668, -0.02107660472393036, -0.015234194695949554, -0.009181535802781582, 0.02705957368016243, -0.025056298822164536, -0.054777417331933975, 0.06825503706932068, 0.09443248808383942, -0.0036104435566812754, 0.013537545688450336, 0.010388145223259926, -0.0022453207056969404, 0.011797559447586536, -0.08146335184574127, -0.0318746492266655, 0.09720233082771301, 0.00906662829220295, -0.006441793404519558, -0.06192965805530548, -0.002214648062363267, 0.07000187784433365, 0.05874400958418846, -0.024750467389822006, 0.02480810321867466]'),
(1526, 'Dr. Tenpenny Interviews Robert O Young', 'https://drrobertyoung.com/dr-tenpenny-interviews-robert-o-young/', 'https://clouthub.com/v/dbf1300a-2395-45d2-b8c8-c377b1fd4109\nhttps://www.bitchute.com/video/wkiZcWbmC4Vj/\nExtraordinary and riveting account of healing from terminal lung cancer and recovering from COVID symptoms on the pH Miracle Lifestyle healing program of alkaline diet, exercise, and healing foods from Dr. Robert Young, who describes the healing power of the right foods and actions to maintain the right pH balance in the interstitial fluids of the body, and encourages all to learn more about how disease is not transmitted by germs—as Virology would have it—but cultured in acidic environments, and how switching our diets and lifestyles from acidic to alkaline can transform our lives.\nInger’s story at Dr. Young’s website: https://www.drrobertyoung.com/surviving-cancer https://www.drrobertyoung.com/post/the-prevention-cure-for-cancer\nPREVIOUS PODCASTS WITH DR. YOUNG ON HIS DIET AND LIFESTYLE PARADIGM & on TOXINS FOUND IN THE COVID VACCINES:\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nReport 255 | Dr. Robert Young: All Disease is Outfection Not Infection–Vaccine Nano is Bioweapon!\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nNewsbreak 135–BREAKING: Immense Harm from\nCrystallizing Blood Cells/Graphene Poisoning Post-Vaccine\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nNewsbreak 133: Team of Scientists Confirm Presence of Toxins https://everydayconcerned.net/2021/08/28/newsbreak-133-team-of-scientists-confirm-presence-of-toxins-graphene-aluminium-cadmium-selenide-stainless-steel-lnp-go-capsids-parasites-other-toxins-variously-in-4-covid-vaccines-pfizer-mode/\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nhttps://www.bitchute.com/video/reT2JVKTlWmB/\nScientific Articles – www.drrobertyoung.com/blog CV – www.drrobertyoung.com\nYOUTUBE Videos – https://www.youtube.com/c/RobertYoung555/featured\nRumble Videos – https://rumble.com/user/DrRobertYoung', '[-0.03502858430147171, 0.023952359333634377, 0.025803539901971817, 0.02617076225578785, 0.018403487280011177, 0.03792667016386986, -0.044407058507204056, 0.040762774646282196, -0.04694512486457825, -0.042608778923749924, 0.017489930614829063, 0.03799644857645035, 0.01873241551220417, -0.0024033882655203342, -0.05379091948270798, 0.0033518713898956776, -0.00961337424814701, 0.03177064284682274, -0.09889613091945648, -0.012580097652971745, -0.015822818502783775, 0.07477539032697678, 0.052186138927936554, 0.041803210973739624, 0.021830478683114052, -0.01676252856850624, 0.0024551711976528168, -0.03677640110254288, -0.017435306683182716, -0.03948070481419563, 0.10382936894893646, 0.0010906041134148836, 0.0006445487961173058, -0.054371289908885956, -0.07170262187719345, 0.0034939893521368504, 0.010474261827766895, 0.04634413868188858, -0.04831872135400772, 0.01636243611574173, 0.025151735171675682, -0.01176860649138689, -0.017259353771805763, -0.017605310305953026, 0.012463846243917942, -0.006751878187060356, -0.06303606927394867, -0.06632187962532043, 0.0018129005329683423, 0.07519041001796722, -0.10317432880401611, -0.016139337792992592, 0.002876724349334836, 0.004919721744954586, 0.02015569992363453, 0.03628115728497505, -0.07322577387094498, 0.04194292798638344, -0.02145661599934101, -0.026858016848564148, 0.05546612665057182, -0.10334314405918121, 0.027441570535302162, 0.01875011809170246, 0.0005815158947370946, -0.04959867149591446, -0.010249568149447441, 0.018574461340904236, -0.005002925172448158, -0.018335793167352676, -0.09223473072052002, -0.016630031168460846, 0.049151431769132614, 0.011346772313117981, -0.01459436397999525, 0.04041307419538498, 0.03998405113816261, -0.051113229244947433, -0.08838163316249847, 0.03834010288119316, 0.06581676006317139, 0.038395270705223083, 0.06717261672019958, 0.04163958877325058, -0.003129629883915186, -0.05669180303812027, 0.02458277717232704, -0.04855770617723465, -0.008524581789970398, 0.032869163900613785, -0.01712493598461151, -0.028224268928170204, -0.01007490511983633, 0.058217260986566544, -0.0259118489921093, 0.02003810927271843, -0.020811958238482475, -0.07671620696783066, 0.0012284007389098406, -0.012092971242964268, -0.0191543810069561, 0.017514145001769066, 0.09394866228103638, -0.00965539738535881, 0.014144624583423138, -0.07434755563735962, -0.0855061337351799, 0.03967278078198433, 0.03817044198513031, 0.0608314573764801, 0.08627158403396606, 0.08540142327547073, -0.04336462914943695, -0.01880842261016369, 0.11385650187730789, 0.080290287733078, 0.001263143727555871, -0.0712745264172554, -0.003522441955283284, 0.005166659597307444, -0.010615160688757896, -0.1148122251033783, 0.07645271718502045, -0.03307761996984482, 0.007019198499619961, 0.028530629351735115, 0.038103390485048294, 2.7500119120701314e-33, 0.0186713058501482, -0.040638454258441925, 0.03642347455024719, 0.04947304725646973, 0.07818712294101715, 0.003815331030637026, -0.0413309782743454, -0.07235144078731537, 0.02215096913278103, -0.14217904210090637, 0.11845728754997253, 0.06797309219837189, 0.05925818160176277, -0.016261806711554527, -0.11728298664093018, -0.03237533941864967, -0.1417306810617447, -0.03738998621702194, 0.0350591316819191, -0.013670017011463642, -0.005211864598095417, -0.005029759369790554, -0.014164557680487633, -0.0249408520758152, -0.0173769723623991, -0.01564861834049225, 0.04726475477218628, -0.01234474591910839, 0.04284312203526497, -0.009850993752479553, -0.043325573205947876, 0.03090345486998558, -0.07829102128744125, -0.044624149799346924, -0.055804405361413956, 0.02530517801642418, -0.019951805472373962, -0.062478844076395035, 0.051244691014289856, -0.05438769608736038, -0.01645968295633793, -0.0147421108558774, 0.049683138728141785, 0.0281678419560194, 0.06210885941982269, -0.01583421789109707, -0.07125852257013321, 0.025047477334737778, -0.014672242105007172, -0.005650089122354984, 0.009897974319756031, -0.028471827507019043, -0.03295302391052246, -0.06670074164867401, -0.0038503636606037617, -0.07998166233301163, -0.09354948997497559, 0.010442877188324928, -0.06422406435012817, 0.03824082762002945, 0.1052301824092865, 0.025941384956240654, -0.018317146226763725, 0.027734797447919846, -0.11946345120668411, -0.05876391753554344, -0.019201863557100296, -0.13765519857406616, 0.024775255471467972, 0.04061083495616913, -0.052107252180576324, 0.005317366681993008, 0.051348134875297546, -0.020755985751748085, -0.029389386996626854, -0.04786212369799614, -0.01212389674037695, 0.012432171031832695, -0.033754635602235794, 0.07428096234798431, 0.047806695103645325, 0.07022964954376221, -0.05216650664806366, 0.08865828067064285, -0.033466845750808716, -0.0367172546684742, -0.05667787417769432, -0.013305225409567356, 0.10678352415561676, -0.057190876454114914, -0.02469571866095066, -0.0385100431740284, 0.07957230508327484, 0.06810716539621353, -0.02826029062271118, -3.955655672610095e-33, 0.09600035101175308, -0.048655491322278976, 0.08280356973409653, 0.05980820208787918, 0.11921592801809311, -0.008786095306277275, -0.005962144583463669, 0.041635867208242416, 0.04954734072089195, -0.08590933680534363, 0.0113449115306139, 0.05684478208422661, 0.004840386100113392, -0.002351931994780898, -0.09361111372709274, -0.012530313804745674, 0.0013102510711178184, 0.04577992856502533, -0.06677228957414627, -0.0255627129226923, 0.05358307808637619, 0.13652023673057556, -0.083089180290699, 0.06483472883701324, -0.026728156954050064, 0.05590655654668808, 0.04149888828396797, 0.039040710777044296, 0.0077759381383657455, 0.0015689481515437365, 0.06434115767478943, 0.04056482017040253, -0.02369692176580429, -0.011919712647795677, -0.014058413915336132, 0.03666302189230919, -0.002059060847386718, -0.06743975728750229, -0.007712017744779587, -0.05441020056605339, 0.08768970519304276, -0.03686176612973213, -0.009876560419797897, -0.03860820084810257, 0.04233051836490631, 0.11035452038049698, 0.03606727346777916, -0.021136920899152756, 0.027861732989549637, 0.03337375447154045, 0.07105744630098343, 0.005856605712324381, -0.06934963166713715, 0.011344028636813164, 0.03456800431013107, 0.020346151664853096, -0.034964028745889664, -0.03680919483304024, -0.0707559734582901, -0.006000614259392023, -0.07017460465431213, 0.022493980824947357, -0.02393263764679432, -0.05427908897399902, -0.1044439822435379, 0.022729741409420967, 0.07609699666500092, -0.023058991879224777, -0.01485972385853529, 0.02240242063999176, -0.05367547646164894, -0.013499715365469456, -0.038922738283872604, -0.04602975398302078, 0.04143138229846954, 0.029976801946759224, -0.07240062206983566, -0.09300684183835983, -0.053023893386125565, 0.0018333129119127989, -0.07726889848709106, -0.06290768086910248, 0.006327314767986536, -0.046611711382865906, 0.09871917217969894, 0.022161483764648438, -0.044658757746219635, -0.031461451202631, -0.040099937468767166, 0.042136602103710175, -0.041380345821380615, -0.1396051049232483, -0.1192273497581482, -0.022771580144762993, 0.039581187069416046, -5.441721739884997e-08, 0.10408301651477814, -0.03279576450586319, -0.053762346506118774, 0.0331851989030838, 0.0014457051875069737, 0.0304698683321476, 0.035902414470911026, -0.0012879803543910384, 0.004800956696271896, 0.09832175821065903, -0.04499877244234085, 0.07502471655607224, 0.0093688378110528, 0.10860317200422287, 0.044002849608659744, 0.011821029707789421, 0.034049805253744125, 0.05344236269593239, -0.06912276148796082, -0.05644386634230614, -0.007197587750852108, 0.003166104666888714, 0.06876397132873535, -0.012515680864453316, -0.019510040059685707, 0.01782710663974285, 0.013500954024493694, 0.021589571610093117, -0.018766850233078003, -0.04590762034058571, 0.007958504371345043, 0.0013311381917446852, 0.04916607216000557, 0.0529748797416687, -0.0047339946031570435, -0.02021130733191967, 0.11179334670305252, -0.03965473547577858, 0.0012501886812970042, 0.030183089897036552, 0.031040875241160393, 0.004854233004152775, -0.00040175870526582, 0.04056490585207939, -0.05742115527391434, -0.04194554686546326, -0.021326949819922447, 0.011388130486011505, -0.045744702219963074, 0.02914346754550934, 0.04706556349992752, -0.017910532653331757, 0.06070679426193237, 0.006220552604645491, -0.051686547696590424, 0.08541394025087357, -0.014767160639166832, -0.10017572343349457, 0.03318474814295769, 0.021568985655903816, 0.11230698227882385, 0.01746317557990551, 0.047322653234004974, 0.019110677763819695]'),
(1527, 'How I Reversed My Terminal Metastatic Pulmonary Adenocarcinoma Lung Cancer', 'https://drrobertyoung.com/how-i-reversed-my-terminal-metastatic-pulmonary-adenocarcinoma-lung-cancer/', 'https://www.drrobertyoung.com/surviving-cancer\nAn extraordinary and riveting account of healing from terminal metastatic lung cancer (with less than 6 months to live) and recovering from COVID symptoms on the self-help pH Miracle Lifestyle healing program of alkaline nutrition, exercise, and healing foods and water taught by Dr. Robert O. Young, who describes the healing power of the right foods and actions to maintain the right pH balance in the interstitial and vascular fluids of the body, and encourages all to learn more about how disease is not transmitted by germs—as Virology would have it—but cultured in acidic environments, and how switching our diet and lifestyle from acidity to alkalinity can transform our life.\nhttps://www.bitchute.com/video/wkiZcWbmC4Vj/\nLINKS FOR MORE: Inger’s story at Dr. Young’s website: https://www.drrobertyoung.com/surviving-cancer\nThis article was initially published in the magazine ”Tidslerne”, (Danish Cancer Association Tidslerne) in January 2018.\nThis is how I regained my future from terminal metastatic lung cancer: by Inger Hartelius\nhttps://www.drrobertyoung.com/post/the-prevention-cure-for-cancer\nCystic Fibrosis and Pulmonary Adenocarcinoma Lung Cancer Both Metabolic and Dietary Acidic Conditions of the Interstitial Fluids of the Lung\nhttps://phmiracleproducts.com/collections/books-audio-video/products/cystic-fibrosis-and-pulmonary-adenocarcinoma-booklet\nPREVIOUS PODCASTS WITH DR. YOUNG ON HIS DIET AND LIFESTYLE PARADIGM & on TOXINS FOUND IN THE COVID VACCINES:\nhttps://www.bitchute.com/video/7BM8rMBiQ6f9/\nExplosive news that the COVID Vaccines have been biochemically designed to target specific organs , given that they are now causing specific adverse effects involving specific organs–such as the reproductive organs, heart, brain, blood, etc. Dr. Young shares his experience over 40 years of formulating targeted nutraceuticals which use specific polynucleotides–genetic material, taken from animal tissue–to send herbal nutrition to specific organs; it is this same methodology, he says, using fetal organ cells and animal organ cell lines, undisclosed, kept hidden as trade secrets, which is being used in vaccines for a deleterious purpose, to harm and sterilize.\nVariability of toxicity across batches and selection of batches for targeted reasons–labelled , recorded, and structured by the vaccine-maker scientists conducting these horrific experiments–is the other end of this scenario.\nhttps://www.drrobertyoung.com/post/the-corona-jabb-increases-risk-for-cardiac-arrest-by-25-percent-in-ages-16-to-39\nThis is why we are seeing a rise in myocarditis in boys taking the vaccine, and miscarriages and menstrual changes in women taking the vaccine.\nThis information is borne out by Professor Sir John Bell of Oxford who was recorded saying that 60-70% sterility is intended by the vaccines.\nDr. Young also reads a powerful statement summing up the ongoing experimentation and transhumanizing agenda and encourages people to stand up, to say NO, to not comply with diabolical military and bankster agendas to insidiously destroy humanity.\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nReport 255 | Dr. Robert Young: All Disease is Outfection Not Infection–Vaccine Nano is Bioweapon!\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nNewsbreak 135–BREAKING: Immense Harm from Crystallizing Blood Cells/Graphene Poisoning Post-Vaccine\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nNewsbreak 133: Team of Scientists Confirm Presence of Toxins\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nhttps://everydayconcerned.net/2021/08/28/newsbreak-133-team-of-scientists-confirm-presence-of-toxins-graphene-aluminium-cadmium-selenide-stainless-steel-lnp-go-capsids-parasites-other-toxins-variously-in-4-covid-vaccines-pfizer-mode/\nhttps://www.bitchute.com/video/0wrX2Mwfrx4Z/\nhttps://www.bitchute.com/video/reT2JVKTlWmB/\nhttps://www.bitchute.com/video/K9SZ2AjeLY0W/\nLifesaving information from Dr. Young focused on the nature and reason for widespread vaccine injury and sudden deaths from the COVID vaccines, the toxins found to be contained in the COVID and flu vaccines, the false theory of viruses, the true paradigms of health and disease which lead to vibrant health, and the healing and restorative practices and protocols of naturopathy which could immediately address vaccine damages, with special focus on natural clays, as well as Dr. Young’s COWS protocols : Chlorophyll, Clays , Oils, Oxygen, Water, Sunshine and Exercise.\nhttps://www.drrobertyoung.com/post/the-healing-properties-of-a-smectite-montmorillonite-terra-phirma-clay\nDr. Young addresses the healing of vaccine effects such as convulsions, seizures, neurological disorders, all possible effects of pathological blood coagulation accruing from the coagulates of nano graphene and iron oxide destroying red blood cells and transgressing across the blood-brain and cytoplasmic barriers into the brain as well as into cells all over the body, advising the assistance of a naturopath or knowledgeable doctor to assist the de-acidification and detoxing of the body and re-alkalinizing of the tissues with healthful salts, minerals, vitamins, water as noted in his COWS program .\nYOU NEED HELP from Dr. Robert O. Young’s pH Miracle Protocol and Dr. Robert O. Young NEEDS YOUR HELP!\nDETOX NANOTECH and CLEANSE YOUR PINEAL GLAND Try Clean Slate, Zero-In, and Restore for detox and daily health at this link (which supports this channel): https://therootbrands.com/micmar', '[-0.02384117804467678, 0.035435471683740616, 0.027955949306488037, 0.045896053314208984, 0.042367443442344666, 0.020030278712511063, -0.029559899121522903, 0.05597156286239624, -0.04067853093147278, -0.04429619386792183, -0.01049613207578659, 0.05936460196971893, 0.0453057698905468, 0.002447790000587702, -0.02483193390071392, 0.017989294603466988, -0.023300612345337868, 0.029580773785710335, -0.11914781481027603, 0.005900578573346138, -0.05873895063996315, 0.060050588101148605, 0.04639885947108269, 0.005380409304052591, 0.01756780967116356, -0.008958354592323303, 0.02177003212273121, -0.02442842349410057, -0.03439849615097046, -0.02709946222603321, 0.08013741672039032, -0.0003772254567593336, -0.07137039303779602, -0.04572264105081558, -0.0723799392580986, 0.04459277540445328, 0.009479183703660965, 0.037732865661382675, -0.06842611730098724, 0.023430336266756058, 0.03947529196739197, -0.01792198233306408, -0.02957180142402649, -0.02208300679922104, -0.0015045794425532222, 0.023679343983530998, -0.05846802890300751, -0.088286854326725, 0.005017553456127644, 0.0603330135345459, -0.05347808077931404, -0.019962754100561142, -0.009392263367772102, 0.001646725693717599, 0.010998034849762917, 0.003779994323849678, -0.06171296536922455, 0.04873410984873772, -0.035838622599840164, -0.010162615217268467, 0.04673057422041893, -0.07977202534675598, 0.05583062395453453, 0.029613930732011795, 0.006750975735485554, -0.046380095183849335, -0.002248036675155163, 0.011423526331782341, -0.037151943892240524, -0.009011778049170971, -0.06735724210739136, -0.01292506419122219, 0.041236020624637604, 0.04802526533603668, 0.010389711707830429, 0.04358493909239769, 0.03897504135966301, -0.05384541675448418, -0.05453938618302345, 0.02458815649151802, 0.043849390000104904, 0.054958853870630264, 0.02806168422102928, 0.07075517624616623, -0.04053245484828949, -0.035058848559856415, 0.008693389594554901, 0.01738458313047886, 0.007784930989146233, 0.042194996029138565, -0.037244465202093124, -0.02451634779572487, 0.00852183811366558, 0.04423937946557999, -0.046725913882255554, 0.026822762563824654, -0.0035656276158988476, -0.07400226593017578, -0.023546408861875534, -0.0371406115591526, -0.04564774036407471, 0.04061083123087883, 0.06072181463241577, -0.001861659693531692, 0.00619562529027462, -0.07727190107107162, -0.10347595810890198, 0.0429956428706646, 0.002570641227066517, 0.059452444314956665, 0.05633705481886864, 0.0630779042840004, -0.017119070515036583, -0.01366901770234108, 0.0803651362657547, 0.10120779275894165, -0.03883374482393265, -0.08971859514713287, 0.017709698528051376, -0.020863818004727364, -0.03965715318918228, -0.09886125475168228, 0.06487052142620087, 0.027525493875145912, 0.06938128173351288, 0.05501165986061096, 0.06323351711034775, 3.351589696873661e-33, 0.03964303061366081, -0.05039680376648903, 0.07766629755496979, 0.08336731046438217, 0.08210892975330353, 0.014862929470837116, -0.04842605069279671, -0.06700251996517181, 0.04905933514237404, -0.13972525298595428, 0.11155901849269867, 0.04032463952898979, 0.03342891111969948, -0.04041304066777229, -0.13211846351623535, -0.0183775182813406, -0.13884295523166656, -0.010320983827114105, 0.02204161509871483, 0.0022496660239994526, -0.004600383806973696, -0.012760525569319725, 0.018466966226696968, -0.013036438263952732, -0.02831396460533142, 0.012147370725870132, 0.040613193064928055, -0.003607619320973754, 0.05540730804204941, -0.019941037520766258, -0.03584787994623184, 0.009702290408313274, -0.022330405190587044, -0.06744841486215591, -0.037730131298303604, 0.03807978332042694, 0.003975679632276297, -0.04828174412250519, 0.028723135590553284, -0.0005403662216849625, -0.002285534515976906, 0.014979948289692402, 0.07553338259458542, 0.009682108648121357, 0.009479234926402569, -0.025227535516023636, -0.06366993486881256, -0.0010393024422228336, -0.041576776653528214, -0.02766934037208557, -0.021212449297308922, -0.0030655013397336006, -0.0150054432451725, -0.05407671257853508, 0.0026241580490022898, -0.10175421088933945, -0.11027492582798004, 0.00346997263841331, -0.061831749975681305, 0.02954445593059063, 0.07544642686843872, 0.026156285777688026, -0.03427478298544884, 0.08290641754865646, -0.10762818157672882, -0.07229429483413696, -0.056729260832071304, -0.13801181316375732, -0.005199862644076347, 0.0344172902405262, -0.05390702560544014, 0.004333431366831064, 0.06894588470458984, -0.025728490203619003, -0.019952718168497086, -0.04507925361394882, 0.0019128179410472512, -0.028959985822439194, -0.05255736783146858, 0.0680091381072998, 0.050510846078395844, 0.05821170285344124, -0.0748295858502388, 0.08743453025817871, 0.028170008212327957, -0.021596193313598633, -0.04259458929300308, -0.0636138841509819, 0.08521179109811783, -0.019914958626031876, -0.030515123158693314, -0.02512948028743267, 0.06605800986289978, 0.058768920600414276, -0.033221758902072906, -4.256723653084684e-33, 0.06609788537025452, -0.031126338988542557, 0.08221185207366943, 0.037080541253089905, 0.1346541792154312, -0.016602667048573494, -0.0020024606492370367, 0.08098279684782028, 0.04488673433661461, -0.07748443633317947, 0.011083120480179787, 0.07317383587360382, 0.02101820334792137, 0.014978252351284027, -0.12906375527381897, -0.023597141727805138, 0.02949853613972664, 0.06582379341125488, -0.06660621613264084, -0.024331623688340187, -0.016549574211239815, 0.11118701100349426, -0.09322305023670197, 0.035953227430582047, -0.045987568795681, 0.10770963132381439, 0.019694330170750618, 0.020245308056473732, -0.0029638842679560184, -0.0006241006776690483, 0.0754266083240509, 0.0842423215508461, -0.022204682230949402, -0.01253163069486618, -0.0010610122699290514, 0.04695853218436241, 0.014270542189478874, -0.08264617621898651, -0.016715440899133682, -0.02350027672946453, 0.06477990001440048, -0.05378136783838272, -0.019295793026685715, -0.022859148681163788, 0.0460209883749485, 0.10961975157260895, 0.030987853184342384, -0.03128322213888168, 0.01688137650489807, 0.03751092776656151, 0.04659277945756912, -0.00918818823993206, -0.07897350192070007, 0.00926296692341566, 0.060628123581409454, -0.025580639019608498, 0.0031657519284635782, -0.007736009079962969, -0.08034166693687439, -0.02611641213297844, -0.05217341333627701, 0.05947194620966911, -0.027714302763342857, -0.05604341998696327, -0.10404518246650696, 0.04771554470062256, 0.07179994881153107, -0.022441953420639038, -0.010553487576544285, -0.006867322139441967, -0.035691674798727036, -0.04102461412549019, -0.07919478416442871, -0.04590482637286186, 0.05290963500738144, 0.007918727584183216, -0.04285205528140068, -0.05065437778830528, -0.0464961864054203, 0.021866904571652412, -0.08656605333089828, -0.020379502326250076, -0.013917684555053711, -0.0874968096613884, 0.10098081827163696, 0.04708876460790634, -0.07062408328056335, 0.007345975376665592, -0.04349638521671295, 0.009863285347819328, -0.07255396246910095, -0.10866864770650864, -0.1142716333270073, 0.0011862501269206405, 0.066829152405262, -5.439281736130397e-08, 0.048403769731521606, -0.03545696288347244, -0.0513773038983345, 0.04653771221637726, 0.004492438398301601, 0.0077817849814891815, 0.05768732354044914, 0.025447899475693703, 0.01182425394654274, 0.09283404797315598, -0.05948980152606964, 0.10073532164096832, 0.03203914314508438, 0.08573299646377563, 0.0424039252102375, 0.03270086646080017, 0.06728989630937576, 0.0356641560792923, -0.04566969722509384, -0.038946229964494705, -0.06382252275943756, -0.02096622623503208, 0.0329904779791832, -0.018945232033729553, -0.0763334333896637, 0.0159007478505373, 0.02066298946738243, 0.0165522750467062, 0.0014020605012774467, -0.04189985617995262, 0.018603408709168434, -0.02797713130712509, 0.030891621485352516, 0.05133042857050896, -0.004943410865962505, -0.04593829810619354, 0.11351139098405838, -0.01411297544836998, 0.014419352635741234, 0.0370999313890934, 0.004364794120192528, 0.03226027265191078, -0.019108356907963753, 0.04693743959069252, -0.07476943731307983, -0.03519537299871445, -0.03549689054489136, 0.01505203265696764, -0.042168475687503815, 0.031365618109703064, 0.052906524389982224, -0.02682672068476677, 0.05666433647274971, -0.024727392941713333, -0.05960283800959587, 0.08419713377952576, -0.029714515432715416, -0.061435047537088394, 0.001624344615265727, 0.014685070142149925, 0.09572826325893402, -0.0036779516376554966, 0.03267326578497887, 0.027853237465023994]');
INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1528, 'Boston Mayor Michelle Wu Should be Arrested for Her Unscientific and Unlawful Injection Mandates', 'https://drrobertyoung.com/boston-mayor-michelle-wu-should-be-arrested-for-her-unscientific-and-unlawful-injection-mandates/', 'The Boston Herald reports this week that city police and firefighters lost their lawsuit against the city (for vaccine mandates) — filed by “Boston Police Superior Officers Federation, which filed the suit along with the Boston Police Detectives Benevolent Society and Boston Firefighters Union Local 718”.\nImage: Boston Herald – https://www.bostonherald.com/2021/12/27/michelle-wu-defends-vaccine-mandate-for-boston-city-workers-as-pregnant-police-officers-push-back/\nMichelle Wu tells pregnant police officer concerned about loss of her baby she doesn’t respond to hypotheticals/Note the checkerboard Masonic-floor:\nMichelle Wu, a 36-year-old graduate of Harvard and the Harvard Law School, had no answer to that but regurgitated lawyer-speak and politician-speak about being united, not divisive and coming together during a “public health emergency…where all the scientific experts and doctors” are driving what she defends as “growing the vaccination rate” in Boston, which she admonishes everyone they should be proud to be living in, given its world leadership in the vaccines:\n“We made that vaccine right here which is going in the arms of everyone in the world”.\nImage: CBS/ https://boston.cbslocal.com/2020/02/25/moderna-potential-coronavirus-vaccine-testing-cambridge-massachusetts-news/\nModerna is headquartered in Cambridge and Pfizer has a considerable presence as well . DARPA seems to be squatting inside MIT, also in Cambridge: they funded, initiated, and helped bring the mRNA so-called vaccines into the world. A sad commentary, given the escalating numbers of deaths from both Moderna and Pfizer vaccines, as reported here quite often and here most recently.\nSuper Toxic Batches and Excessive Variability Found in Pfizer, Moderna, and Janssen Vaccines by Data Analysis of CDC VAERS | Find Out How Toxic Your Batch Is\nPosted currently at Bitchute and Screencast, being uploaded at snail speed, massive satellite cyberhacking and next-door neighbor cyberhacking, to Brighteon and Odysee.\nhttps://www.bitchute.com/video/1gYNpCZUtG5W/\nPregnant police officers specifically mentioned the great harm to babies and clear risk of losing pregnancies from an experimental vaccine, to Michelle Wu, mother of two, who declined to sign a statement accepting liability for loss of pregnancy after being invited to by 30-week-pregnant Gianna Mullane, a Boston police officer, covered in national news .\nImage: Boston Globe/ https://boston.cbslocal.com/2020/02/25/moderna-potential-coronavirus-vaccine-testing-cambridge-massachusetts-news/\nThey all seem to be missing the point. But then, this is exactly what is going to happen in the face of pervasive lies and a massively false construct which the City of Boston, the Boston Herald, the Boston Globe, and the entire conglomerate of police officers and firefighters represented by their unions and lawyers are upholding.\nThe latest version of this HUGE LIE is that “Omicron” which does not even exist is spreading like wildfire and newly studding Public Health with continued Emergency status!\nhttps://www.drrobertyoung.com/post/lies-more-lies-and-damn-lies-from-those-we-are-mandated-to-trust\nWhat is Omicron when the PCR tests CANNOT DETECT any proteinaceous, nucleic-acid matter and call it a theoretical virus?\nThat PCR’s inventor, Kary Mullis, said so himself is completely ignored by this contingent. That it has been proved definitively that “the virus hasn’t been isolated” as the Chinese CDC Director Dr. Wu Zunyou stated on NBC News and as the CDC, along with over 150 other organizations and Public Health departments, have themselves conceded, is also being ignored .\nThe entire so-called pandemic — which is most definitely not a pandemic but a contrived, simulated false-flag begun as a live drill for the WHO and International Health Agreements of 2005 under the arbitrary and planned constraints of the Global Pandemic Monitoring Board, an arbitrary arm of the WHO set up to push the false-flag through and offer construct for dozens of new pandemic-false-flags to come, 26 in fact, it appears, from the preparations of the American Pandemic Preparedness document issued by the White House in Sep 2021, covered here — has been built on a lie and scientific fraud and has led to the roll-out of deadly gene-therapy injections which are killing and injuring millions.\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nExplosive news that the COVID Vaccines have been biochemically designed to target specific organs , given that they are now causing specific adverse effects involving specific organs–such as the reproductive organs, heart, brain, blood, etc.\nDr. Young shares his experience over 40 years of formulating targeted nutraceuticals which use specific polynucleotides–genetic material, taken from animal tissue–to send herbal nutrition to specific organs; it is this same methodology, he says, using fetal organ cells and animal organ cell lines, undisclosed, kept hidden as trade secrets, which is being used in vaccines for a deleterious purpose, to harm and sterilize.\nVariability of toxicity across batches and selection of batches for targeted reasons–labelled , recorded, and structured by the vaccine-maker scientists conducting these horrific experiments–is the other end of this scenario.\nThis is why we are seeing a rise in myocarditis in boys taking the vaccine, and miscarriages and menstrual changes in women taking the vaccine.\nPregnant police officers are right to be outraged, all signs point to imminent and clear harm to their babies and themselves , thousands of miscarriages and still births the most immediate signal, as also the study showing 87-91% of first-trimester/20-week pregnancies were aborted by the vaccine. News Report 4 | High Signal of Harm from COVID Vaccines for Pregnant Women – CDC & Media Push a Cocktail of Poisons\nhttps://www.drrobertyoung.com/post/cdc-media-push-a-cocktail-of-poisons\nThe Boston Globe, the Boston Herald and the City Council of Boston however are neither covering nor following these signs, news, or data, rather suppressing, disappearing, censoring, and marginalizing this information so it can be found only at true-media sites like mine–which their readers and consumers are told are unreliable, misinformation, disinformation, and “hate” sites.\nhttps://www.drrobertyoung.com/post/science-team-reveals-graphene-aluminum-lnp-capsids-peg-parasites-in-4-cov-vaccines\nThat’s the inbuilt lie-built-on-lies to disappear the truth.\nThere is no pandemic, but millions are dying from vaccine-injury . The vaccines have been found to be super-toxic in some batches , irrefutable cause of death by scientific analysis from pathologists in all cases of dead-vaccinated studied, as reported by Dr. Sucharit Bhakdi and Dr. Arne Burkhardt , filled with nano graphene and other cytotoxic nanometallic particulates as well as parasitic organisms or nano carbon octopuses, as exposed by Dr. Pablo Campra, La Quinta Columna, Dr. Robert Young, Dr. Andreas Kelcker , Dr. Andreas Noack, Dr. John B, Dr. Erik Enby , and many others, and reported at this site continuously in various articles, collected here, and posted daily in newstream at my Telegram site–as also by numbers of other true-media sites, a partial listing of which I have included here: In a Sea of Lies: mRNA Vaccine Truth, COVID Truth–Resources to Inform Yourself\nAthletes in top physical form are dropping dead on the soccer field and other fields . Pilots are stroking out while flying or going into cardiac arrest. Television anchors, reporters, singers, chefs are literally dropping dead on camera–as nurse Tiffany Dover did, many months ago (see the video reporting her death here, in this article explaining why children should not be vaccinated ).\nAnd keep watching this–a compilation of sudden-death-in-public videos, entirely due to Government, Media, and Pharma lies:\nOne of the most disturbing bits of information I have helped report on lately is Dr. Robert Young’s incredible revelation from his assessment and knowledge that the vaccines have been formulated to target fertility and cardiac health:\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nBreaking News: Dr. Young Reveals the COVID Injections are Intelligent Targeting Bioweapons Using Specific Genetic Markers to Reach Specific Organs–Like Heart, Ovaries, Brain:\nLethal Vaccine Outcomes are Intentional\nSupporting his information is Professor Sir John Bell’s major bombshell video disclosure that 60-70% of sterility is being aimed at for the vaccines: this is a man on the UK Vaccine Council who like Hancock, Witty, Ferguson is behind the deliberately-deceiving policies and protocols rolled out by the UK Government.\nI have posted that snippet of video in a few articles, including Mass Sterilization (and Deaths) of Children and Youth with Toxin-Laden COVID-19 Experimental Vaccines is Underway; Doctors Plead for a Halt: Pregnant Women and Children Must NOT Get the Vaccine.\nDr. Ryan Cole, a pathologist has reported that cancer has gone up by 20 times in the vaccinated, as reported here:\nExplosive News–Irrefutable Scientific Evidence All COVID Vaccines are Causing Massive Death: Top Immunologist & Top Pathologist, Dr. Bhakdi & Dr. Burkhardt Reveal Killer Lymphocytes Have Caused Auto-Immune Death in All Dead-Vaccinated Studied & Call for IMMEDIATE VACCINE HALT Worldwide\nhttps://www.drrobertyoung.com/post/the-vaccine-death-report-millions-have-died-from-the-injections\nhttps://www.drrobertyoung.com/post/the-worlds-greatest-hoax\nThese are scenarios to be rejected, not upheld, sanctioned, permitted, encouraged, as I wrote on New Year’s Day. They spell the end of organic humanity, and the end of freedom of bodily autonomy and movement, expression, existence.\nBoston police and firefighters have the choice today: to break out of that absurd and false construct of “pandemic and public health emergency” and both save themselves, their unborn children, their living children, and all of ours–or succumb and permit DARPA’s hybridizing-human “vaccine” into their bloodstreams. Heading toward decline of health, death within 1-3 years, in the estimation of several scientists and doctors, death of unborn children they are carrying, neurodamage, sterility, cancer, and other grave harms.\nI don’t see how they can at the same time uphold the Public Lie ongoing–that Omicron is spreading and is deadly–and also believe they can win a fight for bodily autonomy against a clearly Establishment-installed, probably Soros-and-Rothschild-protected Harvard lawyer who is publicly expressing the DARPA, Blackrock, Vanguard British Empire and Bankers’ agenda.\nWhy uphold the lie when it is a lie?\nThe rock-solid scientific data shows the vaccines are unwarranted, unproven, experimental, toxic, and lethal–and are not really vaccines! “They are ‘Directed Targeting Bio-Weapons’ poisoning and destroying human lives.” Robert O. Young MSc, DSc, PhD, Naturopathic Practitioner\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nhttps://www.bitchute.com/video/jnpG3weGmOui/\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nAs I wrote in Super Toxic Batches and Excessive Variability Found in Pfizer, Moderna, and Janssen Vaccines by Data Analysis of CDC VAERS | Find Out How Toxic Your Batch Is :\nAcceptance of Liability for Post-Vaccine Death, Disability, Injury, Disease, Surviving Family Expenses Should Cover It\nGianna Mullane is right to demand an Acceptance of Liability from Michelle Wu, as indeed every other police officer and firefighter and city worker should. A clause to cover funeral expenses and provide monetarily for surviving family post-vaccine should be added in.\nSeveral sites online offer forms and templates for such statements that employers mandating vaccines should be asked to sign, along with providing advice on religious exemptions, including Peggy Hall’s The Healthy American .\nThousands of doctors and scientists in the USA and worldwide have called for an immediate halt to the vaccines. Attorneys and doctor groups have filed lawsuits against governments. Military attorney from the UK Anna De Buisseret advises each of us to know our rights and claim them .\nIn the UK and in Australia, retired police officers have handed in information to local police stations demanding the arrest of government officials–for criminally pushing vaccines and vaccine mandates when people and children are being killed and maimed by the toxic injections, and when they ignore such evidence of clear vaccine-inflicted deaths and injury.\nIS THIS AN AMERICAN SCANDAL OF HUMUNGOUS PROPORTIONS YET? OVER 20,000 AMERICAN DEATHS RECORDED IN CDC VAERS FOR 2020-2021, AS AGAINST LESS THAN 100 DEATHS PER YEAR FOR ALL OTHER VACCINES TO DATE SINCE 1990–THOSE VACCINES WERE STOPPED AFTER DEATHS, THE COVID VACCINES ARE BEING ADVERTISED BY CRIMINAL MEDIA AS “SAFE” AND STILL ONGOING!\nArrest Michelle Wu and the Boston City Council. Then head to where Governor Charlie Baker hangs and arrest him too. Media outlets next. Moderna and co. after. That would be a useful application of “Law Enforcement” for Boston Police: from all evidence, it is very clear to millions in Massachusetts and the world that great crimes are being committed by city, state, and federal governments. And Media. In addition of course to the vaccine makers and FDA/CDC pushers: prime movers of this pandemic-narrative and all associated vaccine-crimes, mask-crimes, nasal-swab-crimes.\nWe need a better world than this!\nBoston Police are very welcome to hire me to write a science-based report on the truth and facts of the dangers of these non-vaccines for the misled Mayor Wu, but are also advised to drop the ridiculous lies being pushed by MSM and: make use of the true-media journalism online, please, there’s plenty of it !\nThe antigen tests rolling out now are dangerous too: the constant testing for a major-lie and the constant use of nanotoxin-laden nasal swabs will also poison you, please see more here:\nWhen the kerosene coating on the Theragripper reaches body temperature, the devices close autonomously and clamp onto the wall of the colon. Because of the sealing action, the tiny, six-pointed devices burrow into the mucosa and attach to the colon, where they are held and gradually release their drug load graphene oxide poison into the body. Eventually, the Theragripper lose their grip on the tissue and are removed from the colon through normal gastrointestinal muscle function.\nHere we report that GI parasite-inspired active mechanochemical therapeutic grabs, or theragrippers, can survive 24 hours in the gastrointestinal tract of live animals by autonomously adhering to mucosal tissue. We also observe a remarkable six-fold increase in elimination half-life when using ripper-mediated delivery of the model analgesic ketorolac tromethamine. These results provide excellent evidence that shape-shifting and self-locking microdevices improve the effectiveness of long-term drug delivery.\nMillions in COVID-19 Test Contracts & Pandemic Plans Signal Escalating Build-Up of Testing, Vaccine, Pandemic Industry in Treasonous DARPA/WEF Hybridizing Humans Agenda: Reject The Tests & Vaccines Both !\nMorgan Wallace at New Hanover County Board of Education Regular Meeting, January 4, 2022\nhttps://cdn.lbryplayer.xyz/api/v4/streams/free/Dr-Morgan-Wallace-SchoolBd/5fa92d54d532ca28dc63bc97c006c322863163eb/d07a8f\nPREVIOUS PODCASTS WITH DR. YOUNG WHERE HE EXPLAINS MORE ON THESE SUBJECTS: Report 255 | Dr. Robert Young: All Disease is Outfection Not Infection–Vaccine Nano is Bioweapon! https://www.bitchute.com/video/rdQhuY455VmK/\nNewsbreak 135–BREAKING: Immense Harm from Crystallizing Blood Cells/Graphene Poisoning Post-Vaccine https://www.bitchute.com/video/PRBfJ6U9EZvM/\nNewsbreak 133: Team of Scientists Confirm Presence of Toxins https://everydayconcerned.net/2021/08/28/newsbreak-133-team-of-scientists-confirm-presence-of-toxins-graphene-aluminium-cadmium-selenide-stainless-steel-lnp-go-capsids-parasites-other-toxins-variously-in-4-covid-vaccines-pfizer-mode/ https://www.bitchute.com/video/Z2sAH0Woz38r/\nDETOX NANOTECH and CLEANSE YOUR PINEAL GLAND\nTry Clean Slate, Zero-In, and Restore for detox and daily health at this link (which supports this channel): https://therootbrands.com/micmar\nFREE YOURSELF FROM THE MATRIX OF MORTGAGES, DEBT, AND RIGGED COURTS: Sign in to the Matrix Freedom platform for more information: https://matrixfreedom.life/know-the-biggest-secret/?code=15059&ag=Ramola%20D\nCONTACT WITH REFERRALS FOR INTERVIEWS, INFO: ramolad@everydayconcerned.net\nYou can read more of Rusere’s work at: https://plagueonbothhouses.com', '[-0.04167892783880234, 0.07912243157625198, 0.012176917865872383, 0.05008178576827049, 0.06892799586057663, 0.08358395844697952, -0.017384646460413933, 0.009675329551100731, -0.07876002788543701, 0.0968942865729332, 0.05009631812572479, -0.027842849493026733, -0.03154508396983147, -0.0022311885841190815, -0.03728127479553223, 0.0719698816537857, 0.06498505175113678, -0.04805002734065056, -0.07624614238739014, 0.09632574766874313, -0.07789760082960129, 0.013826864771544933, 0.04974979907274246, 0.0912841260433197, 0.005362160969525576, 0.023516904562711716, -0.0511506050825119, -0.0008906606235541403, -0.046703506261110306, 0.03999181464314461, -0.02628469653427601, -0.07649001479148865, -0.010297751054167747, 0.06541531533002853, 0.004584360867738724, -0.05416000634431839, 0.11179084330797195, 0.03115985356271267, 0.049351517111063004, 0.10031294822692871, 0.03876819834113121, -0.07091625034809113, -0.05749273672699928, 0.0781368836760521, -0.04020032286643982, 0.07219260185956955, 0.00010246897727483884, 0.021303463727235794, -0.012916005216538906, -0.040049824863672256, -0.0728030800819397, -0.07283079624176025, 0.0026920903474092484, 0.003003577934578061, -0.019071761518716812, -0.0996784120798111, -0.023096654564142227, 0.05861019715666771, -0.008778120391070843, -0.016148196533322334, -0.0679662674665451, -0.03313983976840973, -0.028562478721141815, 0.044682152569293976, 0.08230534940958023, -0.01190437562763691, -0.03674852102994919, -0.010184871964156628, 0.0378572903573513, -0.030323700979351997, 0.0661390870809555, 0.07139904052019119, 0.09618065506219864, 0.10577335208654404, 0.04691952466964722, 0.07768013328313828, 0.061723742634058, 0.08370277285575867, 0.11136274039745331, -0.06965426355600357, 0.08090679347515106, -0.061374910175800323, -0.05031956359744072, 0.09452684968709946, -0.011554472148418427, -0.04968142509460449, -0.06000267341732979, -0.04152084141969681, 0.023998862132430077, -0.03594370558857918, -0.05054732412099838, -0.03140575811266899, 0.04447814077138901, 0.0019665067084133625, -0.011964499950408936, 0.00836135819554329, -0.0712725967168808, 0.002253575250506401, -0.04486515000462532, 0.003951039630919695, -0.08852563798427582, 0.005712912883609533, -0.020247643813490868, -0.09189057350158691, 0.024079279974102974, -0.07071799039840698, -0.0658649206161499, -0.07569007575511932, -0.011954797431826591, 0.053398121148347855, 0.04913754016160965, 0.005993761587888002, -0.04355946183204651, 0.017492609098553658, 0.07911276072263718, 0.033203646540641785, -0.027841078117489815, 0.002176792360842228, -0.02746850624680519, -0.11847717314958572, -0.01150867622345686, -0.034334976226091385, -0.10937239974737167, -0.016830917447805405, 0.044162653386592865, -0.0702885314822197, 0.045787911862134933, 1.310349174965032e-33, 0.059230998158454895, 0.01538118813186884, 0.042202457785606384, 0.04969070851802826, 0.03846702724695206, 0.028930068016052246, 0.003408358432352543, -0.030285341665148735, 0.035251960158348083, -0.009378939867019653, -0.07120659947395325, -0.002560240915045142, 0.027936533093452454, -0.05442830175161362, -0.02430172823369503, 0.07679452002048492, -0.05572369694709778, -0.025764890015125275, -0.08550941199064255, 0.07279935479164124, 0.07747694104909897, 0.029811542481184006, -0.07437510788440704, 0.0027637332677841187, -0.07659605890512466, 0.0008986887405626476, 0.05659693107008934, 0.028285520151257515, -0.004484032746404409, 0.0023006871342658997, -0.08037029951810837, 0.09892619401216507, 0.04548226296901703, -0.02379891276359558, 0.06752742826938629, 0.005127458833158016, 0.026313981041312218, 0.019967790693044662, 0.004443486221134663, 0.0033723872620612383, -0.08314408361911774, 0.0008875097846612334, 0.03563530370593071, 0.00962105393409729, 0.01152532547712326, -0.05131007358431816, -0.06160605326294899, -0.11795493960380554, 0.005686032585799694, -0.06113898381590843, 0.09198874980211258, -0.03337034583091736, 0.04478461667895317, -0.01218391489237547, 0.05190208926796913, 0.006707238499075174, -0.060557104647159576, 0.058705076575279236, 0.03284071013331413, -0.01658768579363823, 0.03776825964450836, 0.01215504389256239, -0.03437560424208641, 0.028228921815752983, -0.05235494300723076, -0.03993690013885498, -0.011805946007370949, -0.017701013013720512, 0.03875701129436493, 0.028060710057616234, 0.03002297505736351, 0.06484682112932205, -0.06356694549322128, -0.03007105551660061, -0.11051107197999954, -0.015698103234171867, 0.07465512305498123, -0.01366680022329092, 0.017009487375617027, -0.006036384031176567, 0.0201152041554451, -0.033565860241651535, 0.012536140158772469, 0.062289733439683914, 0.05501798912882805, -0.08260010927915573, 0.013272932730615139, 0.0033236644230782986, -0.04704635590314865, -0.006721164099872112, -0.0364021435379982, -0.01230479497462511, 0.06851097196340561, 0.011093739420175552, -0.025051794946193695, -3.971079627860822e-33, -8.08452932687942e-06, -0.05925748869776726, -0.029726319015026093, 0.02043822407722473, -0.043799880892038345, -0.059763818979263306, 0.013534175232052803, -0.04077480360865593, 0.058707691729068756, -0.02561851404607296, 0.0006010031211189926, -0.10799306631088257, 0.05093860998749733, 0.06377112865447998, -0.02349266968667507, -0.006641809828579426, -0.0018026229226961732, -0.01447071973234415, -0.05651920288801193, -0.03685205429792404, 0.06017089635133743, 0.028216281905770302, -0.01960005797445774, 0.05542028695344925, 0.008054669015109539, 0.005481134168803692, 0.044516030699014664, 0.04890430346131325, 0.04818151891231537, -0.059885669499635696, -0.05433252826333046, 0.052069224417209625, -0.03758439049124718, 0.005392257124185562, -0.030823322013020515, 0.03374367207288742, 0.04661043733358383, -0.02046186290681362, 0.02093208208680153, -0.0866818055510521, 0.004864711780101061, -0.07458935678005219, -0.07238226383924484, 0.026428893208503723, 0.05132035166025162, 0.026237208396196365, 0.07820228487253189, 0.012340999208390713, -0.014589468017220497, 0.05177189037203789, -0.0022513819858431816, -0.0620209202170372, -0.11164160817861557, 0.0819772481918335, -0.06931935995817184, -0.011962879449129105, -0.020341625437140465, -0.06220782920718193, 0.0006501710740849376, -0.01851419173181057, 0.06161842867732048, 0.010933161713182926, -0.11257513612508774, -0.012571759521961212, -0.09127897024154663, 0.021235493943095207, 0.09026753157377243, -0.011984643526375294, 0.09576689451932907, 0.01671759970486164, 0.05430014431476593, 0.015900081023573875, -0.039870426058769226, -0.051648370921611786, 0.004372869152575731, -0.0003835843235719949, 0.002824085997417569, 0.07872085273265839, -0.051038794219493866, 0.1461317241191864, 0.03552664443850517, -0.049430057406425476, -0.006273523438721895, 0.030443962663412094, 0.09213627874851227, 0.03348258510231972, 0.026494387537240982, -0.02372097596526146, -0.04332762956619263, 0.05821556970477104, -0.08665422350168228, -0.04474220052361488, -0.0017953964415937662, -0.014755064621567726, -0.08545659482479095, -5.6753737709414054e-08, 0.12064409255981445, 0.05879705771803856, -0.04120098054409027, 0.013401609845459461, 0.0076889656484127045, -0.03934408351778984, -0.07983410358428955, -0.05678011104464531, -0.027544593438506126, 0.012628044001758099, 0.05713088437914848, 0.09181729704141617, -0.04673874378204346, 0.0016076398314908147, -0.009262213483452797, -0.03060079924762249, 0.01291585061699152, -0.015597647055983543, -0.040123626589775085, 0.025893496349453926, -0.024474749341607094, -0.0058183250948786736, -0.03733077272772789, 0.029999280348420143, 0.00048650710959918797, 0.051705438643693924, -0.08385833352804184, -0.03384499251842499, -0.06141427531838417, 0.019965149462223053, -0.04364938661456108, -0.01979754865169525, -0.043469563126564026, -0.031792718917131424, -0.04402514919638634, -0.08413945883512497, 0.07849811017513275, 0.03608080744743347, 0.01510110218077898, -0.08085831999778748, 0.03579327091574669, 0.012345205061137676, 0.020385701209306717, 0.02454996481537819, 0.006664462387561798, -0.09436409920454025, -0.0034534416627138853, 0.0253598652780056, 0.041868194937705994, 0.007467154413461685, -0.013896893709897995, -0.09334983676671982, -0.01777399517595768, -0.024312445893883705, -0.007958170026540756, 0.023137254640460014, 0.011428209021687508, -0.06069069728255272, -0.05447446182370186, -0.009941397234797478, 0.054925136268138885, -0.04307565838098526, 0.03972756117582321, 0.04561978578567505]');
INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1529, 'COVID-19 So-Called Vaccines: Scientific Proof of Lethality!', 'https://drrobertyoung.com/covid-19-so-called-vaccines-scientific-proof-of-lethality/', 'Post published: 5 January 2022 at https://www.saveusnow.org.uk/covid-vaccine-scientific-proof-lethal\nOver One Thousand Scientific Studies Prove That the COVID-19 So-Called Vaccines Are Dangerous, and All Those Pushing This Agenda Are Committing the Indictable Crime of Gross Misconduct in Public Office!\nhttps://www.drrobertyoung.com/post/lies-more-lies-and-damn-lies-from-those-we-are-mandated-to-trust\nJust over 12 months from deployment of the COVID 19 emergency use experimental vaccines, scientific studies in the thousands, and reports of criminal complaints of assault and murder from the illegal, unlawful use of biochemical poisons made to police forces around the country, verify an assault on an unsuspecting Worlod population.\nIrrefutable science shows that the COVID 19 vaccine is not safe and not effective in limiting transmission or infection from the so-called phantom SARS-CoV-2, coronavirus pathogens that have NEVER been isolate or even proven to exist by anyone, anywhere in the world!\nhttps://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines\nThe “safe and effective” false propaganda, put out by public officials who now are continuing to push this vaccine, is a clear breach of duty. A public office holder is subject to, and aware of, a duty to prevent death or serious injury that arises only by virtue of the functions of the public office.\nMany have breached that duty and, in doing so, are recklessly causing a risk of death or serious injury, by carrying on regardless of the now-confirmed dangers associated with COVID 19 injections. Some of these risks are blood clotting, myocarditis, pericarditis, thrombosis, thrombocytopenia, anaphylaxis, Bell’s palsy, Guillain-Barre, cancer including death, etc.\nAll of these are confirmed in the following science-and-government-gathered data from the UK Health and Security agency on COVID 19 regarding vaccine damage.\nThe term “vaccine” was changed recently to incorporate this illegal, unlawful medical experiment to facilitate usage of mRNA technology that is demonstrably not a vaccine, and which contains biologically toxic nano-metamaterials associated with 5G urban data gathering capability.\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nMetal nanoparticulates are known in science to be genotoxic—a poison that can also cause sterilization. The dangers posed to the victims in the near term from this medical battery are now known. However, the long term lethality of this weapon is not as yet realized due to the debilitating effects it has on the immune system, causing Acquired Immunodeficiency Syndrome(AIDS).\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nhttps://www.bitchute.com/on/jnpG3weGmOui/\nWe can now confirm the 2017 depopulation defence-intelligence documents, showing the planned murder of hundreds of millions of men, women and children across Canda, USA, United Kingdom, Europe, Eastern Europe, India, Central America, South America, Africa, Australia, China and Russia by 2025 using a directed targeting biochemical weapon in combination with 4G, 5G, and 6G directed targeting radiation poisoning weapon .\nhttps://www.drrobertyoung.com/post/coronavirus-means-radiation-poisoning\nThe Medicines and Healthcare (products) Regulatory Agency (MHRA) had prior warning of the expected large numbers of adverse reactions before the deployment—confirming the premeditated nature of the crime and public conduct offences then and now.\nCerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/\nCerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/\nVaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1052305721003414\nVaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1052305721003414\nFatal cerebral hemorrhage after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33928772/\nFatal cerebral hemorrhage after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33928772/\nMyocarditis after mRNA vaccination against SARS-CoV-2, a case series: https://www.sciencedirect.com/science/article/pii/S2666602221000409\nMyocarditis after mRNA vaccination against SARS-CoV-2, a case series: https://www.sciencedirect.com/science/article/pii/S2666602221000409\nThree cases of acute venous thromboembolism in women after vaccination against COVID-19: https://www.sciencedirect.com/science/article/pii/S2213333X21003929\nThree cases of acute venous thromboembolism in women after vaccination against COVID-19: https://www.sciencedirect.com/science/article/pii/S2213333X21003929\nAcute thrombosis of the coronary tree after vaccination against COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988\nAcute thrombosis of the coronary tree after vaccination against COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988\nUS case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020: https://pubmed.ncbi.nlm.nih.gov/33929487/\nUS case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020: https://pubmed.ncbi.nlm.nih.gov/33929487/\nPortal vein thrombosis associated with ChAdOx1 nCov-19 vaccine: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/\nPortal vein thrombosis associated with ChAdOx1 nCov-19 vaccine: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/\nManagement of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET): https://pubmed.ncbi.nlm.nih.gov/33871350/\nManagement of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET): https://pubmed.ncbi.nlm.nih.gov/33871350/\nVaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review: https://www.sciencedirect.com/science/article/pii/S0022510X21003014\nVaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review: https://www.sciencedirect.com/science/article/pii/S0022510X21003014\nThrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381\nThrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381\nCovid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma: https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505\nCovid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma: https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505\nThrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904\nThrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904\nCOVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis: https://www.sciencedirect.com/science/article/pii/S1665268121000557\nCOVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis: https://www.sciencedirect.com/science/article/pii/S1665268121000557\nThe roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): https://www.sciencedirect.com/science/article/pii/S1050173821000967\nThe roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): https://www.sciencedirect.com/science/article/pii/S1050173821000967\nRoots of autoimmunity of thrombotic events after COVID-19 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160\nRoots of autoimmunity of thrombotic events after COVID-19 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160\nCerebral venous sinus thrombosis after vaccination: the United Kingdom experience: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext\nCerebral venous sinus thrombosis after vaccination: the United Kingdom experience: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext\nThrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: https://www.nejm.org/doi/full/10.1056/nejme2106315\nThrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: https://www.nejm.org/doi/full/10.1056/nejme2106315\nMyocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601\nMyocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601\nAssociation of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\nAssociation of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\nPost-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19): https://haematologica.org/article/view/haematol.2021.279075\nPost-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19): https://haematologica.org/article/view/haematol.2021.279075\nThrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://www.sciencedirect.com/science/article/pii/S0264410X21005247\nThrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://www.sciencedirect.com/science/article/pii/S0264410X21005247\nAcute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination: https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478\nAcute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination: https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478\nAphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005\nAphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005\nComparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895\nComparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895\nHypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315\nHypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315\nBlood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data: https://www.sciencedirect.com/science/article/pii/S0896841121000937\nBlood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data: https://www.sciencedirect.com/science/article/pii/S0896841121000937\nCerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine: https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098\nCerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine: https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098\nPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://www.sciencedirect.com/science/article/pii/S0953620521002363\nPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://www.sciencedirect.com/science/article/pii/S0953620521002363\nMyocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers: https://www.sciencedirect.com/science/article/pii/S0828282X21006243\nMyocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers: https://www.sciencedirect.com/science/article/pii/S0828282X21006243\n“Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”: https://www.sciencedirect.com/science/article/pii/S2666572721000389\n“Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”: https://www.sciencedirect.com/science/article/pii/S2666572721000389\nEarly results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S0196064421003425\nEarly results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S0196064421003425\nMyocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1443950621011562\nMyocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1443950621011562\nMechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706\nMechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706\nProthrombotic immune thrombocytopenia after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0006497121009411\nProthrombotic immune thrombocytopenia after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0006497121009411\nVaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story: https://www.sciencedirect.com/science/article/pii/S2589936821000256\nVaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story: https://www.sciencedirect.com/science/article/pii/S2589936821000256\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation: https://www.sciencedirect.com/science/article/pii/S1871402121002046\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation: https://www.sciencedirect.com/science/article/pii/S1871402121002046\nThrombosis after COVID-19 vaccination: possible link to ACE pathways: https://www.sciencedirect.com/science/article/pii/S0049384821004369\nThrombosis after COVID-19 vaccination: possible link to ACE pathways: https://www.sciencedirect.com/science/article/pii/S0049384821004369\nCerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://www.sciencedirect.com/science/article/pii/S0735109721051949\nCerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://www.sciencedirect.com/science/article/pii/S0735109721051949\nA rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0735675721005714\nA rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0735675721005714\nCerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X\nCerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X\nImmune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19): https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.\nImmune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19): https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.\nAntiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ\nAntiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ\nVaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?: https://www.sciencedirect.com/science/article/pii/S0953620521002314\nVaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?: https://www.sciencedirect.com/science/article/pii/S0953620521002314\nThrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”: https://pubmed.ncbi.nlm.nih.gov/33918932/\nThrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”: https://pubmed.ncbi.nlm.nih.gov/33918932/\nThrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33606296/\nThrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33606296/\nSevere and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33854395/\nSevere and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33854395/\nPurpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/\nPurpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/\nCOVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase: https://pubmed.ncbi.nlm.nih.gov/33863748/\nCOVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase: https://pubmed.ncbi.nlm.nih.gov/33863748/\nCerebral venous thrombosis associated with the covid-19 vaccine in Germany: https://onlinelibrary.wiley.com/doi/10.1002/ana.26172\nCerebral venous thrombosis associated with the covid-19 vaccine in Germany: https://onlinelibrary.wiley.com/doi/10.1002/ana.26172\nCerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event: https://pubmed.ncbi.nlm.nih.gov/34133027/\nCerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event: https://pubmed.ncbi.nlm.nih.gov/34133027/\nThe importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34001390/\nThe importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34001390/\nThrombosis with thrombocytopenia after messenger RNA vaccine -1273: https://pubmed.ncbi.nlm.nih.gov/34181446/\nThrombosis with thrombocytopenia after messenger RNA vaccine -1273: https://pubmed.ncbi.nlm.nih.gov/34181446/\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://www.nature.com/articles/s41591-021-01408-4\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://www.nature.com/articles/s41591-021-01408-4\nExacerbation of immune thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34075578/\nExacerbation of immune thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34075578/\nFirst report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105244/\nFirst report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105244/\nPF4 immunoassays in vaccine-induced thrombotic thrombocytopenia: https://www.nejm.org/doi/full/10.1056/NEJMc2106383\nPF4 immunoassays in vaccine-induced thrombotic thrombocytopenia: https://www.nejm.org/doi/full/10.1056/NEJMc2106383\nAntibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia: https://www.nature.com/articles/s41586-021-03744-4\nAntibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia: https://www.nature.com/articles/s41586-021-03744-4\nMyocarditis with COVID-19 mRNA vaccines: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135\nMyocarditis with COVID-19 mRNA vaccines: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135\nMyocarditis and pericarditis after COVID-19 vaccination: https://jamanetwork.com/journals/jama/fullarticle/2782900\nMyocarditis and pericarditis after COVID-19 vaccination: https://jamanetwork.com/journals/jama/fullarticle/2782900\nMyocarditis temporally associated with COVID-19 vaccination: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.\nMyocarditis temporally associated with COVID-19 vaccination: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.\nCOVID-19 Vaccination Associated with Myocarditis in Adolescents: https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf\nCOVID-19 Vaccination Associated with Myocarditis in Adolescents: https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://pubmed.ncbi.nlm.nih.gov/33994339/\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://pubmed.ncbi.nlm.nih.gov/33994339/\nTemporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature: https://www.sciencedirect.com/science/article/pii/S1553838921005789\nTemporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature: https://www.sciencedirect.com/science/article/pii/S1553838921005789\nCOVID-19 vaccine-induced myocarditis: a case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121002253\nCOVID-19 vaccine-induced myocarditis: a case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121002253\nPotential association between COVID-19 vaccine and myocarditis: clinical and CMR findings: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X\nPotential association between COVID-19 vaccine and myocarditis: clinical and CMR findings: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X\nRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.sciencedirect.com/science/article/pii/S002234762100617X\nRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.sciencedirect.com/science/article/pii/S002234762100617X\nFulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://www.sciencedirect.com/science/article/pii/S0167527321012286.\nFulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://www.sciencedirect.com/science/article/pii/S0167527321012286.\nAcute myocarditis after administration of BNT162b2 vaccine: https://www.sciencedirect.com/science/article/pii/S2214250921001530\nAcute myocarditis after administration of BNT162b2 vaccine: https://www.sciencedirect.com/science/article/pii/S2214250921001530\nLymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector: https://www.sciencedirect.com/science/article/pii/S2352906721001573\nLymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector: https://www.sciencedirect.com/science/article/pii/S2352906721001573\nMyocarditis following vaccination with BNT162b2 in a healthy male: https://www.sciencedirect.com/science/article/pii/S0735675721005362\nMyocarditis following vaccination with BNT162b2 in a healthy male: https://www.sciencedirect.com/science/article/pii/S0735675721005362\nAcute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/pii/S1930043321005549\nAcute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/pii/S1930043321005549\nMyopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents: https://www.sciencedirect.com/science/article/pii/S002234762100665X\nMyopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents: https://www.sciencedirect.com/science/article/pii/S002234762100665X\nPericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine: https://www.sciencedirect.com/science/article/pii/S1885585721002218\nPericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine: https://www.sciencedirect.com/science/article/pii/S1885585721002218\nAcute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA: https://www.sciencedirect.com/science/article/pii/S2589790X21001931\nAcute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA: https://www.sciencedirect.com/science/article/pii/S2589790X21001931\nTemporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection: https://www.sciencedirect.com/science/article/pii/S2352906721000622\nTemporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection: https://www.sciencedirect.com/science/article/pii/S2352906721000622\nMyopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age: https://www.sciencedirect.com/science/article/pii/S0022347621007368\nMyopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age: https://www.sciencedirect.com/science/article/pii/S0022347621007368\nAcute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: https://www.sciencedirect.com/science/article/pii/S0870255121003243\nAcute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: https://www.sciencedirect.com/science/article/pii/S0870255121003243\nImportant information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: https://www.sciencedirect.com/science/article/pii/S0022347621007496\nImportant information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: https://www.sciencedirect.com/science/article/pii/S0022347621007496\nA series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://www.sciencedirect.com/science/article/pii/S1936878X21004861\nA series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://www.sciencedirect.com/science/article/pii/S1936878X21004861\nTakotsubo cardiomyopathy after vaccination with mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S1443950621011331\nTakotsubo cardiomyopathy after vaccination with mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S1443950621011331\nCOVID-19 mRNA vaccination and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34268277/\nCOVID-19 mRNA vaccination and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34268277/\nCOVID-19 vaccine and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34399967/\nCOVID-19 vaccine and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34399967/\nCOVID-19 vaccines and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34246566/\nCOVID-19 vaccines and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34246566/\nMyocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines\nMyocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines\nMyocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34340927/\nMyocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34340927/\nMyocarditis with covid-19 mRNA vaccines: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135\nMyocarditis with covid-19 mRNA vaccines: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135\nAssociation of myocarditis with COVID-19 mRNA vaccine in children: https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/\nAssociation of myocarditis with COVID-19 mRNA vaccine in children: https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/\nAssociation of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\nAssociation of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\nMyocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C\nMyocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C\nMyocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600\nMyocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600\nMyocarditis following immunization with Covid-19 mRNA: https://www.nejm.org/doi/full/10.1056/NEJMc2109975\nMyocarditis following immunization with Covid-19 mRNA: https://www.nejm.org/doi/full/10.1056/NEJMc2109975\nPatients with acute myocarditis after vaccination withCOVID-19 mRNA: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602\nPatients with acute myocarditis after vaccination withCOVID-19 mRNA: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602\nMyocarditis associated with vaccination with COVID-19 mRNA: https://pubs.rsna.org/doi/10.1148/radiol.2021211430\nMyocarditis associated with vaccination with COVID-19 mRNA: https://pubs.rsna.org/doi/10.1148/radiol.2021211430\nSymptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination: https://pediatrics.aappublications.org/content/148/3/e2021052478\nSymptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination: https://pediatrics.aappublications.org/content/148/3/e2021052478\nCardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4\nCardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4\nClinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA: https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis\nClinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA: https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis\nCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\nCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\nCase report: acute myocarditis after second dose of mRNA-1273 SARS-CoV-2 mRNA vaccine: https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567\nCase report: acute myocarditis after second dose of mRNA-1273 SARS-CoV-2 mRNA vaccine: https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567\nMyocarditis / pericarditis associated with COVID-19 vaccine: https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html\nMyocarditis / pericarditis associated with COVID-19 vaccine: https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html\nTransient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx\nTransient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543\nThe new COVID-19 mRNA vaccine platform and myocarditis: clues to the possible underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34312010/\nThe new COVID-19 mRNA vaccine platform and myocarditis: clues to the possible underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34312010/\nAcute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the Vaccine Adverse Event Reporting System database: https://pubmed.ncbi.nlm.nih.gov/34219532/\nAcute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the Vaccine Adverse Event Reporting System database: https://pubmed.ncbi.nlm.nih.gov/34219532/\nBe alert to the risk of adverse cardiovascular events after COVID-19 vaccination: https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033\nBe alert to the risk of adverse cardiovascular events after COVID-19 vaccination: https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033\nMyocarditis associated with COVID-19 vaccination: echocardiographic, cardiac tomography, and magnetic resonance imaging findings: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236\nMyocarditis associated with COVID-19 vaccination: echocardiographic, cardiac tomography, and magnetic resonance imaging findings: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236\nIn-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038\nIn-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038\nOccurrence of acute infarct-like myocarditis after COVID-19 vaccination: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?: https://pubmed.ncbi.nlm.nih.gov/34333695/\nOccurrence of acute infarct-like myocarditis after COVID-19 vaccination: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?: https://pubmed.ncbi.nlm.nih.gov/34333695/\nRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/\nRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/\nMyocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?: https://pubmed.ncbi.nlm.nih.gov/34118375/\nMyocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?: https://pubmed.ncbi.nlm.nih.gov/34118375/\nSelf-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\nSelf-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\nMyopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: https://pubmed.ncbi.nlm.nih.gov/34133825/\nMyopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: https://pubmed.ncbi.nlm.nih.gov/34133825/\nBiopsy-proven lymphocytic myocarditis after first COVID-19 mRNA vaccination in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\nBiopsy-proven lymphocytic myocarditis after first COVID-19 mRNA vaccination in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\nInsights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059\nInsights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059\nUnusual presentation of acute perimyocarditis after modern SARS-COV-2 mRNA-1237 vaccination: https://pubmed.ncbi.nlm.nih.gov/34447639/\nUnusual presentation of acute perimyocarditis after modern SARS-COV-2 mRNA-1237 vaccination: https://pubmed.ncbi.nlm.nih.gov/34447639/\nPerimyocarditis after the first dose of mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 vaccine in a young healthy male: case report: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183\nPerimyocarditis after the first dose of mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 vaccine in a young healthy male: case report: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183\nAcute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or causal relationship: https://pubmed.ncbi.nlm.nih.gov/34236331/\nAcute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or causal relationship: https://pubmed.ncbi.nlm.nih.gov/34236331/\nRhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34435250/\nRhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34435250/\nCOVID-19 vaccine-induced rhabdomyolysis: case report with literature review: https://pubmed.ncbi.nlm.nih.gov/34186348/.\nCOVID-19 vaccine-induced rhabdomyolysis: case report with literature review: https://pubmed.ncbi.nlm.nih.gov/34186348/.\nGuillain-Barré syndrome after AstraZeneca COVID-19 vaccination: causal or casual association: https://www.sciencedirect.com/science/article/pii/S0303846721004169\nGuillain-Barré syndrome after AstraZeneca COVID-19 vaccination: causal or casual association: https://www.sciencedirect.com/science/article/pii/S0303846721004169\nSensory Guillain-Barré syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://www.sciencedirect.com/science/article/pii/S0165572821002186\nSensory Guillain-Barré syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://www.sciencedirect.com/science/article/pii/S0165572821002186\nGuillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://www.sciencedirect.com/science/article/pii/S2214250921000998.\nGuillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://www.sciencedirect.com/science/article/pii/S2214250921000998.\nGuillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19: a case report: https://www.sciencedirect.com/science/article/pii/S0736467921006442\nGuillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19: a case report: https://www.sciencedirect.com/science/article/pii/S0736467921006442\nGuillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://www.sciencedirect.com/science/article/pii/S0035378721005853.\nGuillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://www.sciencedirect.com/science/article/pii/S0035378721005853.\nSARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination: https://www.sciencedirect.com/science/article/pii/S2049080121005343\nSARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination: https://www.sciencedirect.com/science/article/pii/S2049080121005343\nAcute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report: https://www.sciencedirect.com/science/article/pii/S2049080121007536\nAcute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report: https://www.sciencedirect.com/science/article/pii/S2049080121007536\nFacial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database: https://www.sciencedirect.com/science/article/pii/S1201971221007049\nFacial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database: https://www.sciencedirect.com/science/article/pii/S1201971221007049\nNew-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0165572821001569\nNew-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0165572821001569\nAcute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association: https://www.sciencedirect.com/science/article/pii/S0165572821002137\nAcute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association: https://www.sciencedirect.com/science/article/pii/S0165572821002137\nBell’s palsy and SARS-CoV-2 vaccines: an unfolding story: https://www.sciencedirect.com/science/article/pii/S1473309921002735\nBell’s palsy and SARS-CoV-2 vaccines: an unfolding story: https://www.sciencedirect.com/science/article/pii/S1473309921002735\nBell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy: https://www.sciencedirect.com/science/article/pii/S266635462100020X\nBell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy: https://www.sciencedirect.com/science/article/pii/S266635462100020X\nAcute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine:. https://www.sciencedirect.com/science/article/pii/S2451993621001456.\nAcute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine:. https://www.sciencedirect.com/science/article/pii/S2451993621001456.\nBell’s palsy after COVID-19 vaccination: case report: https://www.sciencedirect.com/science/article/pii/S217358082100122X.\nBell’s palsy after COVID-19 vaccination: case report: https://www.sciencedirect.com/science/article/pii/S217358082100122X.\nAn academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history: https://www.sciencedirect.com/science/article/pii/S2213219821007972\nAn academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history: https://www.sciencedirect.com/science/article/pii/S2213219821007972\nCOVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET: https://www.sciencedirect.com/science/article/pii/S1930043321002612\nCOVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET: https://www.sciencedirect.com/science/article/pii/S1930043321002612\nANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine: https://www.sciencedirect.com/science/article/pii/S0272638621007423\nANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine: https://www.sciencedirect.com/science/article/pii/S0272638621007423\nLate cutaneous reactions after administration of COVID-19 mRNA vaccines: https://www.sciencedirect.com/science/article/pii/S2213219821007996\nLate cutaneous reactions after administration of COVID-19 mRNA vaccines: https://www.sciencedirect.com/science/article/pii/S2213219821007996\nCOVID-19 vaccine-induced rhabdomyolysis: case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121001880\nCOVID-19 vaccine-induced rhabdomyolysis: case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121001880\nClinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://www.sciencedirect.com/science/article/pii/S0190962221024427\nClinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://www.sciencedirect.com/science/article/pii/S0190962221024427\nThrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381.\nThrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381.\nCOVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization:. https://www.sciencedirect.com/science/article/pii/S1939455121000119.\nCOVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization:. https://www.sciencedirect.com/science/article/pii/S1939455121000119.\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-based anticoagulation:. https://www.sciencedirect.com/science/article/pii/S1871402121002046.\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-based anticoagulation:. https://www.sciencedirect.com/science/article/pii/S1871402121002046.\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19:. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19:. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data:. https://www.sciencedirect.com/science/article/pii/S0896841121000937.\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data:. https://www.sciencedirect.com/science/article/pii/S0896841121000937.\nimmune thrombocytopenia associated with Pfizer-BioNTech’s COVID-19 BNT162b2 mRNA vaccine:. https://www.sciencedirect.com/science/article/pii/S2214250921002018.\nimmune thrombocytopenia associated with Pfizer-BioNTech’s COVID-19 BNT162b2 mRNA vaccine:. https://www.sciencedirect.com/science/article/pii/S2214250921002018.\nBullous drug eruption after the second dose of COVID-19 mRNA-1273 (Moderna) vaccine: Case report: https://www.sciencedirect.com/science/article/pii/S1876034121001878.\nBullous drug eruption after the second dose of COVID-19 mRNA-1273 (Moderna) vaccine: Case report: https://www.sciencedirect.com/science/article/pii/S1876034121001878.\nCOVID-19 RNA-based vaccines and the risk of prion disease: https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf\nCOVID-19 RNA-based vaccines and the risk of prion disease: https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf\nThis study notes that 115 pregnant women lost their babies, out of 827 who participated in a study on the safety of covid-19 vaccines: https://www.nejm.org/doi/full/10.1056/NEJMoa2104983.\nThis study notes that 115 pregnant women lost their babies, out of 827 who participated in a study on the safety of covid-19 vaccines: https://www.nejm.org/doi/full/10.1056/NEJMoa2104983.\nCOVID-19 mRNA vaccine causing CNS inflammation: a case series: https://link.springer.com/article/10.1007/s00415-021-10780-7\nCOVID-19 mRNA vaccine causing CNS inflammation: a case series: https://link.springer.com/article/10.1007/s00415-021-10780-7\nAllergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33475702/\nAllergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33475702/\nAllergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol: https://pubmed.ncbi.nlm.nih.gov/33320974/\nAllergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol: https://pubmed.ncbi.nlm.nih.gov/33320974/\nPfizer Vaccine Raises Allergy Concerns: https://pubmed.ncbi.nlm.nih.gov/33384356/\nPfizer Vaccine Raises Allergy Concerns: https://pubmed.ncbi.nlm.nih.gov/33384356/\nAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020: https://pubmed.ncbi.nlm.nih.gov/33444297/\nAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020: https://pubmed.ncbi.nlm.nih.gov/33444297/\nAllergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33507892/\nAllergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33507892/\nReports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021: https://pubmed.ncbi.nlm.nih.gov/34414880/\nReports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021: https://pubmed.ncbi.nlm.nih.gov/34414880/\nReports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021: https://pubmed.ncbi.nlm.nih.gov/33576785/\nReports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021: https://pubmed.ncbi.nlm.nih.gov/33576785/\nImmunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data: https://pubmed.ncbi.nlm.nih.gov/34269740/\nImmunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data: https://pubmed.ncbi.nlm.nih.gov/34269740/\nRelationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34215453/\nRelationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34215453/\nSevere Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA: Position Statement of the German Allergy Societies: German Medical Association of Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA): https://pubmed.ncbi.nlm.nih.gov/33643776/\nSevere Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA: Position Statement of the German Allergy Societies: German Medical Association of Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA): https://pubmed.ncbi.nlm.nih.gov/33643776/\nAllergic reactions and anaphylaxis to LNP-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/33571463/\nAllergic reactions and anaphylaxis to LNP-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/33571463/\nReported orofacial adverse effects from COVID-19 vaccines: the known and the unknown: https://pubmed.ncbi.nlm.nih.gov/33527524/\nReported orofacial adverse effects from COVID-19 vaccines: the known and the unknown: https://pubmed.ncbi.nlm.nih.gov/33527524/\nCutaneous adverse effects of available COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34518015/\nCutaneous adverse effects of available COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34518015/\nCumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report: https://pubmed.ncbi.nlm.nih.gov/34347278/\nCumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report: https://pubmed.ncbi.nlm.nih.gov/34347278/\nCOVID-19 vaccines increase the risk of anaphylaxis: https://pubmed.ncbi.nlm.nih.gov/33685103/\nCOVID-19 vaccines increase the risk of anaphylaxis: https://pubmed.ncbi.nlm.nih.gov/33685103/\nBiphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/\nBiphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/\nAllergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation: https://pubmed.ncbi.nlm.nih.gov/33657648/\nAllergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation: https://pubmed.ncbi.nlm.nih.gov/33657648/\nPolyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33825239/\nPolyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33825239/\nAcute allergic reactions to COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/33683290/\nAcute allergic reactions to COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/33683290/\nPolyethylene glycole allergy of the SARS CoV2 vaccine recipient: case report of a young adult recipient and management of future exposure to SARS-CoV2: https://pubmed.ncbi.nlm.nih.gov/33919151/\nPolyethylene glycole allergy of the SARS CoV2 vaccine recipient: case report of a young adult recipient and management of future exposure to SARS-CoV2: https://pubmed.ncbi.nlm.nih.gov/33919151/\nElevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data: https://pubmed.ncbi.nlm.nih.gov/34128049/\nElevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data: https://pubmed.ncbi.nlm.nih.gov/34128049/\nAllergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience: https://pubmed.ncbi.nlm.nih.gov/34474708/\nAllergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience: https://pubmed.ncbi.nlm.nih.gov/34474708/\nAllergic reactions to COVID-19 vaccines: statement of the Belgian Society of Allergy and Clinical Immunology (BelSACI): https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447\nAllergic reactions to COVID-19 vaccines: statement of the Belgian Society of Allergy and Clinical Immunology (BelSACI): https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447\n.IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34318537/\n.IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34318537/\nAllergic reactions after COVID-19 vaccination: putting the risk in perspective: https://pubmed.ncbi.nlm.nih.gov/34463751/\nAllergic reactions after COVID-19 vaccination: putting the risk in perspective: https://pubmed.ncbi.nlm.nih.gov/34463751/\nAnaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: https://pubmed.ncbi.nlm.nih.gov/33846043/ 188.\nAnaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: https://pubmed.ncbi.nlm.nih.gov/33846043/ 188.\nRisk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts: https://pubmed.ncbi.nlm.nih.gov/33752263/\nRisk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts: https://pubmed.ncbi.nlm.nih.gov/33752263/\nCOVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\nCOVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\nFatal brain hemorrhage after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33928772/\nFatal brain hemorrhage after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33928772/\nA case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/\nA case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/\nSkin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases: https://pubmed.ncbi.nlm.nih.gov/33838206/\nSkin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases: https://pubmed.ncbi.nlm.nih.gov/33838206/\nClinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://pubmed.ncbi.nlm.nih.gov/34517079/\nClinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://pubmed.ncbi.nlm.nih.gov/34517079/\nSkin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases: https://pubmed.ncbi.nlm.nih.gov/34254291/\nSkin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases: https://pubmed.ncbi.nlm.nih.gov/34254291/\nVaricella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry: https://pubmed.ncbi.nlm.nih.gov/34487581/\nVaricella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry: https://pubmed.ncbi.nlm.nih.gov/34487581/\nImmune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome: https://pubmed.ncbi.nlm.nih.gov/33987882/\nImmune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome: https://pubmed.ncbi.nlm.nih.gov/33987882/\nLaboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34138513/\nLaboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34138513/\nIntracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\nIntracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\nRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\nRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\nVaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review: https://pubmed.ncbi.nlm.nih.gov/34365148/.\nVaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review: https://pubmed.ncbi.nlm.nih.gov/34365148/.\nNerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials: https://pubmed.ncbi.nlm.nih.gov/34452064/.\nNerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials: https://pubmed.ncbi.nlm.nih.gov/34452064/.\nA rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33917902/\nA rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33917902/\nPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://pubmed.ncbi.nlm.nih.gov/34256983/\nPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://pubmed.ncbi.nlm.nih.gov/34256983/\nAcute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\nAcute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\nThromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/\nThromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/\n59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34117206/\n59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34117206/\nCerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: https://pubmed.ncbi.nlm.nih.gov/34033927/\nCerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: https://pubmed.ncbi.nlm.nih.gov/34033927/\nMyocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\nMyocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\nPericarditis after administration of COVID-19 mRNA BNT162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34364831/\nPericarditis after administration of COVID-19 mRNA BNT162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34364831/\nUnusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Modern: https://pubmed.ncbi.nlm.nih.gov/34447639/\nUnusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Modern: https://pubmed.ncbi.nlm.nih.gov/34447639/\nCase report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34514306/\nCase report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34514306/\nImmune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\nImmune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\nInsights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis: https://pubmed.ncbi.nlm.nih.gov/34453510/\nInsights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis: https://pubmed.ncbi.nlm.nih.gov/34453510/\nImmune thrombocytopenia in a 22-year-old post Covid-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33476455/\nImmune thrombocytopenia in a 22-year-old post Covid-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33476455/\npropylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34451967/\npropylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34451967/\nSecondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34377889/\nSecondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34377889/\nThrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\nThrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\nCOVID-19 vaccination association and facial nerve palsy: A case-control study: https://pubmed.ncbi.nlm.nih.gov/34165512/\nCOVID-19 vaccination association and facial nerve palsy: A case-control study: https://pubmed.ncbi.nlm.nih.gov/34165512/\nThe association between COVID-19 vaccination and Bell’s palsy: https://pubmed.ncbi.nlm.nih.gov/34411533/\nThe association between COVID-19 vaccination and Bell’s palsy: https://pubmed.ncbi.nlm.nih.gov/34411533/\nBell’s palsy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33611630/\nBell’s palsy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33611630/\nAcute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222): https://pubmed.ncbi.nlm.nih.gov/33981305/\nAcute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222): https://pubmed.ncbi.nlm.nih.gov/33981305/\nBell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine: https://pubmed.ncbi.nlm.nih.gov/34336436/\nBell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine: https://pubmed.ncbi.nlm.nih.gov/34336436/\nSequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34281950/.\nSequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34281950/.\nTransverse myelitis induced by SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34458035/\nTransverse myelitis induced by SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34458035/\nPeripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33734623/\nPeripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33734623/\nAcute abducens nerve palsy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34044114/.\nAcute abducens nerve palsy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34044114/.\nFacial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database: https://pubmed.ncbi.nlm.nih.gov/34492394/\nFacial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database: https://pubmed.ncbi.nlm.nih.gov/34492394/\nTransient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34369471/\nTransient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34369471/\nBell’s palsy after Ad26.COV2.S COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34014316/\nBell’s palsy after Ad26.COV2.S COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34014316/\nBell’s palsy after COVID-19 vaccination: case report: https://pubmed.ncbi.nlm.nih.gov/34330676/\nBell’s palsy after COVID-19 vaccination: case report: https://pubmed.ncbi.nlm.nih.gov/34330676/\nA case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34272622/\nA case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34272622/\nGuillian Barré syndrome after vaccination with mRNA-1273 against COVID-19: https://pubmed.ncbi.nlm.nih.gov/34477091/\nGuillian Barré syndrome after vaccination with mRNA-1273 against COVID-19: https://pubmed.ncbi.nlm.nih.gov/34477091/\nAcute facial paralysis as a possible complication of SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33975372/.\nAcute facial paralysis as a possible complication of SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33975372/.\nBell’s palsy after COVID-19 vaccination with high antibody response in CSF: https://pubmed.ncbi.nlm.nih.gov/34322761/.\nBell’s palsy after COVID-19 vaccination with high antibody response in CSF: https://pubmed.ncbi.nlm.nih.gov/34322761/.\nParsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy” by Coll et al. Articular Spine 2021; 88: 10519: https://pubmed.ncbi.nlm.nih.gov/34139321/.\nParsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy” by Coll et al. Articular Spine 2021; 88: 10519: https://pubmed.ncbi.nlm.nih.gov/34139321/.\nBell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report: https://pubmed.ncbi.nlm.nih.gov/34032902/.\nBell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report: https://pubmed.ncbi.nlm.nih.gov/34032902/.\nAutoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim?: https://pubmed.ncbi.nlm.nih.gov/33862041/\nAutoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim?: https://pubmed.ncbi.nlm.nih.gov/33862041/\nAutoimmune hepatitis triggered by vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/\nAutoimmune hepatitis triggered by vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/\nAcute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity: https://pubmed.ncbi.nlm.nih.gov/34293683/.\nAcute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity: https://pubmed.ncbi.nlm.nih.gov/34293683/.\nAutoimmune hepatitis after COVID vaccine: https://pubmed.ncbi.nlm.nih.gov/34225251/\nAutoimmune hepatitis after COVID vaccine: https://pubmed.ncbi.nlm.nih.gov/34225251/\nA novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34449715/\nA novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34449715/\nComparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://pubmed.ncbi.nlm.nih.gov/34139631/.\nComparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://pubmed.ncbi.nlm.nih.gov/34139631/.\nBilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/33864750/\nBilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/33864750/\nDiagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33914590/\nDiagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33914590/\nVenous sinus thrombosis after vaccination with ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34420802/\nVenous sinus thrombosis after vaccination with ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34420802/\nCerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\nCerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\nRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\nRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\nBlood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\nArterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\nArterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\nCerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/\nCerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/\nMalignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\nMalignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\nceliac artery and splenic artery thrombosis complicated by splenic infarction 7 days after the first dose of Oxford vaccine, causal relationship or coincidence: https://pubmed.ncbi.nlm.nih.gov/34261633/.\nceliac artery and splenic artery thrombosis complicated by splenic infarction 7 days after the first dose of Oxford vaccine, causal relationship or coincidence: https://pubmed.ncbi.nlm.nih.gov/34261633/.\nPrimary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34256983/\nPrimary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34256983/\nThrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34332437/.\nThrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34332437/.\nCerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33845870/.\nCerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33845870/.\nThrombosis with thrombocytopenia syndrome after COVID-19 immunization: https://pubmed.ncbi.nlm.nih.gov/34236343/\nThrombosis with thrombocytopenia syndrome after COVID-19 immunization: https://pubmed.ncbi.nlm.nih.gov/34236343/\nAcute myocardial infarction within 24 hours after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34364657/.\nAcute myocardial infarction within 24 hours after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34364657/.\nBilateral acute macular neuroretinopathy after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34287612/\nBilateral acute macular neuroretinopathy after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34287612/\ncentral venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\ncentral venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\nIntracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\nIntracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\nCerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/\nCerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/\nA case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34137813/\nA case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34137813/\nVaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines: https://pubmed.ncbi.nlm.nih.gov/34191218/\nVaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines: https://pubmed.ncbi.nlm.nih.gov/34191218/\nAcute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: https://pubmed.ncbi.nlm.nih.gov/34175640/\nAcute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: https://pubmed.ncbi.nlm.nih.gov/34175640/\nNew-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34153802/\nNew-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34153802/\nThrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://pubmed.ncbi.nlm.nih.gov/34092488/\nThrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://pubmed.ncbi.nlm.nih.gov/34092488/\nPulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261635/\nPulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261635/\nThromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/.\nThromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/.\nSpontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34144250/\nSpontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34144250/\nDeep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/33687691/\nDeep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/33687691/\nProcoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34011137/.\nProcoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34011137/.\nVaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series: https://pubmed.ncbi.nlm.nih.gov/34393988/.\nVaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series: https://pubmed.ncbi.nlm.nih.gov/34393988/.\nProcoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/.\nProcoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/.\nAtypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca): data from the French network of regional pharmacovigilance centers: https://pubmed.ncbi.nlm.nih.gov/34083026/.\nAtypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca): data from the French network of regional pharmacovigilance centers: https://pubmed.ncbi.nlm.nih.gov/34083026/.\nAcute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\nAcute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\nVaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage: https://pubmed.ncbi.nlm.nih.gov/34235757/.\nVaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage: https://pubmed.ncbi.nlm.nih.gov/34235757/.\nPalmar digital vein thrombosis after Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34473841/.\nPalmar digital vein thrombosis after Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34473841/.\nCutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\nCutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\nCerebral venous thrombosis following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34045111/.\nCerebral venous thrombosis following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34045111/.\nLipschütz ulcers after AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34366434/.\nLipschütz ulcers after AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34366434/.\nAmyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19: https://pubmed.ncbi.nlm.nih.gov/34330677/\nAmyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19: https://pubmed.ncbi.nlm.nih.gov/34330677/\nThrombosis with thrombocytopenia after Messenger vaccine RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34181446/\nThrombosis with thrombocytopenia after Messenger vaccine RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34181446/\nIntracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34477089/\nIntracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34477089/\nCoronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34033367/\nCoronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34033367/\nComparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites: https://pubmed.ncbi.nlm.nih.gov/34375510/\nComparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites: https://pubmed.ncbi.nlm.nih.gov/34375510/\nImmunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34107198/\nImmunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34107198/\nSevere vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19: an autopsy case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34355379/.\nSevere vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19: an autopsy case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34355379/.\nA case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34452028/\nA case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34452028/\nNeurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\nNeurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\nThrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.\nThrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.\nAcquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105247/.\nAcquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105247/.\nImmune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34405870/.\nImmune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34405870/.\nSensory Guillain-Barré syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34416410/.\nSensory Guillain-Barré syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34416410/.\nVogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccination: https://pubmed.ncbi.nlm.nih.gov/34462013/.\nVogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccination: https://pubmed.ncbi.nlm.nih.gov/34462013/.\nReactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34224024/.\nReactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34224024/.\nPost-vaccinal encephalitis after ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34324214/\nPost-vaccinal encephalitis after ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34324214/\nFatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma: https://pubmed.ncbi.nlm.nih.gov/34459725/\nFatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma: https://pubmed.ncbi.nlm.nih.gov/34459725/\nPolyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\nPolyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\nThree cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome: https://pubmed.ncbi.nlm.nih.gov/34043800/.\nThree cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome: https://pubmed.ncbi.nlm.nih.gov/34043800/.\nFacial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine: https://pubmed.ncbi.nlm.nih.gov/34447646/\nFacial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine: https://pubmed.ncbi.nlm.nih.gov/34447646/\nAssociation between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/.\nAssociation between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/.\nfulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://pubmed.ncbi.nlm.nih.gov/34416319/.\nfulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://pubmed.ncbi.nlm.nih.gov/34416319/.\nAdverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\nAdverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\nInduction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/\nInduction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/\nPetechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34513435/\nPetechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34513435/\nHepatitis C virus reactivation after COVID-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34512037/\nHepatitis C virus reactivation after COVID-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34512037/\nBilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine: https://pubmed.ncbi.nlm.nih.gov/34483273/.\nBilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine: https://pubmed.ncbi.nlm.nih.gov/34483273/.\nImmune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34513446/\nImmune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34513446/\nPlatelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × 1 nCov-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34474550/\nPlatelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × 1 nCov-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34474550/\nReactive arthritis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34033732/.\nReactive arthritis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34033732/.\nTwo cases of Graves’ disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants: https://pubmed.ncbi.nlm.nih.gov/33858208/\nTwo cases of Graves’ disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants: https://pubmed.ncbi.nlm.nih.gov/33858208/\nAcute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/\nAcute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/\nWidespread fixed bullous drug eruption after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34482558/\nWidespread fixed bullous drug eruption after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34482558/\nCOVID-19 mRNA vaccine causing CNS inflammation: a case series: https://pubmed.ncbi.nlm.nih.gov/34480607/\nCOVID-19 mRNA vaccine causing CNS inflammation: a case series: https://pubmed.ncbi.nlm.nih.gov/34480607/\nThymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19: https://pubmed.ncbi.nlm.nih.gov/34462647/\nThymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19: https://pubmed.ncbi.nlm.nih.gov/34462647/\nAcute disseminated encephalomyelitis following vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34325334/\nAcute disseminated encephalomyelitis following vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34325334/\nTolosa-Hunt syndrome occurring after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34513398/\nTolosa-Hunt syndrome occurring after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34513398/\nSystemic capillary extravasation syndrome following vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/\nSystemic capillary extravasation syndrome following vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/\nImmune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson): https://pubmed.ncbi.nlm.nih.gov/34469919/.\nImmune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson): https://pubmed.ncbi.nlm.nih.gov/34469919/.\nTransient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: https://pubmed.ncbi.nlm.nih.gov/34516272/.\nTransient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: https://pubmed.ncbi.nlm.nih.gov/34516272/.\nAcute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report: https://pubmed.ncbi.nlm.nih.gov/34512961/\nAcute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report: https://pubmed.ncbi.nlm.nih.gov/34512961/\nTransient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34077949/\nTransient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34077949/\nAutoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34171435/\nAutoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34171435/\nSevere relapse of multiple sclerosis after COVID-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34447349/\nSevere relapse of multiple sclerosis after COVID-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34447349/\nLymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/\nLymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/\nHemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34406660/.\nHemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34406660/.\nIgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/\nIgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/\nA case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34196469/.\nA case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34196469/.\nOnset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: https://pubmed.ncbi.nlm.nih.gov/34350668/\nOnset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: https://pubmed.ncbi.nlm.nih.gov/34350668/\nHailey-Hailey disease exacerbation after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34436620/\nHailey-Hailey disease exacerbation after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34436620/\nSupraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/.\nSupraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/.\nCOVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems: https://pubmed.ncbi.nlm.nih.gov/34509271/.\nCOVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems: https://pubmed.ncbi.nlm.nih.gov/34509271/.\nReport of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34462996/\nReport of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34462996/\nImmune thrombocytopenia after vaccination during the COVID-19 pandemic: https://pubmed.ncbi.nlm.nih.gov/34435486/\nImmune thrombocytopenia after vaccination during the COVID-19 pandemic: https://pubmed.ncbi.nlm.nih.gov/34435486/\nCOVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries: https://pubmed.ncbi.nlm.nih.gov/34435142/\nCOVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries: https://pubmed.ncbi.nlm.nih.gov/34435142/\nRituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34429981/\nRituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34429981/\nExacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases: https://pubmed.ncbi.nlm.nih.gov/34427024/\nExacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases: https://pubmed.ncbi.nlm.nih.gov/34427024/\nVaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34510014/.\nVaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34510014/.\nVesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34236711/\nVesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34236711/\nVaccine-induced thrombocytopenia with severe headache: https://pubmed.ncbi.nlm.nih.gov/34525282/\nVaccine-induced thrombocytopenia with severe headache: https://pubmed.ncbi.nlm.nih.gov/34525282/\nAcute perimyocarditis after the first dose of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34515024/\nAcute perimyocarditis after the first dose of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34515024/\nRhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34435250/.\nRhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34435250/.\nRare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34363637/\nRare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34363637/\nImmune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921002018\nImmune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921002018\nSecondary immune thrombocytopenia putatively attributable to COVID-19 vaccination: https://casereports.bmj.com/content/14/5/e242220.abstract.\nSecondary immune thrombocytopenia putatively attributable to COVID-19 vaccination: https://casereports.bmj.com/content/14/5/e242220.abstract.\nImmune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34155844/\nImmune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34155844/\nNewly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/.\nNewly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/.\nIdiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine: https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext.\nIdiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine: https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext.\nThrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/.\nThrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/.\nImmune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination: https://casereports.bmj.com/content/14/7/e242678.\nImmune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination: https://casereports.bmj.com/content/14/7/e242678.\nCollection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic\nCollection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic\nPetechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results: https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794\nPetechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results: https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794\nCOVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria: https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in\nCOVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria: https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in\nCerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/.\nCerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/.\nCerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management: https://pubmed.ncbi.nlm.nih.gov/34327553/.\nCerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management: https://pubmed.ncbi.nlm.nih.gov/34327553/.\nCerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33878469/.\nCerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33878469/.\nCerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://pubmed.ncbi.nlm.nih.gov/33857630/.\nCerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://pubmed.ncbi.nlm.nih.gov/33857630/.\nCerebral venous thrombosis induced by SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34090750/.\nCerebral venous thrombosis induced by SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34090750/.\nCarotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34312301/.\nCarotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34312301/.\nCerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34333995/\nCerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34333995/\nThe roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34455073/\nThe roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34455073/\nCerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34111775/.\nCerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34111775/.\nCerebral venous thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34045111/\nCerebral venous thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34045111/\nLethal cerebral venous sinus thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33983464/\nLethal cerebral venous sinus thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33983464/\nCerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://pubmed.ncbi.nlm.nih.gov/34116145/\nCerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://pubmed.ncbi.nlm.nih.gov/34116145/\nCerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine: https://pubmed.ncbi.nlm.nih.gov/34286453/.\nCerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine: https://pubmed.ncbi.nlm.nih.gov/34286453/.\nCentral venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\nCentral venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\nCerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI: https://pubmed.ncbi.nlm.nih.gov/34244448/\nCerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI: https://pubmed.ncbi.nlm.nih.gov/34244448/\nEarly results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34226070/\nEarly results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34226070/\nCerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/.\nCerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/.\nCerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/.\nCerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/.\nVaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with a high mortality rate: a case series: https://pubmed.ncbi.nlm.nih.gov/34393988/.\nVaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with a high mortality rate: a case series: https://pubmed.ncbi.nlm.nih.gov/34393988/.\nAdenovirus interactions with platelets and coagulation and vaccine-associated autoimmune thrombocytopenia thrombosis syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/.\nAdenovirus interactions with platelets and coagulation and vaccine-associated autoimmune thrombocytopenia thrombosis syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/.\nHeadache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study: https://pubmed.ncbi.nlm.nih.gov/34313952/\nHeadache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study: https://pubmed.ncbi.nlm.nih.gov/34313952/\nAdverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\nAdverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\nCerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\nCerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\nA rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34274191/\nA rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34274191/\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\nCerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\nArterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\nArterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\nProcoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/\nProcoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/\nS. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021: https://pubmed.ncbi.nlm.nih.gov/33929487/.\nS. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021: https://pubmed.ncbi.nlm.nih.gov/33929487/.\nMalignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\nMalignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\nAcute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: https://pubmed.ncbi.nlm.nih.gov/34175640/\nAcute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: https://pubmed.ncbi.nlm.nih.gov/34175640/\nVaccine-induced immune thrombotic immune thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: https://pubmed.ncbi.nlm.nih.gov/34159588/.\nVaccine-induced immune thrombotic immune thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: https://pubmed.ncbi.nlm.nih.gov/34159588/.\nImaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\nImaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\nAutoimmunity roots of thrombotic events after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/\nAutoimmunity roots of thrombotic events after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/\nCerebral venous sinus thrombosis after vaccination: the UK experience: https://pubmed.ncbi.nlm.nih.gov/34370974/\nCerebral venous sinus thrombosis after vaccination: the UK experience: https://pubmed.ncbi.nlm.nih.gov/34370974/\nMassive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34373991/\nMassive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34373991/\nAustralian and New Zealand approach to the diagnosis and treatment of vaccine-induced immune thrombosis and immune thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34490632/\nAustralian and New Zealand approach to the diagnosis and treatment of vaccine-induced immune thrombosis and immune thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34490632/\nAn observational study to identify the prevalence of thrombocytopenia and anti-PF4 / polyanion antibodies in Norwegian health care workers after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33909350/\nAn observational study to identify the prevalence of thrombocytopenia and anti-PF4 / polyanion antibodies in Norwegian health care workers after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33909350/\nAcute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 (AZD1222) vaccine: https://pubmed.ncbi.nlm.nih.gov/33981305/.\nAcute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 (AZD1222) vaccine: https://pubmed.ncbi.nlm.nih.gov/33981305/.\nA case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/34272622/\nA case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/34272622/\nThrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/33877737/\nThrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/33877737/\nPredicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34254476/\nPredicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34254476/\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\nFirst dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\nChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107,720 doses of ChAdOx1 vaccination in Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/.\nChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107,720 doses of ChAdOx1 vaccination in Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/.\nPulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261635/\nPulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261635/\nNeurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\nNeurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\nLarge hemorrhagic stroke after vaccination against ChAdOx1 nCoV-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34273119/\nLarge hemorrhagic stroke after vaccination against ChAdOx1 nCoV-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34273119/\nPolyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\nPolyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\nA rare case of thrombosis and thrombocytopenia of the superior ophthalmic vein after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34276917/\nA rare case of thrombosis and thrombocytopenia of the superior ophthalmic vein after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34276917/\nThrombosis and severe acute respiratory syndrome Coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.\nThrombosis and severe acute respiratory syndrome Coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.\nRenal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34268278/.\nRenal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34268278/.\nLimb ischemia and pulmonary artery thrombosis after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): a case of vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33990339/.\nLimb ischemia and pulmonary artery thrombosis after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): a case of vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33990339/.\nAssociation between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/.\nAssociation between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/.\nSecondary thrombocytopenia after SARS-CoV-2 vaccination: case report of haemorrhage and hematoma after minor oral surgery: https://pubmed.ncbi.nlm.nih.gov/34314875/.\nSecondary thrombocytopenia after SARS-CoV-2 vaccination: case report of haemorrhage and hematoma after minor oral surgery: https://pubmed.ncbi.nlm.nih.gov/34314875/.\nVenous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/\nVenous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/\nFatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins: a rationale for monitoring immunoglobulin G levels: https://pubmed.ncbi.nlm.nih.gov/34382387/\nFatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins: a rationale for monitoring immunoglobulin G levels: https://pubmed.ncbi.nlm.nih.gov/34382387/\nA case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/.\nA case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/.\nIntracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\nIntracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\nMassive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34261296/\nMassive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34261296/\nNephrotic syndrome after ChAdOx1 nCoV-19 vaccine against SARScoV-2: https://pubmed.ncbi.nlm.nih.gov/34250318/.\nNephrotic syndrome after ChAdOx1 nCoV-19 vaccine against SARScoV-2: https://pubmed.ncbi.nlm.nih.gov/34250318/.\nA case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34059191/\nA case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34059191/\nCutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\nCutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\nThrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\nThrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\nVaccine-induced thrombocytopenia with severe headache: https://pubmed.ncbi.nlm.nih.gov/34525282/\nVaccine-induced thrombocytopenia with severe headache: https://pubmed.ncbi.nlm.nih.gov/34525282/\nMyocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1\nMyocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1\nCOVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis: https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09.\nCOVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis: https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09.\nSevere autoimmune hemolytic anemia after receipt of SARS-CoV-2 mRNA vaccine: https://onlinelibrary.wiley.com/doi/10.1111/trf.16672\nSevere autoimmune hemolytic anemia after receipt of SARS-CoV-2 mRNA vaccine: https://onlinelibrary.wiley.com/doi/10.1111/trf.16672\nIntravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model: https://t.co/j0IEM8cMXI\nIntravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model: https://t.co/j0IEM8cMXI\nA report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics: https://pubmed.ncbi.nlm.nih.gov/34601006/\nA report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics: https://pubmed.ncbi.nlm.nih.gov/34601006/\nThis study concludes that: “The vaccine was associated with an excess risk of myocarditis (1 to 5 events per 100,000 persons). The risk of this potentially serious adverse event and of many other serious adverse events increased substantially after SARS-CoV-2 infection”: https://www.nejm.org/doi/full/10.1056/NEJMoa2110475\nThis study concludes that: “The vaccine was associated with an excess risk of myocarditis (1 to 5 events per 100,000 persons). The risk of this potentially serious adverse event and of many other serious adverse events increased substantially after SARS-CoV-2 infection”: https://www.nejm.org/doi/full/10.1056/NEJMoa2110475\nBilateral uveitis after inoculation with COVID-19 vaccine: a case report: https://www.sciencedirect.com/science/article/pii/S1201971221007797\nBilateral uveitis after inoculation with COVID-19 vaccine: a case report: https://www.sciencedirect.com/science/article/pii/S1201971221007797\nMyocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.\nMyocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.\nImmune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed: https://www.sciencedirect.com/science/article/pii/S0168827821020936\nImmune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed: https://www.sciencedirect.com/science/article/pii/S0168827821020936\nExtensive investigations revealed consistent pathophysiologic alterations after vaccination with COVID-19 vaccines: https://www.nature.com/articles/s41421-021-00329-3\nExtensive investigations revealed consistent pathophysiologic alterations after vaccination with COVID-19 vaccines: https://www.nature.com/articles/s41421-021-00329-3\nLobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA-based SARS-CoV-2 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/\nLobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA-based SARS-CoV-2 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/\nMrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: a caution: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712\nMrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: a caution: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712\nChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome:https://www.science.org/doi/10.1126/sciadv.abl8213\nChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome:https://www.science.org/doi/10.1126/sciadv.abl8213\nLethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 26.COV2.S: first documented case outside the U.S.: https://pubmed.ncbi.nlm.nih.gov/34626338/\nLethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 26.COV2.S: first documented case outside the U.S.: https://pubmed.ncbi.nlm.nih.gov/34626338/\nA prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination: https://europepmc.org/article/PPR/PPR304469 435.\nA prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination: https://europepmc.org/article/PPR/PPR304469 435.\nVITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34731555/\nVITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34731555/\nVaccine-induced immune thrombotic thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: https://pubmed.ncbi.nlm.nih.gov/34159588/\nVaccine-induced immune thrombotic thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: https://pubmed.ncbi.nlm.nih.gov/34159588/\nTreatment of acute ischemic stroke associated with ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34461442/\nTreatment of acute ischemic stroke associated with ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34461442/\nSpectrum of neurological complications after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34719776/.\nSpectrum of neurological complications after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34719776/.\nCerebral venous sinus thrombosis after vaccination: the UK experience: https://pubmed.ncbi.nlm.nih.gov/34370974/\nCerebral venous sinus thrombosis after vaccination: the UK experience: https://pubmed.ncbi.nlm.nih.gov/34370974/\nCerebral venous vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34373413/\nCerebral venous vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34373413/\nPortal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34598301/\nPortal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34598301/\nHematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34620638/\nHematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34620638/\nMyocardial infarction and azygos vein thrombosis after vaccination with ChAdOx1 nCoV-19 in a hemodialysis patient: https://pubmed.ncbi.nlm.nih.gov/34650896/\nMyocardial infarction and azygos vein thrombosis after vaccination with ChAdOx1 nCoV-19 in a hemodialysis patient: https://pubmed.ncbi.nlm.nih.gov/34650896/\nTakotsubo (stress) cardiomyopathy after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34625447/\nTakotsubo (stress) cardiomyopathy after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34625447/\nHumoral response induced by Prime-Boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines in a patient with multiple sclerosis treated with teriflunomide: https://pubmed.ncbi.nlm.nih.gov/34696248/\nHumoral response induced by Prime-Boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines in a patient with multiple sclerosis treated with teriflunomide: https://pubmed.ncbi.nlm.nih.gov/34696248/\nGuillain-Barré syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34548920/\nGuillain-Barré syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34548920/\nRefractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE): https://pubmed.ncbi.nlm.nih.gov/34672380/.\nRefractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE): https://pubmed.ncbi.nlm.nih.gov/34672380/.\nRare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis: https://pubmed.ncbi.nlm.nih.gov/34556531/.\nRare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis: https://pubmed.ncbi.nlm.nih.gov/34556531/.\nDelayed headache after COVID-19 vaccination: a warning sign for vaccine-induced cerebral venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34535076/.\nDelayed headache after COVID-19 vaccination: a warning sign for vaccine-induced cerebral venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34535076/.\nClinical features of vaccine-induced thrombocytopenia and immune thrombosis: https://pubmed.ncbi.nlm.nih.gov/34379914/.\nClinical features of vaccine-induced thrombocytopenia and immune thrombosis: https://pubmed.ncbi.nlm.nih.gov/34379914/.\nPredictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score: https://pubmed.ncbi.nlm.nih.gov/34545400/\nPredictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score: https://pubmed.ncbi.nlm.nih.gov/34545400/\nIschemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34035134/\nIschemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34035134/\nIn-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34688190/\nIn-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34688190/\nEndovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: report of three cases: https://pubmed.ncbi.nlm.nih.gov/34782400/\nEndovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: report of three cases: https://pubmed.ncbi.nlm.nih.gov/34782400/\nCardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34710832/\nCardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34710832/\nCerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more: https://pubmed.ncbi.nlm.nih.gov/34695859/\nCerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more: https://pubmed.ncbi.nlm.nih.gov/34695859/\nCerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases: https://pubmed.ncbi.nlm.nih.gov/34453762/.\nCerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases: https://pubmed.ncbi.nlm.nih.gov/34453762/.\nPossible triggers of thrombocytopenia and/or hemorrhage by BNT162b2 vaccine, Pfizer-BioNTech: https://pubmed.ncbi.nlm.nih.gov/34660652/.\nPossible triggers of thrombocytopenia and/or hemorrhage by BNT162b2 vaccine, Pfizer-BioNTech: https://pubmed.ncbi.nlm.nih.gov/34660652/.\nMultiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx1 (AstraZeneca), which required emergency femoral and carotid surgical thrombectomy: https://pubmed.ncbi.nlm.nih.gov/34644642/\nMultiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx1 (AstraZeneca), which required emergency femoral and carotid surgical thrombectomy: https://pubmed.ncbi.nlm.nih.gov/34644642/\nCase series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital: https://pubmed.ncbi.nlm.nih.gov/34694650/\nCase series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital: https://pubmed.ncbi.nlm.nih.gov/34694650/\nNeuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34726934/\nNeuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34726934/\nThrombotic events after COVID-19 vaccination in over 50 years of age: results of a population-based study in Italy: https://pubmed.ncbi.nlm.nih.gov/34835237/\nThrombotic events after COVID-19 vaccination in over 50 years of age: results of a population-based study in Italy: https://pubmed.ncbi.nlm.nih.gov/34835237/\nIntracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\nIntracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\nAge- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34724036/.\nAge- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34724036/.\nGenital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34839563/\nGenital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34839563/\nCerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34783932/.\nCerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34783932/.\nCOVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation: https://pubmed.ncbi.nlm.nih.gov/34624910/\nCOVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation: https://pubmed.ncbi.nlm.nih.gov/34624910/\nInflammatory myositis after vaccination with ChAdOx1: https://pubmed.ncbi.nlm.nih.gov/34585145/\nInflammatory myositis after vaccination with ChAdOx1: https://pubmed.ncbi.nlm.nih.gov/34585145/\nAcute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34580132/.\nAcute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34580132/.\nA rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital: https://pubmed.ncbi.nlm.nih.gov/34535492/\nA rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital: https://pubmed.ncbi.nlm.nih.gov/34535492/\nCOVID-19 vaccine-induced thrombotic thrombocytopenia: a case series: https://pubmed.ncbi.nlm.nih.gov/34527501/\nCOVID-19 vaccine-induced thrombotic thrombocytopenia: a case series: https://pubmed.ncbi.nlm.nih.gov/34527501/\nThrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: a risk-benefit analysis for persons <60% risk-benefit analysis for people <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\nThrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: a risk-benefit analysis for persons <60% risk-benefit analysis for people <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\nImmune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australia: https://pubmed.ncbi.nlm.nih.gov/34756770/\nImmune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australia: https://pubmed.ncbi.nlm.nih.gov/34756770/\nCharacteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622\nCharacteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622\nCase study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34781321/\nCase study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34781321/\nThrombosis with Thrombocytopenia Syndrome Associated with COVID-19 Vaccines: https://pubmed.ncbi.nlm.nih.gov/34062319/\nThrombosis with Thrombocytopenia Syndrome Associated with COVID-19 Vaccines: https://pubmed.ncbi.nlm.nih.gov/34062319/\nCerebral venous sinus thrombosis following vaccination with ChAdOx1: the first case of definite thrombosis with thrombocytopenia syndrome in India: https://pubmed.ncbi.nlm.nih.gov/34706921/\nCerebral venous sinus thrombosis following vaccination with ChAdOx1: the first case of definite thrombosis with thrombocytopenia syndrome in India: https://pubmed.ncbi.nlm.nih.gov/34706921/\nCOVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): systematic review and post hoc analysis: https://pubmed.ncbi.nlm.nih.gov/34698582/.\nCOVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): systematic review and post hoc analysis: https://pubmed.ncbi.nlm.nih.gov/34698582/.\nCase report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34751013/.\nCase report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34751013/.\nAcute transverse myelitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34684047/.\nAcute transverse myelitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34684047/.\nConcerns for adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34541935/\nConcerns for adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34541935/\nMajor hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34273119/\nMajor hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34273119/\nCerebral venous sinus thrombosis after COVID-19 vaccination: neurologic and radiologic management: https://pubmed.ncbi.nlm.nih.gov/34327553/.\nCerebral venous sinus thrombosis after COVID-19 vaccination: neurologic and radiologic management: https://pubmed.ncbi.nlm.nih.gov/34327553/.\nThrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33877737/\nThrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33877737/\nIntracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34646685/\nIntracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34646685/\nMinimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34242687/.\nMinimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34242687/.\nCase report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34609603/\nCase report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34609603/\nCase report: Pityriasis rosea-like rash after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34557507/\nCase report: Pityriasis rosea-like rash after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34557507/\nExtensive longitudinal transverse myelitis after ChAdOx1 nCOV-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34641797/.\nExtensive longitudinal transverse myelitis after ChAdOx1 nCOV-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34641797/.\nAcute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222: https://pubmed.ncbi.nlm.nih.gov/34812326/.\nAcute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222: https://pubmed.ncbi.nlm.nih.gov/34812326/.\nThrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://pubmed.ncbi.nlm.nih.gov/34006408/\nThrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://pubmed.ncbi.nlm.nih.gov/34006408/\nA case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/\nA case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/\nVaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a new hypothesis on mechanisms and implications for future vaccine development: https://pubmed.ncbi.nlm.nih.gov/34664303/.\nVaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a new hypothesis on mechanisms and implications for future vaccine development: https://pubmed.ncbi.nlm.nih.gov/34664303/.\nThrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34649281/.\nThrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34649281/.\nNewly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination: https://pubmed.ncbi.nlm.nih.gov/34420249/\nNewly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination: https://pubmed.ncbi.nlm.nih.gov/34420249/\nCerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34610990/.\nCerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34610990/.\nSweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34590397/\nSweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34590397/\nSudden sensorineural hearing loss after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34670143/.\nSudden sensorineural hearing loss after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34670143/.\nPrevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021: https://pubmed.ncbi.nlm.nih.gov/34819146/.\nPrevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021: https://pubmed.ncbi.nlm.nih.gov/34819146/.\nAcute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccination: https://pubmed.ncbi.nlm.nih.gov/34581453/\nAcute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccination: https://pubmed.ncbi.nlm.nih.gov/34581453/\nRecurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy: https://pubmed.ncbi.nlm.nih.gov/34741583/\nRecurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy: https://pubmed.ncbi.nlm.nih.gov/34741583/\nShingles-like skin lesion after vaccination with AstraZeneca for COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34631069/\nShingles-like skin lesion after vaccination with AstraZeneca for COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34631069/\nThrombosis after COVID-19 vaccination: possible link to ACE pathways: https://pubmed.ncbi.nlm.nih.gov/34479129/\nThrombosis after COVID-19 vaccination: possible link to ACE pathways: https://pubmed.ncbi.nlm.nih.gov/34479129/\nThrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\nThrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\nLeukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 corona virus vaccine nCoV-19 (recombinant): https://pubmed.ncbi.nlm.nih.gov/34546608/\nLeukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 corona virus vaccine nCoV-19 (recombinant): https://pubmed.ncbi.nlm.nih.gov/34546608/\nAbdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34546343/\nAbdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34546343/\nLongitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34849183/\nLongitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34849183/\nInduction of cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34853744/.\nInduction of cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34853744/.\nA case of toxic epidermal necrolysis after vaccination with ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34751429/.\nA case of toxic epidermal necrolysis after vaccination with ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34751429/.\nOcular adverse events following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34559576/\nOcular adverse events following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34559576/\nDepression after ChAdOx1-S / nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34608345/.\nDepression after ChAdOx1-S / nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34608345/.\nVenous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34384129/.\nVenous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34384129/.\nRecurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients: https://pubmed.ncbi.nlm.nih.gov/34755433/\nRecurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients: https://pubmed.ncbi.nlm.nih.gov/34755433/\nMajor artery thrombosis and vaccination against ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34839830/\nMajor artery thrombosis and vaccination against ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34839830/\nRare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings: https://pubmed.ncbi.nlm.nih.gov/34667486/\nRare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings: https://pubmed.ncbi.nlm.nih.gov/34667486/\nCutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality: https://pubmed.ncbi.nlm.nih.gov/34726187/.\nCutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality: https://pubmed.ncbi.nlm.nih.gov/34726187/.\nPancreas allograft rejection after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34781027/\nPancreas allograft rejection after ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34781027/\nUnderstanding the risk of thrombosis with thrombocytopenia syndrome following Ad26.COV2.S vaccination: https://pubmed.ncbi.nlm.nih.gov/34595694/\nUnderstanding the risk of thrombosis with thrombocytopenia syndrome following Ad26.COV2.S vaccination: https://pubmed.ncbi.nlm.nih.gov/34595694/\nCutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19: a prospective cohort study in health care workers: https://pubmed.ncbi.nlm.nih.gov/34661934/\nCutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19: a prospective cohort study in health care workers: https://pubmed.ncbi.nlm.nih.gov/34661934/\nComments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34788138\nComments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34788138\nEosinophilic dermatosis after AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34753210/.\nEosinophilic dermatosis after AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34753210/.\nSevere immune thrombocytopenia following COVID-19 vaccination: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34653943/.\nSevere immune thrombocytopenia following COVID-19 vaccination: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34653943/.\nRelapse of immune thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34591991/\nRelapse of immune thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34591991/\nThrombosis in pre- and post-vaccination phase of COVID-19; https://pubmed.ncbi.nlm.nih.gov/34650382/\nThrombosis in pre- and post-vaccination phase of COVID-19; https://pubmed.ncbi.nlm.nih.gov/34650382/\nCOVID-19 vaccine in patients with hypercoagulability disorders: a clinical perspective: https://pubmed.ncbi.nlm.nih.gov/34786893/\nCOVID-19 vaccine in patients with hypercoagulability disorders: a clinical perspective: https://pubmed.ncbi.nlm.nih.gov/34786893/\nVaccine-associated thrombocytopenia and thrombosis: venous endotheliopathy leading to combined venous micro-macrothrombosis: https://pubmed.ncbi.nlm.nih.gov/34833382/\nVaccine-associated thrombocytopenia and thrombosis: venous endotheliopathy leading to combined venous micro-macrothrombosis: https://pubmed.ncbi.nlm.nih.gov/34833382/\nThrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad26.COV2.S vaccine (Janssen): https://pubmed.ncbi.nlm.nih.gov/34670287/\nThrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad26.COV2.S vaccine (Janssen): https://pubmed.ncbi.nlm.nih.gov/34670287/\nAn unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34790811/\nAn unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34790811/\nImmediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein: https://pubmed.ncbi.nlm.nih.gov/34023956/.\nImmediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein: https://pubmed.ncbi.nlm.nih.gov/34023956/.\nThrombosis formation after COVID-19 vaccination immunologic aspects: review article: https://pubmed.ncbi.nlm.nih.gov/34629931/\nThrombosis formation after COVID-19 vaccination immunologic aspects: review article: https://pubmed.ncbi.nlm.nih.gov/34629931/\nImaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\nImaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\nSpectrum of neuroimaging findings in post-CoVID-19 vaccination: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34842783/\nSpectrum of neuroimaging findings in post-CoVID-19 vaccination: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34842783/\nCerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34630307/\nCerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34630307/\nFatal cerebral venous sinus thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33983464/\nFatal cerebral venous sinus thrombosis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33983464/\nAutoimmune roots of thrombotic events after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34508917/.\nAutoimmune roots of thrombotic events after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34508917/.\nNew portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19: https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext.\nNew portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19: https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext.\nImages of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33962903/.\nImages of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33962903/.\nCerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34796065/.\nCerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34796065/.\nIncreased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccination in health care workers taking ACE inhibitors: https://pubmed.ncbi.nlm.nih.gov/34579248/\nIncreased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccination in health care workers taking ACE inhibitors: https://pubmed.ncbi.nlm.nih.gov/34579248/\nA case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis: https://pubmed.ncbi.nlm.nih.gov/34843991/\nA case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis: https://pubmed.ncbi.nlm.nih.gov/34843991/\nCerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2): https://pubmed.ncbi.nlm.nih.gov/34595867/\nCerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2): https://pubmed.ncbi.nlm.nih.gov/34595867/\nA case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162b2 vaccine (Pfizer-Biontech): https://pubmed.ncbi.nlm.nih.gov/34820240/\nA case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162b2 vaccine (Pfizer-Biontech): https://pubmed.ncbi.nlm.nih.gov/34820240/\nVaccine-induced immune thrombotic immune thrombocytopenia (VITT): targeting pathologic mechanisms with Bruton’s tyrosine kinase inhibitors: https://pubmed.ncbi.nlm.nih.gov/33851389/\nVaccine-induced immune thrombotic immune thrombocytopenia (VITT): targeting pathologic mechanisms with Bruton’s tyrosine kinase inhibitors: https://pubmed.ncbi.nlm.nih.gov/33851389/\nThrombotic thrombocytopenic purpura after vaccination with Ad26.COV2-S: https://pubmed.ncbi.nlm.nih.gov/33980419/\nThrombotic thrombocytopenic purpura after vaccination with Ad26.COV2-S: https://pubmed.ncbi.nlm.nih.gov/33980419/\nThromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34264151/\nThromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34264151/\nPotential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen: https://pubmed.ncbi.nlm.nih.gov/34734086/\nPotential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen: https://pubmed.ncbi.nlm.nih.gov/34734086/\nThrombosis after adenovirus-vectored COVID-19 vaccination: a concern for underlying disease: https://pubmed.ncbi.nlm.nih.gov/34755555/\nThrombosis after adenovirus-vectored COVID-19 vaccination: a concern for underlying disease: https://pubmed.ncbi.nlm.nih.gov/34755555/\nAdenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/\nAdenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/\nThrombotic thrombocytopenic purpura: a new threat after COVID bnt162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34264514/.\nThrombotic thrombocytopenic purpura: a new threat after COVID bnt162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34264514/.\nUnusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34840204/\nUnusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34840204/\nNeurological side effects of SARS-CoV-2 vaccines: https://pubmed.ncbi.nlm.nih.gov/34750810/\nNeurological side effects of SARS-CoV-2 vaccines: https://pubmed.ncbi.nlm.nih.gov/34750810/\nCoagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: https://pubmed.ncbi.nlm.nih.gov/34639132/\nCoagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: https://pubmed.ncbi.nlm.nih.gov/34639132/\nIsolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up: https://pubmed.ncbi.nlm.nih.gov/34804412/\nIsolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up: https://pubmed.ncbi.nlm.nih.gov/34804412/\nCentral retinal vein occlusion after vaccination with SARS-CoV-2 mRNA: case report: https://pubmed.ncbi.nlm.nih.gov/34571653/.\nCentral retinal vein occlusion after vaccination with SARS-CoV-2 mRNA: case report: https://pubmed.ncbi.nlm.nih.gov/34571653/.\nComplicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A: https://pubmed.ncbi.nlm.nih.gov/34835275/.\nComplicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A: https://pubmed.ncbi.nlm.nih.gov/34835275/.\nDeep venous thrombosis after vaccination with Ad26.COV2.S in adult males: https://pubmed.ncbi.nlm.nih.gov/34659839/.\nDeep venous thrombosis after vaccination with Ad26.COV2.S in adult males: https://pubmed.ncbi.nlm.nih.gov/34659839/.\nNeurological autoimmune diseases after SARS-CoV-2 vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34668274/.\nNeurological autoimmune diseases after SARS-CoV-2 vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34668274/.\nSevere autoimmune hemolytic autoimmune anemia after receiving SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34549821/\nSevere autoimmune hemolytic autoimmune anemia after receiving SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34549821/\nOccurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant): https://pubmed.ncbi.nlm.nih.gov/34528522/\nOccurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant): https://pubmed.ncbi.nlm.nih.gov/34528522/\nPrevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\nPrevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179.\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179.\nMyocarditis after 2019 coronavirus disease mRNA vaccine: a case series and determination of incidence rate: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408\nMyocarditis after 2019 coronavirus disease mRNA vaccine: a case series and determination of incidence rate: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408\nMyocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\nMyocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\nEpidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\nEpidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\nShedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\nShedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\nMyocarditis Following mRNA COVID-19 Vaccine: https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.\nMyocarditis Following mRNA COVID-19 Vaccine: https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.\nMyocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel: https://pubmed.ncbi.nlm.nih.gov/34614328/.\nMyocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel: https://pubmed.ncbi.nlm.nih.gov/34614328/.\nMyocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination: https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext\nMyocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination: https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext\nMyocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\nMyocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\nPossible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings: https://pubmed.ncbi.nlm.nih.gov/34246586/\nPossible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings: https://pubmed.ncbi.nlm.nih.gov/34246586/\nHypersensitivity Myocarditis and COVID-19 Vaccines: https://pubmed.ncbi.nlm.nih.gov/34856634/.\nHypersensitivity Myocarditis and COVID-19 Vaccines: https://pubmed.ncbi.nlm.nih.gov/34856634/.\nSevere myocarditis associated with COVID-19 vaccine: zebra or unicorn?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext.\nSevere myocarditis associated with COVID-19 vaccine: zebra or unicorn?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext.\nAcute myocardial infarction and myocarditis after COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/\nAcute myocardial infarction and myocarditis after COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/\nMyocarditis after Covid-19 vaccination in a large healthcare organization: https://www.nejm.org/doi/10.1056/NEJMoa2110737\nMyocarditis after Covid-19 vaccination in a large healthcare organization: https://www.nejm.org/doi/10.1056/NEJMoa2110737\nAssociation of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\nAssociation of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\nSTEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:. https://pubmed.ncbi.nlm.nih.gov/34756746/\nSTEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:. https://pubmed.ncbi.nlm.nih.gov/34756746/\nMyocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/\nMyocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/\nMyocarditis after COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34546329/.\nMyocarditis after COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34546329/.\nPatients with acute myocarditis after COVID-19 mRNA vaccination:. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602.\nPatients with acute myocarditis after COVID-19 mRNA vaccination:. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602.\nMyocarditis after COVID-19 vaccination: a case series: https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub.\nMyocarditis after COVID-19 vaccination: a case series: https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub.\nMyocarditis associated with COVID-19 vaccination in adolescents: https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357\nMyocarditis associated with COVID-19 vaccination in adolescents: https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357\nMyocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents:. https://pubmed.ncbi.nlm.nih.gov/34704459/\nMyocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents:. https://pubmed.ncbi.nlm.nih.gov/34704459/\nMyocarditis after COVID-19 vaccination: magnetic resonance imaging study: https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6 421640.\nMyocarditis after COVID-19 vaccination: magnetic resonance imaging study: https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6 421640.\nAcute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/\nAcute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/\nMyocarditis after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S2352906721001603\nMyocarditis after COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S2352906721001603\nCase report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34712717/.\nCase report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34712717/.\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X.\nAcute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X.\nMyocarditis associated with COVID-19 mRNA vaccination: https://pubs.rsna.org/doi/10.1148/radiol.2021211430\nMyocarditis associated with COVID-19 mRNA vaccination: https://pubs.rsna.org/doi/10.1148/radiol.2021211430\nAcute myocarditis after COVID-19 vaccination: a case report: https://www.sciencedirect.com/science/article/pii/S0248866321007098\nAcute myocarditis after COVID-19 vaccination: a case report: https://www.sciencedirect.com/science/article/pii/S0248866321007098\nAcute myopericarditis after COVID-19 vaccination in adolescents:. https://pubmed.ncbi.nlm.nih.gov/34589238/.\nAcute myopericarditis after COVID-19 vaccination in adolescents:. https://pubmed.ncbi.nlm.nih.gov/34589238/.\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination: https://academic.oup.com/jpids/article/10/10/962/6329543.\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination: https://academic.oup.com/jpids/article/10/10/962/6329543.\nAcute myocarditis associated with anti-COVID-19 vaccination: https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.\nAcute myocarditis associated with anti-COVID-19 vaccination: https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.\nMyocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:. https://pubmed.ncbi.nlm.nih.gov/34428917/.\nMyocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:. https://pubmed.ncbi.nlm.nih.gov/34428917/.\nAcute symptomatic myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination:. https://pubmed.ncbi.nlm.nih.gov/34088762/.\nAcute symptomatic myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination:. https://pubmed.ncbi.nlm.nih.gov/34088762/.\nMyocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/64 42104.\nMyocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/64 42104.\nCOVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis: https://www.mdpi.com/2036-7503/13/3/61.\nCOVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis: https://www.mdpi.com/2036-7503/13/3/61.\nCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\nCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\nMyocarditis temporally associated with COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34133885/\nMyocarditis temporally associated with COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34133885/\nAcute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the vaccine adverse event reporting system database: https://pubmed.ncbi.nlm.nih.gov/34219532/\nAcute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the vaccine adverse event reporting system database: https://pubmed.ncbi.nlm.nih.gov/34219532/\nAcute myocarditis associated with COVID-19 vaccination: report of a case: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/\nAcute myocarditis associated with COVID-19 vaccination: report of a case: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/\nMyocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series: https://pubmed.ncbi.nlm.nih.gov/34840235/.\nMyocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series: https://pubmed.ncbi.nlm.nih.gov/34840235/.\nMyocarditis in the setting of a recent COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34712497/.\nMyocarditis in the setting of a recent COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34712497/.\nAcute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.\nAcute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.\nPrevalence of thrombocytopenia, antiplatelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\nPrevalence of thrombocytopenia, antiplatelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179\nMyocarditis after 2019 coronavirus disease mRNA vaccine: a case series and incidence rate determination: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408.\nMyocarditis after 2019 coronavirus disease mRNA vaccine: a case series and incidence rate determination: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408.\nMyocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\nMyocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\nEpidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\nEpidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\nShedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\nShedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\nDiffuse prothrombotic syndrome after administration of ChAdOx1 nCoV-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34615534/\nDiffuse prothrombotic syndrome after administration of ChAdOx1 nCoV-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34615534/\nThree cases of acute venous thromboembolism in women after coronavirus 2019 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/\nThree cases of acute venous thromboembolism in women after coronavirus 2019 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/\nClinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19; https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.\nClinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19; https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.\nCOV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count: https://pubmed.ncbi.nlm.nih.gov/34632750/\nCOV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count: https://pubmed.ncbi.nlm.nih.gov/34632750/\nPost-mortem findings in vaccine-induced thrombotic thrombocytopenia: https://haematologica.org/article/view/haematol.2021.279075\nPost-mortem findings in vaccine-induced thrombotic thrombocytopenia: https://haematologica.org/article/view/haematol.2021.279075\nCOVID-19 vaccine-induced thrombosis: https://pubmed.ncbi.nlm.nih.gov/34802488/.\nCOVID-19 vaccine-induced thrombosis: https://pubmed.ncbi.nlm.nih.gov/34802488/.\nInflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis: https://pubmed.ncbi.nlm.nih.gov/34887867/.\nInflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis: https://pubmed.ncbi.nlm.nih.gov/34887867/.\nVaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience: https://www.sciencedirect.com/science/article/pii/S235255682100093X\nVaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience: https://www.sciencedirect.com/science/article/pii/S235255682100093X\nOccurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34876440/\nOccurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34876440/\nDeep venous thrombosis more than two weeks after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33928773/\nDeep venous thrombosis more than two weeks after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33928773/\nInformation on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34587242/\nInformation on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34587242/\nChange in blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome: https://pubmed.ncbi.nlm.nih.gov/34868465/\nChange in blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome: https://pubmed.ncbi.nlm.nih.gov/34868465/\nManagement of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34097311/\nManagement of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34097311/\nBilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors: https://pubmed.ncbi.nlm.nih.gov/34820232/.\nBilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors: https://pubmed.ncbi.nlm.nih.gov/34820232/.\nThrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258\nThrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258\nIncidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series: https://pubmed.ncbi.nlm.nih.gov/34579636/\nIncidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series: https://pubmed.ncbi.nlm.nih.gov/34579636/\nSuccessful treatment of vaccine-induced immune immune thrombotic thrombocytopenia in a 26-year-old female patient: https://pubmed.ncbi.nlm.nih.gov/34614491/\nSuccessful treatment of vaccine-induced immune immune thrombotic thrombocytopenia in a 26-year-old female patient: https://pubmed.ncbi.nlm.nih.gov/34614491/\nCase report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34790684/\nCase report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34790684/\nIdiopathic idiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33624509/.\nIdiopathic idiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33624509/.\nSquamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech): https://pubmed.ncbi.nlm.nih.gov/34612003/\nSquamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech): https://pubmed.ncbi.nlm.nih.gov/34612003/\nVaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism: https://pubmed.ncbi.nlm.nih.gov/34096082/\nVaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism: https://pubmed.ncbi.nlm.nih.gov/34096082/\nMyocarditis associated with COVID-19 vaccination in three adolescent boys: https://pubmed.ncbi.nlm.nih.gov/34851078/.\nMyocarditis associated with COVID-19 vaccination in three adolescent boys: https://pubmed.ncbi.nlm.nih.gov/34851078/.\nCardiovascular magnetic resonance findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34496880/\nCardiovascular magnetic resonance findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34496880/\nPerimyocarditis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34866957/\nPerimyocarditis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34866957/\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://pubmed.ncbi.nlm.nih.gov/34849657/.\nEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://pubmed.ncbi.nlm.nih.gov/34849657/.\nMyocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings: https://pubmed.ncbi.nlm.nih.gov/34664804/\nMyocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings: https://pubmed.ncbi.nlm.nih.gov/34664804/\nAcute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older: https://pubmed.ncbi.nlm.nih.gov/34605853/\nAcute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older: https://pubmed.ncbi.nlm.nih.gov/34605853/\nRecurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male: https://pubmed.ncbi.nlm.nih.gov/34166671/\nRecurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male: https://pubmed.ncbi.nlm.nih.gov/34166671/\nYoung male with myocarditis after mRNA-1273 coronavirus disease-2019 (COVID-19) mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34744118/\nYoung male with myocarditis after mRNA-1273 coronavirus disease-2019 (COVID-19) mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34744118/\nAcute myocarditis after SARS-CoV-2 vaccination in a 24-year-old male: https://pubmed.ncbi.nlm.nih.gov/34334935/.\nAcute myocarditis after SARS-CoV-2 vaccination in a 24-year-old male: https://pubmed.ncbi.nlm.nih.gov/34334935/.\nGa-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34746968/\nGa-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34746968/\nOccurrence of acute infarct-like myocarditis after vaccination with COVID-19: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?”: https://pubmed.ncbi.nlm.nih.gov/34333695/.\nOccurrence of acute infarct-like myocarditis after vaccination with COVID-19: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?”: https://pubmed.ncbi.nlm.nih.gov/34333695/.\nSelf-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\nSelf-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\nMyocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military: https://pubmed.ncbi.nlm.nih.gov/34185045/\nMyocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military: https://pubmed.ncbi.nlm.nih.gov/34185045/\nMyocarditis after BNT162b2 vaccination in a healthy male: https://pubmed.ncbi.nlm.nih.gov/34229940/\nMyocarditis after BNT162b2 vaccination in a healthy male: https://pubmed.ncbi.nlm.nih.gov/34229940/\nMyopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: https://pubmed.ncbi.nlm.nih.gov/34133825/\nMyopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: https://pubmed.ncbi.nlm.nih.gov/34133825/\nAcute myocarditis after SARS-CoV-2 mRNA-1273 mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34308326/.\nAcute myocarditis after SARS-CoV-2 mRNA-1273 mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34308326/.\nChest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna: https://pubmed.ncbi.nlm.nih.gov/34866106/\nChest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna: https://pubmed.ncbi.nlm.nih.gov/34866106/\nBiopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\nBiopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\nMultimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34848416/\nMultimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34848416/\nReport of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male: https://pubmed.ncbi.nlm.nih.gov/34636504/\nReport of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male: https://pubmed.ncbi.nlm.nih.gov/34636504/\nAcute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34367386/\nAcute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34367386/\nAcute myocarditis in a young adult two days after vaccination with Pfizer: https://pubmed.ncbi.nlm.nih.gov/34709227/\nAcute myocarditis in a young adult two days after vaccination with Pfizer: https://pubmed.ncbi.nlm.nih.gov/34709227/\nCase report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation: https://pubmed.ncbi.nlm.nih.gov/34778411/\nCase report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation: https://pubmed.ncbi.nlm.nih.gov/34778411/\nAcute myocarditis after 2019 coronavirus disease vaccination: https://pubmed.ncbi.nlm.nih.gov/34734821/\nAcute myocarditis after 2019 coronavirus disease vaccination: https://pubmed.ncbi.nlm.nih.gov/34734821/\nA series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34246585/\nA series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34246585/\nMyopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents: https://pubmed.ncbi.nlm.nih.gov/34228985/\nMyopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents: https://pubmed.ncbi.nlm.nih.gov/34228985/\nPost-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34852213/\nPost-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34852213/\nAcute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease: https://pubmed.ncbi.nlm.nih.gov/34866122/\nAcute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease: https://pubmed.ncbi.nlm.nih.gov/34866122/\nBiventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination: https://pubmed.ncbi.nlm.nih.gov/34601566/\nBiventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination: https://pubmed.ncbi.nlm.nih.gov/34601566/\nMyocarditis following COVID-19 vaccination: MRI study: https://pubmed.ncbi.nlm.nih.gov/34739045/.\nMyocarditis following COVID-19 vaccination: MRI study: https://pubmed.ncbi.nlm.nih.gov/34739045/.\nAcute myocarditis after COVID-19 vaccination: case report: https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e\nAcute myocarditis after COVID-19 vaccination: case report: https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e\nAssociation of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine COVID-19 in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\nAssociation of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine COVID-19 in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\nMyocarditis following vaccination with Covid-19 in a large healthcare organization: https://pubmed.ncbi.nlm.nih.gov/34614329/\nMyocarditis following vaccination with Covid-19 in a large healthcare organization: https://pubmed.ncbi.nlm.nih.gov/34614329/\nAstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link: https://pubmed.ncbi.nlm.nih.gov/34560365/\nAstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link: https://pubmed.ncbi.nlm.nih.gov/34560365/\nCOVID-19, Guillain-Barré and vaccineA dangerous mix: https://pubmed.ncbi.nlm.nih.gov/34108736/.\nCOVID-19, Guillain-Barré and vaccineA dangerous mix: https://pubmed.ncbi.nlm.nih.gov/34108736/.\nGuillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases: https://pubmed.ncbi.nlm.nih.gov/34796417/.\nGuillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases: https://pubmed.ncbi.nlm.nih.gov/34796417/.\nGuillain-Barre syndrome after BNT162b2 COVID-19 vaccine: https://link.springer.com/article/10.1007%2Fs10072-021-05523-5.\nGuillain-Barre syndrome after BNT162b2 COVID-19 vaccine: https://link.springer.com/article/10.1007%2Fs10072-021-05523-5.\nCOVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy: https://onlinelibrary.wiley.com/doi/10.1002/ana.26258.\nCOVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy: https://onlinelibrary.wiley.com/doi/10.1002/ana.26258.\nAssociation of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021: https://jamanetwork.com/journals/jama/fullarticle/2785009\nAssociation of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021: https://jamanetwork.com/journals/jama/fullarticle/2785009\nA case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34567447/\nA case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34567447/\nGuillain-Barré syndrome associated with COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34648420/.\nGuillain-Barré syndrome associated with COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34648420/.\nRate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine: https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708\nRate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine: https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708\nGuillain-Barre syndrome after COVID-19 vaccination in an adolescent: https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.\nGuillain-Barre syndrome after COVID-19 vaccination in an adolescent: https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.\nGuillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34114256/.\nGuillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34114256/.\nGuillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34767184/.\nGuillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34767184/.\nGuillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients: https://pubmed.ncbi.nlm.nih.gov/34644738/.\nGuillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients: https://pubmed.ncbi.nlm.nih.gov/34644738/.\nGuillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients: https://pubmed.ncbi.nlm.nih.gov/34649856/\nGuillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients: https://pubmed.ncbi.nlm.nih.gov/34649856/\nA rare case of Guillain-Barré syndrome after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34671572/\nA rare case of Guillain-Barré syndrome after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34671572/\nNeurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33758714/\nNeurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33758714/\nCOVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect: https://pubmed.ncbi.nlm.nih.gov/34484780/\nCOVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect: https://pubmed.ncbi.nlm.nih.gov/34484780/\nGuillain-Barre syndrome after the first dose of COVID-19 vaccination: case report; https://pubmed.ncbi.nlm.nih.gov/34779385/.\nGuillain-Barre syndrome after the first dose of COVID-19 vaccination: case report; https://pubmed.ncbi.nlm.nih.gov/34779385/.\nMiller Fisher syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34817727/.\nMiller Fisher syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34817727/.\nMiller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination: https://pubmed.ncbi.nlm.nih.gov/34789193/.\nMiller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination: https://pubmed.ncbi.nlm.nih.gov/34789193/.\nBilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261746/\nBilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261746/\nGuillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://pubmed.ncbi.nlm.nih.gov/34217513/.\nGuillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://pubmed.ncbi.nlm.nih.gov/34217513/.\nA case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34871447/\nA case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34871447/\nReporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/\nReporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/\nA variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN: https://pubmed.ncbi.nlm.nih.gov/34370408/.\nA variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN: https://pubmed.ncbi.nlm.nih.gov/34370408/.\nA rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34703690/.\nA rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34703690/.\nGuillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome: https://pubmed.ncbi.nlm.nih.gov/34810163/\nGuillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome: https://pubmed.ncbi.nlm.nih.gov/34810163/\nGuillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.\nGuillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.\nAcute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34482455/.\nAcute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34482455/.\nVariant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34114269/.\nVariant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34114269/.\nGuillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine: https://pubmed.ncbi.nlm.nih.gov/34722067/\nGuillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine: https://pubmed.ncbi.nlm.nih.gov/34722067/\nGuillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://pubmed.ncbi.nlm.nih.gov/33968610/\nGuillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://pubmed.ncbi.nlm.nih.gov/33968610/\nSARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy: https://pubmed.ncbi.nlm.nih.gov/34525410/\nSARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy: https://pubmed.ncbi.nlm.nih.gov/34525410/\nClinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine: https://pubmed.ncbi.nlm.nih.gov/34808658/\nClinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine: https://pubmed.ncbi.nlm.nih.gov/34808658/\nAdverse event reporting and risk of Bell’s palsy after COVID-19 vaccination: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.\nAdverse event reporting and risk of Bell’s palsy after COVID-19 vaccination: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.\nBilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence: https://pubmed.ncbi.nlm.nih.gov/34522557/\nBilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence: https://pubmed.ncbi.nlm.nih.gov/34522557/\nLeft Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34763263/.\nLeft Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34763263/.\nBell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report: https://pubmed.ncbi.nlm.nih.gov/34621891/\nBell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report: https://pubmed.ncbi.nlm.nih.gov/34621891/\nNeurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34697502/\nNeurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34697502/\nType I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy: https://pubmed.ncbi.nlm.nih.gov/33858693/\nType I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy: https://pubmed.ncbi.nlm.nih.gov/33858693/\nAcute transverse myelitis following inactivated COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34370410/\nAcute transverse myelitis following inactivated COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34370410/\nAcute transverse myelitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34579245/.\nAcute transverse myelitis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34579245/.\nA case of longitudinally extensive transverse myelitis following Covid-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34182207/\nA case of longitudinally extensive transverse myelitis following Covid-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34182207/\nPost COVID-19 transverse myelitis; a case report with review of the literature: https://pubmed.ncbi.nlm.nih.gov/34457267/.\nPost COVID-19 transverse myelitis; a case report with review of the literature: https://pubmed.ncbi.nlm.nih.gov/34457267/.\nBeware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189662/\nBeware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189662/\nNeuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34660149/\nNeuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34660149/\nAcute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34131771/\nAcute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34131771/\nA case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States: https://pubmed.ncbi.nlm.nih.gov/34635376/\nA case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States: https://pubmed.ncbi.nlm.nih.gov/34635376/\nAcute pericarditis and cardiac tamponade after vaccination with Covid-19: https://pubmed.ncbi.nlm.nih.gov/34749492/\nAcute pericarditis and cardiac tamponade after vaccination with Covid-19: https://pubmed.ncbi.nlm.nih.gov/34749492/\nMyocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34849667/\nMyocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34849667/\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34319393/\nPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34319393/\nAcute myopericarditis after COVID-19 vaccine in adolescents: https://pubmed.ncbi.nlm.nih.gov/34589238/\nAcute myopericarditis after COVID-19 vaccine in adolescents: https://pubmed.ncbi.nlm.nih.gov/34589238/\nPericarditis after administration of the BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34149145/\nPericarditis after administration of the BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34149145/\nCase report: symptomatic pericarditis post COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34693198/.\nCase report: symptomatic pericarditis post COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34693198/.\nAn outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient: https://pubmed.ncbi.nlm.nih.gov/34797392/\nAn outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient: https://pubmed.ncbi.nlm.nih.gov/34797392/\nHemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19): https://pubmed.ncbi.nlm.nih.gov/34862234/\nHemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19): https://pubmed.ncbi.nlm.nih.gov/34862234/\nMyocarditis after SARS-CoV-2 mRNA vaccination, a case series: https://pubmed.ncbi.nlm.nih.gov/34396358/.\nMyocarditis after SARS-CoV-2 mRNA vaccination, a case series: https://pubmed.ncbi.nlm.nih.gov/34396358/.\nMiller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34848426/.\nMiller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34848426/.\nImmune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\nImmune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\nPost-mortem investigation of deaths after vaccination with COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34591186/\nPost-mortem investigation of deaths after vaccination with COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34591186/\nAcute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352309/\nAcute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352309/\nRelapse of immune thrombocytopenia after covid-19 vaccination in young male patient: https://pubmed.ncbi.nlm.nih.gov/34804803/.\nRelapse of immune thrombocytopenia after covid-19 vaccination in young male patient: https://pubmed.ncbi.nlm.nih.gov/34804803/.\nImmune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2: https://pubmed.ncbi.nlm.nih.gov/34077572/\nImmune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2: https://pubmed.ncbi.nlm.nih.gov/34077572/\nRetinal hemorrhage after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34884407/.\nRetinal hemorrhage after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34884407/.\nCase report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34859017/\nCase report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34859017/\nIntracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report: https://pubmed.ncbi.nlm.nih.gov/34783899/\nIntracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report: https://pubmed.ncbi.nlm.nih.gov/34783899/\nPeduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34549178/.\nPeduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34549178/.\nBrain death in a vaccinated patient with COVID-19 infection: https://pubmed.ncbi.nlm.nih.gov/34656887/\nBrain death in a vaccinated patient with COVID-19 infection: https://pubmed.ncbi.nlm.nih.gov/34656887/\nGeneralized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34236717/.\nGeneralized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34236717/.\nLobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34729467/.\nLobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34729467/.\nA case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33932458/\nA case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33932458/\nAcral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction: https://pubmed.ncbi.nlm.nih.gov/34092400/742.\nAcral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction: https://pubmed.ncbi.nlm.nih.gov/34092400/742.\nSevere immune thrombocytopenic purpura after SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34754937/\nSevere immune thrombocytopenic purpura after SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34754937/\nGross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy: https://pubmed.ncbi.nlm.nih.gov/33771584/\nGross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy: https://pubmed.ncbi.nlm.nih.gov/33771584/\nAutoimmune encephalitis after ChAdOx1-S SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34846583/\nAutoimmune encephalitis after ChAdOx1-S SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34846583/\nCOVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\nCOVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\nBell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and a nested case-control study: https://pubmed.ncbi.nlm.nih.gov/34411532/\nBell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and a nested case-control study: https://pubmed.ncbi.nlm.nih.gov/34411532/\nEpidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval: https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1\nEpidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval: https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1\nAnaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria: https://pubmed.ncbi.nlm.nih.gov/33851711/\nAnaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria: https://pubmed.ncbi.nlm.nih.gov/33851711/\nAnaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination: https://pubmed.ncbi.nlm.nih.gov/34675550/.\nAnaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination: https://pubmed.ncbi.nlm.nih.gov/34675550/.\nAnaphylaxis after Modern COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34734159/.\nAnaphylaxis after Modern COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34734159/.\nAssociation of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34698847/\nAssociation of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34698847/\nSex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19: https://pubmed.ncbi.nlm.nih.gov/34020815/\nSex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19: https://pubmed.ncbi.nlm.nih.gov/34020815/\nAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020: https://pubmed.ncbi.nlm.nih.gov/33641264/\nAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020: https://pubmed.ncbi.nlm.nih.gov/33641264/', '[-0.02658599615097046, 0.019231772050261497, -0.037797145545482635, -0.02786431834101677, 0.08342522382736206, 0.03958765044808388, -0.029681852087378502, 0.045377522706985474, -0.017644012346863747, 0.05498668551445007, 0.03114866465330124, 0.03121059015393257, 0.0472157746553421, 0.10208779573440552, -0.03701096400618553, -0.039498988538980484, 0.028238970786333084, -0.09371092170476913, 0.025200091302394867, 0.06836650520563126, -0.034671880304813385, 0.04536884278059006, 0.10008168965578079, 0.07121597975492477, -0.06312192976474762, 0.007850280031561852, -0.06036407873034477, -0.03861495107412338, -0.034346986562013626, -0.0012464381288737059, 0.04406050965189934, -0.03590921685099602, -0.06655087321996689, 0.0082494355738163, -0.004241923801600933, -0.05793110281229019, 0.09059090912342072, -0.05147717893123627, 0.042884036898612976, 0.016589868813753128, 0.06043293699622154, -0.03920089825987816, 0.025396013632416725, -0.035496581345796585, 0.057126447558403015, 0.052756231278181076, -0.04849771410226822, 0.007756942417472601, -0.023324519395828247, -0.035109587013721466, -0.07644858956336975, -0.07438256591558456, 0.052647508680820465, -0.013304587453603745, -0.026500115171074867, -0.12919127941131592, -0.06720681488513947, -0.01552430260926485, 0.02808438614010811, -0.005622275173664093, 0.012680771760642529, 0.0007181836408562958, -0.029380053281784058, 0.016892505809664726, -0.058074865490198135, -0.010734857991337776, 0.019229892641305923, 0.00035913210012950003, 0.04527578502893448, 0.06332328170537949, 0.060116611421108246, -0.01736372895538807, 0.014301659539341927, 0.041917912662029266, -0.06675209850072861, 0.0798879936337471, 0.05819128081202507, 0.03821072354912758, 0.08114892244338989, -0.06514357030391693, 0.07088346034288406, -0.058307647705078125, 0.10166633874177933, 0.008300360292196274, -0.006209826562553644, -0.04413184896111488, 0.0010706130415201187, 0.004839891567826271, 0.06952665746212006, -0.02968251332640648, 0.05119642615318298, -0.02446696348488331, 0.12891605496406555, 0.09383407980203629, -0.019493797793984413, -0.0038089673034846783, 0.04722436144948006, 0.061331525444984436, -0.018817784264683723, -0.0008592086960561574, -0.06546786427497864, -0.03676959127187729, -0.06444793939590454, -0.04094557464122772, 0.04036273434758186, -0.0033570071682333946, -0.04278283566236496, 0.002415973460301757, 0.03901660442352295, -0.014982860535383224, 0.0010192525805905461, 0.14031000435352325, -0.09158821403980255, -0.025495687499642372, 0.08186452835798264, 0.1086447462439537, 0.011521494016051292, -0.06342335790395737, -0.0070314607582986355, -0.018063360825181007, 0.03229229524731636, -0.09877959638834, -0.021984810009598732, -0.0011724811047315598, 0.08966105431318283, 0.0018372328486293554, -0.0036661734338849783, 2.7123927867659565e-33, 0.012147678062319756, 0.07032383978366852, 0.10970141738653183, 0.026879578828811646, -0.050141122192144394, 0.0022187584545463324, -0.04009838029742241, 0.033704400062561035, -0.008687296882271767, -0.01915920339524746, 0.003165720496326685, 0.02433095872402191, 0.015458098612725735, 0.06655749678611755, -0.0014953652862459421, 0.026057904586195946, -0.02194366045296192, -0.007911569438874722, -0.045516904443502426, -0.002896684454753995, 0.09879481792449951, -0.010011541657149792, 0.03963698446750641, 0.0545162670314312, -0.03390603885054588, -0.01684003882110119, -0.021911760792136192, -0.0008590001962147653, 0.07337068766355515, 0.03222889080643654, -0.001777155208401382, -0.009122948162257671, 0.04756877198815346, 0.03986206650733948, -0.013679531402885914, 0.0009581191698089242, -0.09147212654352188, -0.03410976007580757, -0.007012603338807821, 0.04941411316394806, 0.11098090559244156, 0.029841428622603416, -0.04384474828839302, 0.002234915504232049, 0.08682175725698471, -0.05088178068399429, -0.04342149198055267, -0.08682463318109512, -0.07242421805858612, -0.010866452008485794, -0.019682539626955986, 0.088622085750103, -0.015909802168607712, -0.009773612022399902, 0.0070076934061944485, 0.05022211745381355, -0.03164646774530411, 0.022098395973443985, 0.06727161258459091, -0.04680051654577255, 0.0674986019730568, 0.03765928000211716, -0.06008579209446907, 0.02505507506430149, -0.0729285255074501, -0.002493649022653699, 0.01418230589479208, -0.049890123307704926, -0.027263425290584564, 0.049980681389570236, 0.024828150868415833, 0.006149795837700367, -0.08096639811992645, -0.09799348562955856, 0.002965182065963745, -0.052814748138189316, 0.025257933884859085, -0.02611435204744339, 0.049906060099601746, -0.01733388751745224, 0.0009845832828432322, 0.010701000690460205, 0.039703212678432465, 0.008661330677568913, -0.035900261253118515, -0.002372555900365114, -0.03597918897867203, 0.023930441588163376, -0.04606616124510765, 0.06295499950647354, 0.011369612067937851, 0.022392870858311653, 0.034125883132219315, 0.0003653056628536433, -0.06771450489759445, -3.3557832729702194e-33, -0.03987912833690643, -0.016849281266331673, -0.04285627603530884, -0.007817301899194717, -0.09713279455900192, 0.0605679526925087, 0.012583380565047264, 0.01838160678744316, 0.08014630526304245, -0.023989474400877953, -0.021259944885969162, -0.01835465431213379, 0.05475849658250809, -0.008154772222042084, -0.025309553369879723, -0.01561401505023241, -0.01004958339035511, 0.034756362438201904, -0.08073582500219345, -0.05510683357715607, 0.09320614486932755, -0.008653602562844753, -0.010499590076506138, 0.024530433118343353, -0.029514223337173462, 0.034041669219732285, 0.08989377319812775, -0.07481853663921356, 0.034653421491384506, -0.023826470598578453, -0.056010715663433075, 0.07295439392328262, 0.0031726823654025793, 0.039776116609573364, -0.04024629667401314, -0.01056689489632845, 0.09683289378881454, -0.006100383587181568, 0.010895012877881527, -0.07808820903301239, -0.05602671951055527, 0.05439247563481331, -0.09650122374296188, -0.04968935623764992, -0.012024395167827606, 0.013086811639368534, 0.020753072574734688, 0.06095825880765915, 0.035513363778591156, 0.037936072796583176, -0.00984135176986456, -0.05379711836576462, -0.06506543606519699, -0.027632737532258034, -0.03541615232825279, -0.053507234901189804, -0.036027662456035614, -0.034373801201581955, 0.0012317545479163527, 0.005773392505943775, 0.021275490522384644, 0.01654324308037758, -0.15933004021644592, -0.027374738827347755, 0.07425270974636078, 0.04509725049138069, 0.01635574921965599, 0.032635822892189026, 0.06628619879484177, -0.09144917875528336, 0.029787950217723846, -0.001052877982147038, -0.054672446101903915, -0.10595057904720306, -0.047392357140779495, -7.289863424375653e-05, 0.014359038323163986, -0.052375126630067825, -0.021980592980980873, 0.004355674609541893, 0.10109323263168335, -0.10675185918807983, 0.0904288962483406, -0.03433443605899811, 0.059804435819387436, -0.015344489365816116, 0.03589224815368652, -0.09609504789113998, -0.11794210970401764, 0.08107786625623703, -0.1025155633687973, -0.11546996980905533, -0.018237167969346046, 0.006322631612420082, 0.014152192510664463, -5.111548517788833e-08, 0.11942160129547119, -0.007421484682708979, -0.027893323451280594, 0.004085657652467489, 0.005189912859350443, 0.02027539722621441, -0.067620187997818, -0.022511430084705353, 0.008325206115841866, 0.05112535133957863, 0.08208219707012177, 0.01963810995221138, 0.021583421155810356, -0.000696102564688772, -0.038070473819971085, 0.01700325310230255, -0.08544395864009857, -0.04774909093976021, -0.06964866816997528, 0.004825688432902098, -0.006488552782684565, 0.038356807082891464, 0.01163395494222641, 0.0182185135781765, -0.008793299086391926, 0.024325119331479073, 0.009726532734930515, -0.0032049284782260656, 0.04266407713294029, -0.06569665670394897, -0.14841939508914948, -0.052796412259340286, 0.038915667682886124, 0.06985445320606232, -0.05857791379094124, -0.08654885739088058, 0.05252235010266304, 0.023899568244814873, 0.011907012201845646, -0.011226308532059193, 0.030650591477751732, -0.029462790116667747, 0.0034352075308561325, 0.046526238322257996, -0.014775453135371208, 0.020076876506209373, -0.05586126074194908, -0.026202907785773277, -0.006773270666599274, 0.023223435506224632, 0.007994105108082294, -0.037569914013147354, 0.036559559404850006, 0.021280037239193916, -0.09778954833745956, 0.06306716054677963, -0.05597809702157974, -0.08914797008037567, 0.008580132387578487, -0.015862641856074333, 0.10132376849651337, -0.06097785383462906, 0.07187879830598831, 0.0643487349152565]');
INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1530, 'BBC Hosts Big Pharma’s African Vaccine Marketing Campaign', 'https://drrobertyoung.com/bbc-hosts-big-pharmas-african-vaccine-marketing-campaign/', 'ByRusere Shoniwa | Dec 27, 2021\nIf Big Pharma were to run a modestly honest advertisement to recruit dealers for pushing Covid so-called ‘vaccines’ in Africa, it might read something like this below:\nDr Ayoade Alakija on BBC World News at the end of November\n‘International drug cartel requires Western educated Black face to front our public campaign to push experimental and unnecessary Covid vaccines on the impoverished African continent. This is a tough market, highly suspicious of the product and not without good reason. Smile and dial merchants need not apply as you must bypass the consumer to target the decision-maker . Successful applicants must display the ability to rail melodramatically at the ‘racist vaccine-hoarding’ injustices perpetrated by the West against Africa, appealing to the woke sensibilities of those in positions of power within key Western institutions. African leaders will then be expected to do as they’re told.’\nBBC stages agitprop for Big Pharma\nI must confess that I reverse-engineered that ad after watching the successful applicant going through the motions like a performing seal on a BBC World News slot set aside for just such agitprop. Following the latest Covid variant hype, the Co-Chair of the African Union’s Vaccine Delivery Alliance, Dr Ayoade Alakija, announced on the UK’s flagship propaganda organ :\n‘What is going on right now [the emergence of the Omicron Variant] is inevitable. It’s a result of the world’s failure to vaccinate in an equitable, urgent and speedy manner. It is a result of hoarding by high-income countries of the world and quite frankly it is unacceptable. These travel bans are based in politics and not science. It is wrong.’\nAbandoning any pretence at journalism, the BBC presenter plays the role of therapist by responding: “I hear your anger about the immediate reaction and the lack of action beforehand.’\nThe stage direction becomes even more obvious and cringeworthy as the BBC presenter then pauses, providing a cue for the good doctor to glance at her script and resume the televised amateur dramatics:\n‘So this is hopefully a dress rehearsal because until everyone is vaccinated no-one is safe…Why are the Africans unvaccinated?\nIt’s an outrage because we knew we were going to get here. We knew this is where the hoarding, the lack of IP waivers, the lack of cooperation on sharing tech and sharing know-how, we knew this was the cross-roads it was going to bring us to. To a more dangerous variant.’\nThe only valid question she raises concerns the swift travel bans placed on Southern African countries: ‘Why are we locking away Africa when this virus is already on three continents? Nobody is locking away Belgium, nobody is locking away Israel.’\nThis is an emotional ploy to gain the trust of the small handful of privileged Africans watching this drivel. She is saying to them: ‘I am right-on, woke, one of you.’ She quickly jumps back on board the Covid cult train with a policy ‘nudge’ that must have African leaders reaching for their sick bags.\n‘Something needs to be done to everywhere. My recommendation is have a coordinated global shut down of travel, for the next month if you want, but don’t single out Africa.’\nAnd then back to the greedy, vaccine-hoarding West:\n‘The Botswana government ordered 500,000 doses of vaccines at $29 per dose, much higher than the rest of the world paid. They did not get those vaccines because other people jumped ahead in the queue. Moderna supplied to other countries…and so now we have a variant.’\nRule #1 of BBC ‘journalism’ – avoid the most obvious question\nNot a single grain of this guerrilla marketing campaign was challenged by the BBC journalist. The obvious starting point for a presenter with half an ounce of journalistic integrity would be to explore whether the ‘vaccines’ are working and whether they would indeed have prevented a variant. After all, the fact that they do not halt transmission and infection is no longer controversial.\nAfter the The Daily Sceptic blew the lid off the vaccine efficacy lie, The Spectator confirmed that ‘in every age group over 30 in the UK, the rates of Covid infection per 100,000 are now higher among the vaxxed than the unvaxxed’. Even the UK Prime Minister has been forced to admit that the vaccine ‘ doesn’t protect you against catching the disease, and it doesn’t protect you against passing it on ‘.\nThe BBC itself doesn’t pretend to be ignorant of the uselessness of the vaccine in preventing transmission and infection but, in a homage to Orwellian satire, it managed to use vaccine inefficacy to argue for more vaccination.\nAfrican leaders will be wondering why Portugal, one of the world’s most vaccinated places, which has pretty much run out of people to vaccinate, has recently announced it will reimpose restrictions to stop a surge in cases. Emphasizing that the definition of madness – repeatedly doing what has been shown not to work – is no longer a barrier to health policy in the West, Portugal announced that it will ‘continue to bet on vaccination to control the pandemic’ by rolling out booster shots.\nAfrican leaders may ponder why Gibraltar, whose entire eligible population is vaccinated, has cancelled official Christmas events amid a surge in Covid-19 cases . Gibraltar has achieved the mathematical impossibility of a 118% vaccination rate owing to counting doses given to Spaniards who cross the border to work or visit the territory every day. Its health minister in November announced a ‘ drastic increase in the numbers of people testing positive for Covid-19 in recent days’.\nHere is a report on 10 countries where data shows the vaccines have failed miserably.\nIt would have been entertaining to see the Vaccine Delivery Alliance spin doctor weave all of this into her sales pitch for Africa.\nOmicron fear porn demonstrates collapse of the vaccine narrative\nNo sales pitch involving an illness would be complete without recourse to fear-based marketing tactics . Enter the Omicron narrative. Despite her claim that we now have ‘a more dangerous variant’, there was no evidence that this variant would make any difference to disease severity at the time she was invited by the BBC to make her vaccine sales pitch for Africa. (Nor is there proof that vaccination prevents variants from arising in the first place.) Since then, the evidence emerging is that Omicron is less severe than previous variants and more contagious – the ideal combination for hastening herd immunity with minimal population health impact.\nAre there any grounds for believing that the ‘vaccines’ will be any less useless at stopping this variant than they have been with all the preceding variants? Reuters reported on 2nd December that all 14 passengers returning to the Netherlands on two flights from South Africa who tested positive for the Omicron variant were vaccinated. It also reported ‘that most of the 62 people who tested positive for COVID-19 [irrespective of variant] … had been vaccinated, lending weight to a call for pre-flight testing regardless of vaccination status.’\nReports of the worthlessness of the vaccine are too numerous to catalogue. The one above serves the dual purpose of illustrating the collapse of the vaccine narrative and the stupidity of using the variant narrative as an argument for more vaccination. The only thing more depressing than seeing the stale and mold-ridden variant dish being reheated and served up yet again is watching people capable of reading and writing hungrily devouring it.\nIn short, the vaccine narrative is not merely in freefall; it is a fetid corpse being given mouth-to-mouth resuscitation by a political leadership and its media allies whose threshold for self-abasement is boundless. Telling medium-sized lies and half-truths with a straight face has always been the minimum qualification for political office, but Covid has raised the bar to a new height – the ability to swim in a pool of one’s own metaphorical vomit without flinching.\nNever, never mention vaccine safety\nThe ‘discussion’ might have turned to safety to tease out how much personal risk Africans will be expected to bear in submitting to a vaccine that doesn’t perform the primary function of a vaccine. The word ‘safety’, however, was not permitted to impinge in any way on the protestations of the injustice of depriving Africans of the wondrous medical treatments emanating from the hallowed laboratories of Western science.\nThe reticence about safety is understandable from a marketing perspective since, by any objective measure, these ‘vaccines’ are the most dangerous mass medications rolled out in modern history. At 25 November the vaccine safety reporting systems in the US, EU and UK reported deaths following vaccination of 18,853; 31,014; and 1,784 respectively. The total number of adverse reports logged across these systems respectively is 894,145; 386,517 (encompassing 1,271,009 individual events); and 1,181,121 (encompassing 2,859,586 events).\nAlex Berenson, a former New York Times investigative journalist, has made a name for himself reporting the truth about Covid. He made the following sobering observation about relative risk of Covid and injury from vaccination for young college age adults:\n‘The risk of severe disease or death from Covid to healthy college-age adults is too low to measure accurately. The data from Europe suggests that a healthy 18 year-old has a risk of death lower than 1 in 1 million.\n‘The risk of dangerous heart inflammation [following Covid vaccination] is NOT too low to measure. A new study from Hong Kong found that 1 out of 2,300 12-17 year-old boys who received both Pfizer doses suffered acute myocarditis or pericarditis. Most of the risk came after the second dose. The risk is very similar in college-age men.’\nIt has also come to light that Pfizer clinical trial data shows that more vaccine trial recipients died than did the placebo recipients. Berenson points out that ‘all-cause mortality is arguably the MOST important measure for any drug or vaccine – especially one meant to be given prophylactically to large numbers of healthy people, as vaccines are.’\nMeanwhile the US FDA is resisting attempts to get it to release important documents associated with the approval of the Pfizer vaccine , claiming that it could take 75 years to comply with the request. If the FDA gets its way, some 451,000 pages regarding the clinical trials for this vaccine will be off limits to the millions of people being coerced into taking it. Aside from the gall it takes to hide information about a treatment from the patients being forced to take it, how can there be any claims to ‘following The Science™’ when science relies on data and the data is being deliberately hidden?\nAnd who will Africans turn to in the event of serious injury from a treatment to prevent an illness that the vast majority have coped very well with for two years? Perhaps Dr Alakija should have been quizzed about how Africans might react to the drug manufacturer’s lack of confidence in the safety of their own products in light of their refusal to distribute it to countries who refuse to provide blanket immunity from liability for injury.\nHow much of the safety information provided here (which is a tip-of-the-iceberg summary) was explored, even in the vaguest terms, in the BBC World ‘News’ report?\nNot a single word of it was mentioned. Nothing. Neither of the two stooges saw fit to broach the prospect that many young Africans whose risk of dying from Covid is so small that it is hard to measure, may die following vaccination. Recall the vaccine risk to young males highlighted by Alex Berenson and then link it to Africa’s average age of 20.\nThe callousness of this omission is standard operating procedure in Western liberal discourse, a key function of which is to drape a ‘humanitarian’ cloak over policies that enrich corporate interests in the West while harming and exploiting the poor. The only consolation available to Africans is that this time around, the expendability of life in the ostensible cause of furthering scientific progress has been equally applied to their Western counterparts. The game really has changed in that sense. That is obviously not something to be celebrated but it is an important clue to the meaning of Covid as a global change phenomenon, more of which later.\nPropaganda 101 – bury credible dissenting narratives\nUnveiling the farce of the BBC plug for Africa’s vaccination allows us to consider a game in which we imagine what other doctors might say if the BBC were to air credible dissenting voices – a practice that was once regarded as the bread and butter of journalism, but which would now be a radical act of rebellion. It’s not a difficult game to play. In fact, no imagination is required because the actual statements of credible dissenting medical doctors are available on other independent media news channels.\nHere’s what some doctors are saying on a new Austrian TV channel:\nDr Christian Fiala : ‘The Covid-19 vaccine is useless and dangerous. The public has been manipulated and conditioned through scaremongering, and the measures taken are – sadly – completely haphazard. People have steered clear of rational argument when discussing the “pandemic”. This new-fangled mRNA “vaccine” makes the human immune system attack its own body. So, the corona “vaccine” is effectively programmed self-destruction.’\nDr Heiko Schöning : ‘The corona panic is a stage-managed production. It’s a confidence trick. It is now urgent that we understand we are now in the grip of a worldwide Mafioso-style criminal enterprise. We can see we are dealing here with organised crime. So what do we do? We don’t play along any longer. Here and now we have to draw the red line.’\nHad Dr Schöning just finished watching the two stooges on BBC World News when he described ‘the corona panic’ as ‘a stage-managed production’?\nWhether the Austrian doctors are right or wrong is irrelevant to the journalistic duty to present credible dissenting voices to the public. The failure to do so goes a long way to meeting the criteria for propaganda. The question in relation to Dr Alakija’s BBC guerrilla marketing campaign is: do enough Africans know that there are alternative credible narratives to challenge the mainstream BBC vaccine narrative and how would they respond if these competing narratives were presented?\nThe meaning of Covid for Africa – a manufactured crisis is a crisis no less\nDoes Africa, or anywhere else for that matter, need mass vaccination?\nAlmost two years into this global nightmare, with evidence showing that up to 80% of South Africans (how similar for other African nations?) may have already been exposed to the virus, less than 6% of Africa vaccinated, and a death toll a fraction of that in the ageing populations of the West ( Africa’s Covid deaths are 3% of the global total ), it is clear that Africa has already learnt to live with the virus.\nIt must be patently obvious to African leaders that the Covid crisis is a manufactured one, but that does not make it any less of a crisis. On the contrary, it signals a far deeper crisis in the West than might have been the case had there been sincere and rational attempts to deal with a genuinely apocalyptic health threat. Covid containment policies are not about protection of health and nor are they the result of incompetence as many naïve commentators so desperately want to believe.\nThe West’s ruling elite has completely lost confidence (if it ever did have confidence) in the values of democracy and freedom that it tried to impose on the rest of the world through a combination of brute military force and economic terrorism. Notwithstanding that these uncivilized means of delivery signified an absence of faith in the product, the result of the loss of confidence in these values is that Western liberal democracy is being dismantled at breakneck speed under the cover of Covid containment policies.\nThe criminality, coercion, censorship, propaganda and blatant negligence all signal the logical conclusion to a brutal colonial mindset – the attempted colonization of the entire globe to serve the interests of a global elite which has successfully captured Western governments and supranational organizations.\nWe are not experiencing mere change à la 1968. We are witnessing the collapse of a global empire with a mafia style global elite hijacking that collapse to defend its continued survival in the aftermath. The psychopaths whose aim is to introduce a technocratic global system of human control understand only too well that shutting off travel for economies that rely on tourism is a far bigger killer of economies, and therefore lives, than this virus has ever been . The message being sent by the sadistic controllers to Africa’s leaders is a simple one: get serious about imposing vaccines and the technocratic population control measures for which vaccines are the delivery system…or else. This is an audacious global project and, to state the obvious, global tyranny won’t work unless it’s global .\nAfrica is at an epochal crossroads courtesy of Covid policies manufactured in the West and being exported wholesale to Africa. At a superficial level, absolutely everything about the West’s containment policies for Covid can be characterized as voodoo garbage. African leaders understand this. In relation to the punitive global reaction to Omicron, the South African president called out the unscientific basis for the travel bans . And yet still he flirts with lighting a match underneath the seething resentment of forced vaccines by threatening mandated vaccination.\nHis failure to appreciate this is rooted in a failure to comprehend the meaning of Covid. It is a totalitarian coup by global capital using captured Western governments to implement technocratic systems of biomedical and financial control . If Africa is serious about avoiding recolonization, it must get serious about resisting Covid diktats from Western governments and international agencies.\nYou can read more of Rusere’s work at: https://plagueonbothhouses.com\nMany thanks to Rusere Shoniwa for permission to repost this article. May Africa wake and lead the way forward in rejecting and halting the toxic COVID-vaccines which are causing millions worldwide to die and suffer disability. Please share widely!\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nhttps://www.drrobertyoung.com/post/lies-more-lies-and-damn-lies-from-those-we-are-mandated-to-trust\nhttps://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nPREVIOUS PODCASTS WITH DR. YOUNG WHERE HE EXPLAINS MORE ON THESE SUBJECTS: Report 255 | Dr. Robert Young: All Disease is Outfection Not Infection–Vaccine Nano is Bioweapon! https://www.bitchute.com/video/rdQhuY455VmK/\nNewsbreak 135–BREAKING: Immense Harm from Crystallizing Blood Cells/Graphene Poisoning Post-Vaccine https://www.bitchute.com/video/PRBfJ6U9EZvM/\nNewsbreak 133: Team of Scientists Confirm Presence of Toxins https://everydayconcerned.net/2021/08/28/newsbreak-133-team-of-scientists-confirm-presence-of-toxins-graphene-aluminium-cadmium-selenide-stainless-steel-lnp-go-capsids-parasites-other-toxins-variously-in-4-covid-vaccines-pfizer-mode/ https://www.bitchute.com/video/Z2sAH0Woz38r/\nDETOX NANOTECH and CLEANSE YOUR PINEAL GLAND\nTry Clean Slate, Zero-In, and Restore for detox and daily health at this link (which supports this channel): https://therootbrands.com/micmar\nFREE YOURSELF FROM THE MATRIX OF MORTGAGES, DEBT, AND RIGGED COURTS: Sign in to the Matrix Freedom platform for more information: https://matrixfreedom.life/know-the-biggest-secret/?code=15059&ag=Ramola%20D\nCONTACT WITH REFERRALS FOR INTERVIEWS, INFO: ramolad@everydayconcerned.net\nYou can read more of Rusere’s work at: https://plagueonbothhouses.com', '[-0.09590434283018112, 0.06073501333594322, -0.05916378274559975, -0.08338319510221481, 0.04807141050696373, -0.0008929283358156681, 0.03986268863081932, 0.07468447834253311, -0.038265638053417206, 0.04758147522807121, -0.028948266059160233, -0.03743903338909149, 0.0029439141508191824, 0.049461282789707184, -0.02491665631532669, -0.03245316445827484, 0.10703525692224503, -0.07770251482725143, -0.05878787115216255, 0.008100055158138275, -0.02736048586666584, -0.03170158341526985, 0.08196715265512466, 0.02214745432138443, -0.09753242135047913, -0.03876582160592079, -0.05645768344402313, -0.01908944733440876, 0.0037817759439349174, -0.03227108716964722, 0.04163094237446785, 0.007047974970191717, 0.05149323493242264, 0.009928463026881218, -0.024187427014112473, -0.014255546033382416, -0.04108324646949768, 0.022414835169911385, 0.0029669692739844322, -0.015161163173615932, 0.10155598074197769, -0.06412839889526367, -0.07184761017560959, -0.0005038331146351993, 0.11867343634366989, -0.05130307748913765, 0.004769683349877596, 0.10737506300210953, 0.006702573969960213, 0.02944178692996502, -0.10383018106222153, -0.09588661044836044, -0.04110113903880119, -0.026873504742980003, -0.06898286938667297, -0.08816006779670715, -0.04692953824996948, -0.05771779641509056, 0.042293481528759, 0.05058852955698967, -0.040789857506752014, -0.05288997292518616, -0.010859759524464607, 0.0807754322886467, 0.03149314224720001, 0.005171675700694323, 0.03816075623035431, -0.048161838203668594, 0.012271498329937458, 0.04479338228702545, 0.029691893607378006, -0.05216039717197418, -0.012656708247959614, 0.061953507363796234, -0.010411184281110764, 0.06605587154626846, 0.0014749914407730103, 0.019895583391189575, 0.03189076483249664, -0.03727872297167778, 0.1211637333035469, -0.03545623645186424, -0.023393629118800163, 0.03629425913095474, 0.07178491353988647, -0.10736464709043503, 0.013776523061096668, -0.08893942087888718, 0.09700878709554672, -0.05158580467104912, -0.01158280298113823, -0.003563328180462122, 0.04294312372803688, 0.044370315968990326, -0.012952055782079697, -0.038893748074769974, 0.008761000819504261, 0.030329151079058647, -0.0019326983019709587, 0.0802612379193306, -0.06030702963471413, -0.12226323038339615, -0.003465928602963686, -0.07894948869943619, -0.03525127097964287, -0.08355101943016052, -0.04305754974484444, -0.011674946174025536, 0.08239790797233582, 0.024386782199144363, -0.12735095620155334, 0.07746946066617966, -0.01949716918170452, -0.011914155445992947, 0.00021025975001975894, 0.07877656817436218, -0.04123431444168091, -0.054099276661872864, -0.007056696806102991, -0.0143453199416399, 0.014892315492033958, -0.06160062551498413, -0.04565633088350296, -0.061516743153333664, 0.08738464117050171, 0.0239662267267704, 0.028324700891971588, 5.412484759834527e-33, 0.019999969750642776, 1.4787517557124374e-06, 0.04868229851126671, 0.030457206070423126, -0.010363228619098663, 0.05229220911860466, -0.00149850535672158, 0.013193057850003242, -0.04327106475830078, 0.004859060514718294, -0.05416777357459068, 0.03669511154294014, 0.0006199398776516318, 0.1715194284915924, -0.032484766095876694, -0.014800727367401123, -0.018367337062954903, 0.006808117497712374, -0.06569374352693558, 0.039267055690288544, 0.07043854147195816, -0.0005714640719816089, -0.043479930609464645, 0.021603867411613464, 0.031533561646938324, 0.04678650572896004, -0.016136569902300835, 0.02012094482779503, 0.055400945246219635, 0.07903578877449036, -0.022398149594664574, -0.03690306097269058, -0.07084358483552933, -0.03822482377290726, -0.024409044533967972, -0.04226759076118469, -0.06962776929140091, -0.11290346831083298, 0.018751701340079308, -0.006799757480621338, -0.018590083345770836, 0.053915899246931076, -0.06505842506885529, 0.03022320568561554, 0.04382293298840523, 0.02898216061294079, -0.07949025928974152, -0.02050016261637211, -0.07438617199659348, 0.06846428662538528, 0.03280774876475334, 0.026149678975343704, 0.020475709810853004, -0.034088604152202606, -0.039995111525058746, 0.0011519062099978328, -0.03277124837040901, 0.04657503962516785, 0.05691599100828171, -0.022495878860354424, 0.028766365721821785, 0.043833453208208084, -0.051787953823804855, 0.08585156500339508, -0.09530101716518402, -0.021236786618828773, 0.01236599963158369, -0.055020950734615326, -0.009328297339379787, -0.03250476345419884, 0.06550772488117218, 0.029629047960042953, -0.05330513417720795, 0.03363708034157753, -0.041453804820775986, -0.003897100454196334, 0.08620729297399521, 0.07294370234012604, 0.06274987757205963, -0.0049219136126339436, 0.008207847364246845, -0.00827807653695345, 0.01699642278254032, 0.02392936684191227, -0.01504561211913824, -0.04388938471674919, 0.010920283384621143, -0.07850505411624908, -0.038737013936042786, -0.0491940937936306, -0.04678022488951683, 0.06578806787729263, -0.004609863739460707, 0.06989741325378418, -0.024278011173009872, -6.61817205039967e-33, 0.012402309104800224, -0.03880702331662178, -0.006306199356913567, 0.015406384132802486, -0.01992974616587162, 0.04270751029253006, 0.0638669952750206, -0.013971759006381035, 0.0923096239566803, 0.03782730549573898, 0.04439910501241684, -0.0390656404197216, 0.12472359091043472, 0.04007367044687271, -0.03332166373729706, -0.0493927039206028, 0.0594911128282547, 0.08507261425256729, -0.025696713477373123, 0.03571097180247307, 0.05556972697377205, 0.04274829477071762, 0.017146561294794083, 0.010339721105992794, -0.030515305697917938, 0.012909716926515102, 0.08169694244861603, 0.03656887263059616, -0.02404824271798134, -0.034415099769830704, -0.0838506817817688, 0.041795652359724045, -0.08659134805202484, 0.020987773314118385, -0.07185406982898712, 0.05795665085315704, 0.04871632531285286, -0.05817251652479172, -0.057000964879989624, 0.004326628986746073, 0.019845053553581238, -0.03797968104481697, -0.0828266516327858, 0.010489002801477909, -0.011362498626112938, -0.0025300283450633287, 0.01813744567334652, 0.007223796099424362, 0.08234842866659164, -0.027382884174585342, 0.008520063944160938, 0.11398444324731827, -0.0016189819434657693, 0.051208462566137314, -0.0413530096411705, -0.01483321376144886, 0.008971518836915493, -0.0912080928683281, -0.017843816429376602, 0.02320454642176628, 0.0025332386139780283, 0.02533191256225109, -0.008726291358470917, -0.11616700142621994, -0.006000041030347347, 0.022693146020174026, 0.048165686428546906, -0.0017688424559310079, 0.053783830255270004, -0.04209104925394058, 0.05213294178247452, -0.04280184209346771, -0.04425155371427536, -0.0635109394788742, -0.06633684039115906, 0.034752052277326584, -0.01278481725603342, -0.059390775859355927, -0.02368042804300785, -0.026981541886925697, -0.018259631469845772, -0.12698926031589508, 0.08869049698114395, 0.03100297600030899, 0.035462357103824615, 0.08938924968242645, 0.0011927935993298888, -0.03258369117975235, -0.006746761035174131, 0.09218177944421768, -0.05409545823931694, -0.04183945432305336, -0.005616017617285252, 0.048076190054416656, -0.01885380409657955, -6.520527051634417e-08, 0.07913537323474884, 0.007294220384210348, 0.10466564446687698, 0.09728436172008514, 0.00037075692671351135, 0.03362753614783287, -0.15045878291130066, -0.11172731220722198, 0.012844814918935299, -0.00598760973662138, 0.026749683544039726, 0.09101470559835434, -0.03581133112311363, 0.011067936196923256, -0.007175083737820387, 0.08036050200462341, -0.059091921895742416, -0.006232729647308588, -0.048315584659576416, 0.022154981270432472, -0.03472583368420601, 0.02253267727792263, 0.025170283392071724, -0.016726341098546982, 0.053798858076334, -0.030287619680166245, -0.06255058944225311, -0.018850523978471756, 0.04238923639059067, -0.04117816686630249, -0.08897123485803604, 0.008920056745409966, -0.03906368836760521, 0.027467554435133934, -0.03767154738306999, -0.056801725178956985, 0.005906051490455866, 0.0029094666242599487, 0.038690876215696335, -0.01567312516272068, -0.00939312856644392, -0.03369084745645523, 0.016155660152435303, 0.021863294765353203, -0.02796817570924759, 0.016315028071403503, -0.05315925180912018, -0.04012603312730789, -0.02879454381763935, -0.016096331179142, 0.030905770137906075, -0.06048893183469772, 0.005106938537210226, 0.042194120585918427, 0.026842862367630005, 0.009282175451517105, -0.0029697634745389223, -0.07319316267967224, 0.008917844854295254, 0.048825763165950775, 0.0638844445347786, -0.07488672435283661, -0.011052239686250687, 0.031463541090488434]'),
(1531, 'The Truth Always Comes Out!', 'https://drrobertyoung.com/the-truth-always-comes-out/', 'Israeli Professor of clinical microbiology and immunology Qimron of Tel Aviv University , wrote a very important open letter to the Israeli Ministry of Health, that everyone should read and ponder and then send to their government and to everyone they love and care about NOW!\nAlthough a number of points are specific to the Israeli situation (they are now working on the second booster campaign), there is much in it that is very recognizable for the approach in many other countries, including the United States. This is why I place the text in its entirety here.\nRead full article: The Truth Always Comes Out\nMinistry of Health, I t’s Time to Admit the Failure !\nIn the end, the truth will always come out and the truth about coronavirus policy will begin to come out. When the destructive concepts collapse one by one, there is nothing left but to tell the experts who led the management of this so-called pandemic:\nYou finally realize that a respiratory virus is unbeatable ( because there is NO virus ) and that such an effort is doomed to fail.\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nYou don’t admit it, because you have admitted almost no mistakes in the past two years, but in retrospect it is clear that you have failed miserably in almost all your actions, and even the media is already having a hard time hiding your shame.\nYou refused to admit that the infection comes in waves that disappear on its own, despite years of observations and scientific knowledge.\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nYou insisted on attributing every drop of a wave solely to your actions, and so you overcame “the plague” through false propaganda . And again you defeated it, and again and again and again.\nYou refused to admit that mass testing is ineffective , despite your own contingency plans explicitly stating so (“Pandemic Influenza Health System Preparedness Plan, 2007,” p. 26).\nYou refused to admit that a past infection ( caused by radiation and chemical poisoning ) is more protective than a vaccine, despite previous knowledge and observations showing that non-recovered vaccinated people are more likely to get infected than recovered people.\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nYou refused to admit that the vaccinates are contagious despite the observations. On this basis, you hoped to achieve herd immunity through vaccination, and you failed to do so either.\nYou insisted on ignoring that the disease is tens of times more dangerous for at-risk groups and older adults than for young people who are not at risk, despite the knowledge that came from China as early as 2020.\nYou refused to accept the “Barrington Declaration,” signed by more than 60,000 scientists and medical professionals, or other common sense programs.\nYou chose to ridicule, slander, twist and discredit them. Instead of the right programs and people, you have chosen professionals who lack relevant training in pandemic management (physicists as advisers to government leaders, veterinarians, security officers, media personnel, etc.).\nYou have ignored many reports of changes in menstrual intensity and menstrual cycle times.\nYou have hidden data that allows objective and proper investigation (for example, you deleted the data on passengers at Ben Gurion Airport).\nhttps://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines\nYou chose to work with senior Pfizer executives to publish non-objective articles about vaccine effectiveness and safety.\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nBut From the Heights of Your Hubris!\nYou have burned hundreds of billions in vain – for publicizing harassment, for ineffective tests, for destructive lockdowns and for disrupting the routine of life over the past two years.\nYou have destroyed our children’s education and their future .\nhttps://www.drrobertyoung.com/post/does-the-jab-cause-myocarditis\nYou made children feel guilty, afraid, smoked, drunk, became addicted, dropped out and argued, as school principals across the country attest.\nYou have harmed livelihoods, the economy, human rights, mental health and physical health.\nYou slandered colleagues who did not surrender to you, you pitted people against each other, divided society and polarized discourse.\nYou labeled, without any scientific basis, people who chose not to be vaccinated as enemies of the public and as spreaders of disease.\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nYou are promoting, in an unprecedented way, a draconian policy of discrimination, denial of rights and selection of people, including children, for their medical choice.\nA Selection That Has NO Epidemiological Underpinning!\nYou compare the destructive policies you are pursuing with the sensible policies of some other countries, you can clearly see that the destruction you have wrought has only added victims outside of the virus’s vulnerable.\nYou have ruined , the jobless you have caused, and the children whose education you have destroyed – are the needless victims only as a result of your actions.\nhttps://www.drrobertyoung.com/post/cdc-media-push-a-cocktail-of-poisons\nThere is currently no medical emergency , but you have been cultivating such a condition for two years because of lust for power, budgets and control.\nThe Only Emergency Now is That\nYou still make policies and have huge budgets for propaganda and awareness building instead of sending them to strengthen the health care system.\nhttps://www.bitchute.com/video/jnpG3weGmOui/\nProfessor Udi Qimron , Faculty of Medicine, Tel Aviv University Professor Udi Qimron, Faculteit der Geneeskunde, Universiteit van Tel Aviv Article in Hebrew (source): https://www.mako.co.il/news-columns/2022_q1/Article-dfd99ca599e2e71026.htm\nRobert Oldham Young MSc, DSc, PhD, Naturopathic Practitioner\nRead Dr. Robert Young’s Statement and Advisory to All by clicking Here :\nhttps://everydayconcerned.net/2022/01/05/breaking-news-dr-young-reveals-the-covid-injections-are-intelligent-targeting-bioweapons-using-specific-genetic-markers-to-reach-specific-organs-like-heart-ovaries-brain-lethal-vaccine-outcomes/', '[-0.01581098511815071, 0.06775882095098495, 0.04405901953577995, -0.01230370718985796, 0.02031777799129486, 0.029602698981761932, 0.019732030108571053, 0.07256138324737549, -0.03618556633591652, 0.031704697757959366, -0.029942268505692482, 0.02941327542066574, 0.06412245333194733, 0.06458978354930878, -0.001821047393605113, -0.01695370301604271, -0.07305865734815598, -0.07879582047462463, -0.0435672290623188, 0.04936409741640091, -0.013470401056110859, 0.1254575252532959, 0.07085850834846497, -0.025265933945775032, -0.059807490557432175, 0.07327387481927872, -0.06505997478961945, -0.01824743114411831, -0.03282618150115013, -0.0028912064153701067, 0.07326564192771912, 0.007568474858999252, 0.014455842785537243, -0.03680432587862015, 0.03221803903579712, 0.0932382345199585, 0.011479404754936695, 0.022413082420825958, -0.0362778939306736, 0.0009150585974566638, 0.06374609470367432, -0.01682073436677456, 0.01172104012221098, -0.007355530746281147, 0.06005902588367462, 0.04102712869644165, -0.06247435510158539, 0.011041399091482162, 0.003245942061766982, -0.04309239983558655, -0.08587490767240524, -0.05901098623871803, 0.04216651991009712, -0.030530400574207306, -0.01009692158550024, 0.02119143307209015, -0.027102269232273102, -0.04368137568235397, -0.053264979273080826, -0.08658529818058014, -0.0166611410677433, -0.0066508278250694275, -0.0464523509144783, 0.006659003905951977, 0.0023004093673080206, -0.05197007954120636, 0.06474614143371582, 0.033407945185899734, -0.0016463784268125892, 0.08737974613904953, -0.03543967381119728, 0.013460529036819935, -0.046121444553136826, 0.11535309255123138, -0.014028668403625488, -0.006502559408545494, 0.07999677956104279, -0.008141388185322285, 0.12175163626670837, 0.01769094355404377, 0.09240693598985672, -0.06486093997955322, 0.057375866919755936, 0.026613354682922363, -0.0026451179292052984, -0.02468138188123703, -0.035756442695856094, -0.042516473680734634, 0.018668346107006073, -0.043424516916275024, 0.04656178876757622, -0.04861779510974884, 0.1411665380001068, 0.05926787853240967, 0.06320314854383469, 0.02818235196173191, 0.02769598737359047, 0.01990436390042305, -0.04241976886987686, 0.041301995515823364, -0.005108265671879053, -0.10254382342100143, -0.059355709701776505, -0.014512760564684868, -0.014927541837096214, -0.07827980071306229, -0.00280666328035295, -0.014396263286471367, 0.024001063778996468, -0.01472895685583353, 0.01862383633852005, 0.02358992211520672, 0.016748836264014244, -0.07627081125974655, 0.055670253932476044, 0.07328283041715622, 0.026608290150761604, -0.039377205073833466, -0.042162466794252396, -0.010883424431085587, -0.038468923419713974, -0.09912174940109253, -0.03658396005630493, -0.023780107498168945, -0.028536885976791382, 0.02547118254005909, 0.0005186820635572076, 1.7397064762910382e-33, 0.007585734128952026, 0.03261776641011238, 0.0966617539525032, 0.023331711068749428, -0.02806074544787407, -0.03136194124817848, -0.00040791044011712074, -0.028297903016209602, -0.011609787121415138, -0.04247989133000374, -0.0270239170640707, -0.005787513684481382, 0.062077514827251434, 0.05213024467229843, -0.06550978869199753, -0.07312653958797455, -0.07874608784914017, 0.011777583509683609, -0.0026160036213696003, 0.013627431355416775, 0.09294228255748749, 0.007901809178292751, 0.09148676693439484, -0.01631857454776764, 0.07093213498592377, -0.047620903700590134, 0.06463871896266937, 0.007299837656319141, 0.04011344909667969, -0.010375242680311203, -0.011884755454957485, 0.07071921229362488, 0.005060797091573477, -0.08095882087945938, 0.011583510786294937, -0.024777108803391457, -0.07070360332727432, 0.010400466620922089, -0.06041973456740379, -0.0006749987369403243, 0.024427954107522964, 0.06301280856132507, -0.06914287060499191, 0.039251092821359634, 0.07285653799772263, 0.0435132272541523, -0.03730402886867523, -0.06799997389316559, -0.07738900929689407, -0.030129816383123398, -0.0016655653016641736, 0.0839584618806839, -0.010359622538089752, -0.025175804272294044, 0.009883414022624493, 0.011383665725588799, 0.010920936241745949, 0.019444694742560387, -0.03304773196578026, -0.0342378094792366, 0.0699654370546341, 0.01586674526333809, -0.07058879733085632, 0.07785382866859436, -0.10720332711935043, -0.027849683538079262, 0.003372837556526065, -0.05099276080727577, -0.01177101582288742, 0.023332588374614716, 0.05284425616264343, -0.022519603371620178, -0.07165639847517014, -0.05285272002220154, 0.02044638618826866, -0.033740125596523285, -0.03269307315349579, -0.004548692610114813, 0.006343238987028599, -0.09455171227455139, -0.021422266960144043, -0.052406083792448044, 0.0050393566489219666, 0.0584135539829731, -0.04646506533026695, -0.041903696954250336, 0.045191723853349686, 0.0021797416266053915, -0.03312045708298683, -0.01462207268923521, -0.007694751024246216, 0.0574348159134388, 0.09229066222906113, 0.054565899074077606, -0.07827050238847733, -3.172606355623567e-33, 0.017935533076524734, -0.004004246089607477, -0.034467700868844986, -0.04151621088385582, -0.004274512641131878, 0.1425655633211136, 0.035024333745241165, -0.010503764264285564, 0.03438342362642288, -0.028836576268076897, 0.018993431702256203, 0.06127174571156502, 0.07683487981557846, 0.027146965265274048, -0.06979728490114212, 0.029652785509824753, 0.039184343069791794, -0.036376506090164185, -0.09054667502641678, 0.001417089137248695, 0.0332581102848053, -0.003926378209143877, -0.0381074883043766, 0.04287043586373329, -0.028055749833583832, 0.06935148686170578, 0.07313485443592072, 0.046523239463567734, 0.029446421191096306, -0.14543449878692627, 0.0004525196272879839, -0.009791196323931217, -0.07099363207817078, 0.044392697513103485, -0.05618609860539436, 0.044831883162260056, 0.060238584876060486, -0.028825199231505394, -0.04923098906874657, -0.05397433415055275, 0.033630888909101486, -0.011326542124152184, -0.12058471143245697, -0.0043728346936404705, -0.005211561918258667, 0.05616993084549904, 0.05357463285326958, 0.009409456513822079, -0.011160833761096, -0.044365838170051575, -0.05557963624596596, -0.0476984977722168, -0.05329021066427231, 0.05005694553256035, -0.015700362622737885, -0.021168801933526993, 0.02540506236255169, -0.014621787704527378, -0.061117734760046005, 0.016068141907453537, -0.020622851327061653, -0.03198698163032532, -0.055217195302248, -0.03139367699623108, 0.05274329334497452, -0.022406212985515594, 0.07786893099546432, -0.03950318321585655, 0.10102977603673935, -0.06617698073387146, -0.06310367584228516, 0.035691164433956146, -0.06467439979314804, -0.11908961832523346, 0.025926459580659866, 0.06334972381591797, -0.07961394637823105, -0.04955839738249779, -0.03576772287487984, -0.0543491505086422, 0.015721742063760757, -0.05836566910147667, -0.003122085938230157, -0.018886785954236984, 0.04972248151898384, -0.014678885228931904, 0.09347552061080933, -0.103388212621212, 0.016900716349482536, 0.1094999611377716, -0.0923054963350296, -0.03326904773712158, -0.003440815256908536, -0.006233114283531904, 0.011376341804862022, -5.836966820993439e-08, 0.10935191810131073, -0.03666054084897041, -0.026522673666477203, 0.0005276581505313516, -0.034800853580236435, 0.002214693231508136, -0.044914573431015015, -0.001890490297228098, 0.06348314136266708, 0.0823708027601242, 0.05917971581220627, 0.06037823483347893, 0.034716714173555374, 0.03687731549143791, 0.0335681177675724, 0.05323199927806854, -0.08597854524850845, 0.02706889994442463, -0.05048343539237976, -0.059313416481018066, 0.004522829316556454, 0.051870446652173996, -0.07042049616575241, 0.011817676946520805, 0.018595078960061073, 0.019803030416369438, -0.023531781509518623, -0.000781177484896034, -0.0069144899025559425, -0.09907714277505875, -0.12513087689876556, -0.00838631484657526, 0.009424545802175999, 0.01854749210178852, -0.08499988913536072, -0.03790339455008507, 0.12803052365779877, -0.07590515911579132, 0.043037232011556625, -0.03956446796655655, 0.05337916687130928, 0.013649172149598598, 0.006540016736835241, 0.07175035774707794, -0.047662753611803055, -0.06566808372735977, -0.038868922740221024, 0.04247356951236725, 0.02695411629974842, -0.009701036848127842, 0.04294030740857124, 0.019990241155028343, -0.005926557816565037, 0.05245983973145485, -0.028970589861273766, 0.05163941532373428, -0.1166493147611618, -0.02253148704767227, -0.03018624521791935, 0.07448136806488037, 0.06473943591117859, -0.09044025093317032, -0.04688413068652153, 0.0013964548707008362]');
INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1532, 'Cancer Breakthrough! The Prevention & Natural Cure for Cancer', 'https://drrobertyoung.com/cancer-breakthrough-the-prevention-natural-cure-for-cancer/', 'https://www.drrobertyoung.com/surviving-cancer\nThe following is what I announced to the World – The Prevention and Cure for Cancer\nOn February 3rd, 2019, I also announced the release of a new peer-reviewed scientific article on the cure for cancer which was published in the ACTA Cancer Biology Journal, Vol. 3, Issue 2, 2019.\nThe Title of this article: Cystic Fibrosis and Pulmonary Adenocarcinoma Lung Cancer both Metabolic and Dietary Acidic Conditions\nThe following is the abstract:\nThe following is the PDF for my peer-reviewed published article:\nhttps://www.actascientific.com/ASCB/pdf/ASCB-03-0092.pdf\nYou can also read Inger Marie Hartelius’s testimony, including her medical doctor’s statement at the following link:\nhttps://www.drrobertyoung.com/surviving-cancer\nRobert O Young MSc, DSc, PhD, Naturopathic Practitioner\nwww.drrobertyoung.com/cv www.drrobertyoung.com/blog\nPS The following link is an additional peer-reviewed article on the prevention and reversal of any cancerous condition that was published in 2015. You will find the link and PDF below:\nhttps://www.phmiracleproducts.com/collections/books-audio-video\nhttps://medcraveonline.com/…/alkalizing-nutritional…\nMarie Inger Hartelius Testifies After 10 Years in Remission from a Terminal Cancerous Condition\nWant to Learn More then Watch the Following Videos\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nhttps://www.bitchute.com/video/ufDTR2WopE5p/\nhttps://www.bitchute.com/video/PRBfJ6U9EZvM/\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nhttps://www.drrobertyoung.com/post/lies-more-lies-and-damn-lies-from-those-we-are-mandated-to-trust', '[-0.05306311324238777, 0.031801801174879074, -0.035995662212371826, 0.028365306556224823, 0.03238445892930031, 0.011929716914892197, -0.01707174815237522, 0.13229921460151672, -0.03000745363533497, -0.03094514086842537, 0.004180265124887228, 0.11759254336357117, 0.04751189425587654, -0.018410194665193558, -0.057544875890016556, 0.07740268856287003, 0.004378824029117823, 0.044417329132556915, -0.05283409357070923, 0.0600946806371212, -0.025001218542456627, 0.06286793202161789, 0.047377295792102814, 0.02533060684800148, -0.002258139196783304, -0.034173671156167984, 0.0038651993963867426, -0.035797614604234695, -0.063878633081913, 0.02990594319999218, 0.03837011009454727, -0.013835445046424866, 0.0005454301717691123, 0.02736877277493477, 0.053214069455862045, 0.030228642746806145, 0.0001550944580230862, 0.051103830337524414, -0.016001436859369278, -0.02339845523238182, 0.010570250451564789, -0.08101175725460052, -0.05276187136769295, 0.05134806036949158, -0.03217589110136032, -0.03328458592295647, -0.09435700625181198, -0.04212457314133644, 0.0007415937725454569, 0.07030139863491058, -0.09428833425045013, -0.04916748031973839, 0.025203200057148933, -0.0007026921375654638, 0.05568501725792885, -0.0018587650265544653, -0.052146006375551224, 0.025416523218154907, -0.07190502434968948, -0.05681421607732773, 0.01106173824518919, -0.10251392424106598, -0.05204871669411659, 0.047914959490299225, 0.048743944615125656, 0.022800486534833908, 0.04723789542913437, -0.08828093856573105, -0.036041319370269775, 0.02696223184466362, -0.003914478700608015, -0.04493224620819092, 0.029161835089325905, 0.014382690191268921, 0.008273180574178696, 0.014158960431814194, 0.05275767669081688, -0.02859124168753624, -0.030050963163375854, -0.008853327482938766, 0.08496497571468353, 0.015586184337735176, 0.07507309317588806, -0.0029791758861392736, -0.00971339549869299, -0.0362120047211647, 0.016009138897061348, -0.019749555736780167, -0.038900043815374374, 0.03627123683691025, 0.005736516788601875, 0.006012124475091696, -0.01786351203918457, 0.0561915747821331, -0.022725434973835945, -0.008171752095222473, -0.013511274009943008, -0.04305624961853027, 0.04411713406443596, -0.041896577924489975, -0.01003280095756054, 0.018678663298487663, 0.06869418919086456, -0.07198163866996765, 0.0009958762675523758, -0.03681373596191406, -0.060441091656684875, 0.013724409975111485, -0.028820715844631195, 0.027122225612401962, 0.03244277462363243, 0.034739043563604355, -0.03420214354991913, -0.03298971429467201, 0.058891862630844116, 0.1429143100976944, 0.04233384132385254, -0.045561935752630234, -0.035198185592889786, -0.04232235625386238, -0.05209425836801529, -0.11275571584701538, 0.05919116362929344, -0.01673864759504795, 0.025367742404341698, 0.020476941019296646, -0.053653426468372345, 3.3052715460314165e-33, 0.03072560951113701, -0.010266563855111599, 0.04814091697335243, 0.024022143334150314, 0.07235035300254822, 0.017113177105784416, 0.02333834581077099, -0.08725567162036896, 0.028910720720887184, -0.09422754496335983, 0.10807070881128311, 0.004049653187394142, 0.043718092143535614, -0.10232387483119965, -0.12765169143676758, -0.042345862835645676, -0.06001725047826767, -0.025071917101740837, 0.013090897351503372, -0.04317338392138481, 0.05343346297740936, -0.033521950244903564, 0.05340694263577461, -0.059039462357759476, -0.05480767413973808, 0.017435787245631218, 0.03010140173137188, 0.03384288400411606, 0.06271488219499588, 0.005699861329048872, -0.0753137394785881, -0.009366785176098347, -0.05120450258255005, -0.05364460125565529, -0.0027149803936481476, 0.016936274245381355, -0.030965376645326614, -0.011305106803774834, 0.017170200124382973, 0.0926099345088005, -0.05002142861485481, -0.032896749675273895, 0.059964630752801895, -0.013798244297504425, 0.0001110612865886651, -0.10169032216072083, -0.07259675115346909, 0.009589050896465778, 0.0033198711462318897, -0.00917709618806839, 0.0028857921715825796, -0.05791949853301048, -0.033002980053424835, -0.08059307187795639, 0.044417452067136765, -0.1051763966679573, -0.10272500663995743, -0.01953161507844925, -0.04607953503727913, 0.039830636233091354, 0.15723690390586853, 0.020233983173966408, -0.06770598143339157, 0.010307615622878075, -0.12872888147830963, -0.055142492055892944, -0.07784837484359741, -0.1394852101802826, -0.06375186890363693, 0.04312106594443321, 0.013357077725231647, -0.007910612970590591, 0.0938233733177185, -0.02279418334364891, 0.0280702356249094, -0.03566734120249748, -0.001501366845332086, 0.07647009938955307, -0.03517933189868927, 0.05098947510123253, 0.06602010130882263, 0.053576789796352386, -0.015528560616075993, 0.08808889240026474, -0.06772484630346298, -0.0352231040596962, -0.02652301825582981, -0.00553501583635807, 0.013456037268042564, -0.013728370890021324, 0.0475490503013134, -0.03762137517333031, -0.005047953221946955, 0.07765723764896393, -0.006820471491664648, -5.220584572378819e-33, 0.027782665565609932, -0.004848430398851633, 0.07064159959554672, 0.006705919746309519, 0.08552692830562592, 0.022501811385154724, 0.004941017832607031, 0.05154792591929436, 0.04372167959809303, -0.10292157530784607, 0.061551909893751144, 0.05088144168257713, 0.016033092513680458, -0.012133105657994747, -0.12138593196868896, 0.05667205527424812, -0.034235455095767975, -0.012611032463610172, -0.08066975325345993, -0.012812221422791481, 0.004878387786448002, 0.060461290180683136, -0.06119503825902939, 0.05149492248892784, -0.015610245987772942, 0.07815373688936234, 0.06224400922656059, 0.025991400703787804, 0.010708725079894066, -0.03183906897902489, 0.0562487468123436, 0.13794541358947754, -0.04890842363238335, 0.03094382770359516, 0.0013465880183503032, 0.02916211076080799, -0.0040682218968868256, -0.09750379621982574, 0.013959976844489574, -0.0047557842917740345, 0.061419449746608734, 0.021120743826031685, 0.012587158940732479, -0.03886955603957176, 0.07584523409605026, 0.05774795636534691, 0.0716606006026268, -0.06110561639070511, 0.05568842589855194, 0.04667546600103378, 0.07871433347463608, 0.02814369648694992, -0.09542980790138245, 0.06307340413331985, 0.058915093541145325, 0.06391746550798416, -0.015103599056601524, -0.008781954646110535, -0.0047797695733606815, -0.012394968420267105, -0.07465462386608124, 0.043475665152072906, -0.07625328004360199, -0.04498760402202606, 0.02841157279908657, 0.04480980336666107, 0.018698470667004585, -0.028295937925577164, 0.0799601599574089, 0.04711432754993439, -0.04727022722363472, -0.04228656738996506, -0.11238661408424377, -0.05714786797761917, 0.027410252019762993, 0.08396964520215988, -0.03725521266460419, -0.0035950716119259596, -0.03169744834303856, 0.034953195601701736, -0.06133861467242241, 0.02625567466020584, -0.02471292018890381, 0.014921956695616245, 0.04110230132937431, 0.001279765390790999, -0.04151524230837822, -0.08123629540205002, -0.08476109057664871, 0.0038524074479937553, -0.013641892932355404, -0.08271536231040955, -0.053049929440021515, 0.053633663803339005, 0.055840201675891876, -6.481784708967098e-08, 0.060285985469818115, -0.055147551000118256, -0.07757353037595749, -0.05073915794491768, 0.014150380156934261, -0.002628997666761279, 0.08891335874795914, -0.02468002401292324, -0.004093773663043976, 0.08459367603063583, -0.05759289860725403, 0.10781034827232361, 0.027860742062330246, 0.01563517190515995, -0.0049859001301229, -0.05051691085100174, -0.0007805805653333664, -0.0050299689173698425, -0.00589772267267108, -0.02894696593284607, 0.021798666566610336, -0.054424140602350235, -0.014262030832469463, 5.38925378350541e-05, -0.020506883040070534, 0.02923935279250145, -0.018694354221224785, 0.012003320269286633, -0.050330378115177155, -0.038516175001859665, -0.02827148139476776, 0.011380397714674473, -0.06860082596540451, -0.015474706888198853, -0.013130338862538338, -0.06267693638801575, 0.09266546368598938, -0.026577699929475784, -0.027946969494223595, 0.06140264868736267, 0.042442142963409424, -0.009728189557790756, -0.03559756278991699, 0.0928807184100151, 0.01294608786702156, -0.02101413533091545, -0.049339957535266876, -0.03649551421403885, -0.02052510902285576, 0.0035100418608635664, 0.06150740012526512, -0.03615656867623329, 0.059199344366788864, -0.02366972342133522, -0.07364477962255478, 0.08318853378295898, 0.00693376362323761, -0.0016824551858007908, -0.00310302060097456, -0.010701215825974941, 0.03591615706682205, 0.00080633390462026, 0.06183110177516937, 0.03592640534043312]');
INSERT INTO `dr_young_all_articles` (`id`, `title`, `url`, `content`, `embedding`) VALUES
(1533, 'My Mother has COVID…for the last Seven Years!', 'https://drrobertyoung.com/my-mother-has-covidfor-the-last-seven-years/', 'The following is a true story .\nNote to the reader: If you want to get the real meat of this story about the COVID lie and the negligence of the medical establishment, skip ahead to the section COVID Diagnosis.\nThe opening paragraphs provide the reader with the background of the story which leads up the the COVID misdiagnosis of a loved one, a ‘Kevorkian’ COVID treatment protocol and the steps that were taken by loved ones to prevent a fatality at the hands of medical ‘professionals.’\nMy mother is an amazing, loving, kind, caring and always positive woman who has graced us with a wonderful 84-years thus far. But old age has caught up with her. It has a way of catching up with the best of us, reminding us of our mortality. None the less, we forge forward with an unstoppable will and determination to live and flourish, despite the many obstacles we face while on our journey.\nWhere does this power, or force, come from? How is it possible that this same power resides in each and every human being? Whatever this ‘Power’ is and wherever it emanates from, it is the One thing that will save humanity from quite possibly one of the biggest acts of Genocide since the days of Adolf Hitler.\nMy mother is an excellent athlete who participated in various sports throughout her high school and collegiate days. She played tennis into her 70’s until her body began showing signs of wear and tear; knee replacement surgery, back problems, fractured discs, and other physical ailments from years of athletics and other activities.\nA little over ten-years ago I was concerned about her longevity. She was a smoker of fifty-years and developed a chronic cough which was so loud it could be heard three doors down. I am not talking about doors, as in rooms, but doors as in houses.\nHer growing and chronic discomfort from the nagging cough accompanied by the phlegm she coughed up became so bad that she fractured a rib from coughing so hard!\nMiraculously, and to my pleasant surprise, she stopped smoking in 2011 at the age of seventy-four after persistent urging from loved ones. Today, she lives with COPD which has made it very difficult for her, but I am thankful she found the strength to stop smoking over a decade ago. The Anxiety Report ( Gifts from Eykis , Dyer 1989) Anxiety is another unseen force that causes illness for my mother, as well as thousands (if not millions) of other Americans. Since it is not tangible, we do not give it enough respect as a culprit of disease. One of Dr. Wayne Dyer’s first books is entitled, Gifts from Eykis which is a parable about our perception of the world and how much we unwittingly pay homage to anxiety. ‘The gifts that Eykis…brings to the people of Earth help them see themselves in a new light, and compel them to rethink their negative actions. i.e., anxiety, stress, doubt, and so on.’\nFor the past several years my mother has made regular visits to the Emergency Room because of chronic issues of dehydration and low sodium levels. The cause? We do not know, but I can surmise it is from the combination of old age, COPD, anxiety and improper nutrition.\nDehydration is an awful experience and the symptoms seem contradictory to what someone would expect when dehydrated. One of the symptoms is vomiting which makes it very difficult to get fluids and food into the body.\nI can nearly predict the times of year she will go into the ER; the holiday season which is chock full of stress and anxiety from planning a big holiday dinner on both Thanksgiving and Christmas at her home. She prepares for about twenty-five family members and friends in a frenzy of excitement. Additional bouts typically occur with the change of seasons from spring to summer.\nWhen she visits the ER, the doctors run the same battery of tests, starting with an X-ray, followed by a CAT Scan, blood tests and other procedures. Each time, they come back with the same findings; her scans are clear and they cannot find anything wrong with her. After giving her fluids and increasing her sodium levels they typically send her on her way.\nDuring the thick of the pandemic my mother’s bouts of dehydration and low sodium levels persisted, but she was not about to step foot in a hospital after hearing the horror stories about patients dying in hospitals because of the ‘Kevorkian’ COVID treatment protocols.\nWhen her dehydration and low sodium levels returned we had to find a way for her to re-hydrate and increase her sodium levels, which was very difficult task. The nausea and vomiting was difficult for me to watch, but much worse for her to go through.\nExperiencing extreme discomfort, she moaned and groaned as she attempted to throw up in the kitchen sink. Nothing came up, she had the dry heaves. It was time to begin rehydrating.\nOnce she was comfortable enough and settled on the couch, I gave her a cup of shaved ice with a spoon. She battled through the nausea, but didn’t throw up even though she wanted to.\nWe approached my mother’s rehydration ‘protocol’ in gradual steps over several hours by taking tiny bites of the shaved ice in timed intervals beginning at thirty minutes, reducing the intervals by five minute increments until she eventually felt better. This gradual approach worked because it reduced the likelihood of her vomiting. Although it was not much, the little bits of ice in timed intervals allowed her to keep fluids in her stomach ultimately leading to rehydration.\nAfter a few hours of this she was ready for bed. I left her with a cup of ice so she could continue eating spoonfuls of ice in small increments of time until she was able to drink water and eat food without vomiting. This ‘gradually and then suddenly’ approach to rehydration worked for her, but was not something we wanted to do on a regular basis.\nThere had to be a better way for her to remain hydrated while maintaining the proper sodium levels ( She takes pHour Salts on a daily basis to maintain her sodium level as best possible).\nMy mother, like most people, find it difficult to embrace the ‘gradually and then suddenly’ phenomena. When we do things gradually, it seems to take forever, and then suddenly we see the results and rewards of our effort.\nThis same concept applies to life. We are young, and then suddenly, we are old. How did it happen? Gradually, and then suddenly, we are no longer the young twenty something year-old who was taking on the world. If we approach and understand everything in life is a gradual process, then we will not be as discouraged when we do not see immediate results.\nAnother ‘gradually and then suddenly’ situation occurs when she feels good. Again, like most people, when she feels good she wants to take on the world and does everything she can because it feels great!\nWhen we do this, we often throw caution to the wind, disregarding the consequences of such an aggressive approach. The result is often fatigue or pain. In my mother’s case, when she feels great she goes all out, disregarding the importance of remaining hydrated. Plus, when her appetite is not too robust, it leads to a lack of nutrition. She runs herself down until suddenly she feels like garbage, and is left wondering how and why she feels so awful. The core reason for this is a natural part of aging. Her 84-year old immune system is…well it is 84-years old.\nIf a hematologist were to analyze my mother’s blood, or the blood another eighty-year old, they would label her as having a ‘high viral load’. All this means is her body is acidic, out of balance, and no longer in harmony. Symptoms are often the result and we label these symptoms; flu, cold, cancer and so on. Thus, the natural healing miracle of the immune system must commence. But, it takes longer to repair and rebalance the body because of excess toxicity, old age or other factors.\nThe medical field, as well as the entire population, has been misled into believing we are being attacked by viruses, but truth be told these ‘germs’ or ‘viruses’ are really the result of the imbalance.\nGerms, bacteria and viruses are a natural result of a toxic, or acidic, body. It is NOT because germs and viruses have attacked her by magically floating through the air waiting to attack. Rather, it is the result of improper nutrition, toxic food, water, air and thoughts which degrade the immune system resulting in sickness. This is referred to as, ‘I eat too much shit disease.’ (Dr. Robert Young 2021 www.drrobertyoung.com)\nIt can easily be broken down into two processes; respiration and fermentation. When we are healthy we are in a state of respiration. When we are sick, i.e., cancerous, we are in a state of fermentation. (Read On the Origin of Cancer Cells, Otto Warburg and The pH Miracle for Cancer by Robert O Young MSc, DSc, PhD, Naturopathic Practitioner)\nIf you were to analyze your blood under a microscope, hopefully you would see round shaped blood cells. If you see anything other than a healthy, spherical blood cell, then you can consider it a precursor for disease.\nKeeping things simple, whenever a cell becomes imbalanced, the healthy cells will heal the unhealthy ones, or clean up the garbage, to maintain the balance of the body’s immune system which is our true healing power.\nSo, if you were to feed, inhale and inject toxins into your body over an extended period of time, the result will be disease. The toxins compromise the healthy cells (which is the sanitation department) making it more difficult to heal, thus prolonging the healing process or worse, leading to death.\nTo sum it up, my mother’s eighty-four year old body takes much longer to recover and heal than when she had a robust, strong twenty-something year old immune system. Eventually she felt better and resumed her life and routine, but she did not change much of anything to prevent it from recurring. Each time she has these bouts with dehydration and low sodium levels, we talk about the things she needs to consider doing in order to improve her health, but she falls back into her habitual ways (human nature), thus the trips to the ER continue.\nYou might wonder why I haven’t forced her to see a specialist who could treat her for these recurring issues. Well, when you have a loved one who is 100% cognizant, aware, still active and able to make decisions regarding their health, at what point does one step in and take away their rights to decide what they should or shouldn’t do?\nWhen we spoke about it and discussed ways to prevent it, she did not know where to look or who to ask. Her Primary Care Physician was of very little help.\nShe made it through a couple bouts of dehydration through 2020 and into 2021 until we had no choice but to take her to the ER mid-2021 when she found out she had shingles. I repeat, the human body is a miracle in the simple fact that it heals itself. Shingles like any other disease is an expression from the body, tipping us off, that something is wrong and we need to be rebalance. When the immune system is imbalanced disease is the result, which is displayed in the form of symptoms. Yes, it is often as simple as that. When you reclaim the terrain of your body, disease will be mitigated.\nFallacy: The medical profession has been taught a lie and continues to be led astray by believing in, and brainwashed by, a fear of germs. This is pretty funny though! Watching people neurotically washing their hands, practically bathing in hand sanitizer and panicking when someone coughs or sneezes is quite humorous.\n“The germ is nothing and the terrain is everything” were the words uttered by Louis Pasteur on his death bed. This was after years of lies and deceit which he spewed his rhetoric about the unproven germ theory. He admitted he was wrong and Antoine Béchamp was right; the terrain, i.e., the immune system, is everything and holds the key to health.\nThe pH Miracle, Dr. Robert O Young\nAgain, I digress. Plus, I do not want to bog you down with something you most likely are ignorant of and will dismiss entirely because you have been fed a lie your entire life. And, if you don’t see it by now, odds are you never will. Although, I still hold onto a glimmer of hope for the sake of humankind.\nYou, too, have a choice and chance to see the light and wake-up. I get it, because it took me years to clearly understand and embrace the truth. But, once you learn the truth your entire perspective of the world, health and healing changes!\nBack to the shingles diagnosis. After the doctor diagnosed my mother with shingles, she prescribed Valtrex to ‘treat’ the shingles. I acknowledge that it did help, but let me to be clear; a prescription drug IS NOT a cure. All it accomplishes for the patient is that it mitigates the symptoms, but it is the human body that performs the miracle of healing.\nThen the nurse asked my mother if she had the shingles shot. My mother commented that the last time she had the shot, several years before, she ended up coming down with a bout of shingles.\nThe nurse’s insane response was, “Well, that’s what happens. The shot does not prevent you from getting shingles. In fact, you will most likely get shingles after the shot. But, don’t worry, it protects you from the shingles, building your immunity.”\nHuh? The ignorance and stupidity that spewed from the nurse’s mouth was astonishing. I am not sure what was worse, the lie about the shingles shot or the fact that he sounded so convincing. In effect, he was basically saying, “we treat disease with disease so you never get sick.”\nI do believe that nurses and doctors embrace a deep seated belief that they are healing and helping people. Sadly, unbeknownst to them, they are administering drugs and treatments which, in fact, cause more harm rather than actually heal. Many of these treatments and medications cause more disease and often lead to death, if not suddenly, then gradually over time.\nMy mother had a difficult time recovering from shingles. This would prove to be one of her toughest struggles.\nOn Wednesday, December 15th my mother entered the Chester County ER once again. The doctors ran the same battery of tests. Her sodium level was 121, which needed to be at 135 or higher. The doctors hooked her up to an IV to give her fluids. It was determined that my mother would stay over night so the doctors could monitor her progress. My brother, who took her to the ER, decided to leave for a couple hours to run some errands, then come back that evening.\nBetween the time he left and returned to the hospital, the doctors tested my mother for COVID using the faulty PCR test, which ‘has no legitimate role in diagnosing any person with illness.’ (See section below: Truth About the PCR Test ). If she had not been so fatigued and nauseous, she would have declined the test. Truth About the PCR Test\nDr. Kary Mullis who invented the polymerase chain reaction technique (PCRT) which earned him the Nobel Prize in Chemistry, admitted over and over again that his PCR technology invention was not a quantitative test for determining infectivity for any theoretical genetic protein fragment or protein spike endogenously created and found in the blood of asymptomatic or symptomatic humans or animals. (Source: www.DrRobertYoung.com / YouTube: https://youtu.be/MkqQIY7J0fQ )\nThis means PCR instruments have no legitimate role in diagnosing any person with illness or a nCoV-2 or 19 infection. The mere presence of a single viral fragment, multiplied trillions of times through PCR cycling, does not indicate anything of scientific or diagnostic value! The court stated, the test’s reliability depends on the number of cycles used and the viral load present. Citing Jaafar et al. 2020, the court concludes that:\n“if someone is tested by PCR as positive when a threshold of 35 cycles or higher is used (as is the rule in most laboratories in Europe and the USA), the probability that said person is infected is less than 3%, and the probability that said result is a ‘false positive’ is 97%.”\nSimilarly, the Austrian court has ruled that PCR tests are not suitable for CoV – 19 diagnosis and that lockdowns has no legal or scientific basis.\nThe court pointed out that “a PCR test is not suitable for diagnosis and therefore does not in itself say anything about the disease or infection of a person”.\nIf the same approach were used in breathalyzer tests for possible drunk drivers, every living person would be arrested for a DUI, since there is at least one molecule of alcohol circulating in the blood of everyone. (Link to article: HERE)\nAs of December 31, 2021 the PCR test was no longer being used to test for COVID.\nSource: CDC Withdraws PCR Testing Protocol BUT NOT Until December 31st, 2021, Dr. Robert O. Young\nNewsflash! My mother has COVID…for at least seven years! I can almost guarantee you, if she was tested for COVID seven years ago she would have tested positive. Yes, the PCR test was available seven years ago. As a matter of fact, COVID (aka: Coronavirus) has existed for more than seventeen years. The Patent for Coronavirus was filed on April 12, 2004 (Patent: 7,776,521 www.USPTO.gov) . I am not exactly sure how a patent was issued for a virus! If viruses truly occur in nature, how in the world could it be patented when things that emanate from nature CANNOT be patented?\nShe has COVID, for 7-years now, if not more. Therefore, you most likely have it and I most likely have it (or its many aliases; the flu, bird flu, swine flu, SARS, a cold). (Article: Are we making ourselves sick? A story about toxicity, sickness and recovery. )\nIf we use a test that tests for the presence of a single viral fragment, multiplied trillions of times through PCR cycling, well then I guess we all have it and most likely we had it long before the ‘Plandemic.”\nWhen the positive test result came back, they immediately sent her to the COVID ward! Knowing that my mother was in the hospital for her usual dehydration and low sodium, I was happy to hear the doctors were administering fluids. But, after the ‘positive’ COVID diagnosis, they shifted their focus away from the real issue of dehydration and low sodium levels to a ‘Kevorkian’ COVID treatment protocol which ultimately would have caused irreparable harm, possibly death, if I did not intervene.\nI needed to get into the hospital to see her, but I was up against time, up against stringent visiting hours and, sadly, up against other family members who abhorrently disagreed, and still disagree, with my approach to the entire COVID lie.\nOn Thursday, December 16th I faxed the Medical POA to the hospital confirming my assignment as the Medical Agent for my mother. This was the first critical step in what, I believe, averted disaster. I will explain later.\nThe second positive step was the awareness of the symptoms caused by my mother’s recurring condition of dehydration and low sodium levels. The added bonus was having been awakened to the truth regarding the root cause of disease, how people can truly heal and even reverse disease. Lastly, being able to see my mother the following day during visiting hours was critical, as well. I wanted to confirm that they were still treating her for dehydration and low sodium levels. More importantly, I needed to make sure they stopped administering Remdesivir.\nBefore I entered the hospital room in the COVID ward, I was required to gown-up in a plastic biohazard gown, wear a mask and surgical gloves.\nUpon entering the room, I saw my mother in a very weak and tired state. The nurse, Geena, was very pleasant as she greeted me. I asked her what treatments they were administering. She confirmed they were using Remdesivir.\nOh no! I had to stop the Remdesivir immediately, but wanted to double check to make sure it was the right thing to do. I immediately texted my wife and a friend, who is a nurse and has been handling COVID patients for the past couple years. They both said that the Remdesivir must be stopped! As a matter of fact, my nurse friend mentioned the more she saw Remdesivir used on patients, which resulted in adverse affects, the further she wanted to be from the drug.\n“What’s the Remdesivir for?” I asked the nurse.\n“Its a treatment for COVID,” she replied.\n“Are there other treatments you can offer her?” I asked.\n“No. This the only treatment available.”\n“Well, we can only administer what the FDA approves and Remdesivir is the only FDA approved treatment for COVID. I can only do what the doctors tell me and what the FDA says we can do.”\nIt had to stop! Especially after learning that Remdesivir had a 50% mortality rate in the Ebola trials. Yep, you heard that right. It was not proven to be a drug that cured people of Ebola, but rather it was removed from use because it resulted in a 50% kill-rate.\n“After results from the first 499 participants had been reviewed, the trial’s safety monitors recommended that two drugs—ZMapp and remdesivir—be dropped from the remainder of the trial. These two drugs were much less effective at preventing death.”\nBelow is a long list of common Remdesivir side effects ( www.mayoclinic.org ):\npuffiness or swelling of the eyelids or around the eyes, face, lips, or tongue\nVIDEO: Dr. Bryan Ardis | Hospital Protocols Are Murdering Americans by Prescribing Remdesivir Which Causes Renal Failure Conversation with the Infectious Disease Specialist\nThat evening around 9:30pm I received a call from the infectious disease specialist, Dr. Shafinaz. She was surprisingly pleasant and agreed with my decision to stop the Remdesivir, which came as a surprise!\nThe following are snippets from the conversation with the Infections Disease Specialist:\n“From a COVID perspective, She’s on Remdesivir which I don’t think is going to do anything. If you are comfortable with it I think she should stop it…There’s not much else we’re doing here except trying to fix the sodium and I see your point this is sort of a chronic issue for her…,” Dr. Shafinaz said.\n“..taking her off the Remdesivir is a good step…the second thing is they really want that sodium number to be better…the hospital feels liable, God forbid something happens with her heart. They don’t want to discharge her with low sodium.” She continued. “As long as those two things are done, I’m fine with her being discharged.”\n“I have to ask you one thing though..I looked at the advanced directive…and she is clearly a DNR, DNI and I want to verify that with you…God, with those lungs it would be a horrible thing to intubate her..she’ll never get off…its just a bad thing. She’s never coming off, she’s going to die on a machine…I’ll make her a DNR DNI, Do Not Resuscitate, Do Not Intubate, okay? And we’re going to do everything else.”\nWe initially averted the tragic and possibly deadly COVID treatment protocol the hospital was administering by requesting the doctors to stop administering the Remdesivir. Secondly, when the Medical POA was faxed to the hospital and they saw that my mother was DNI (Do Not Intubate), this meant they were not legally allowed to put my mother on a ventilator, therefore putting an end to their treatment.\nBecause of the simple fact that the DNI and DNR were on the Medical POA, it was the spoiler which put the kibosh on the deadly ‘Kevorkian’ COVID treatment protocol, which hospitals continue to administer.\nDr. Shafinaz, the Infectious Disease Specialist , realized she could no longer continue the treatment, so she conceded.\nEspecially after I explained to her that my mother falsely tested positive for COVID. She was simply experiencing her usual symptoms of dehydration and low sodium levels and they needed to refocus their attention on treating the real issue instead of treating for COVID.\nTIP: If you want to ensure hospitals to not use the same ‘Kevorkian’ COVID treatment protocol make sure you set up a Medical POA with a DNI. Fax it to the hospital and all of your doctors so they have the document on record.\nAre Patients Being Used as Guinea Pigs?\nThe next day, Friday, December 17th, I visited my mother again. The nurse on duty, Jennifer, walked into the room. She notified my mother that she was going to give her a shot.\n“What are you giving her?” I asked.\n“It’s an antibiotic,” she replied.\nMy mother interjected in a soft voice, “When I was around 20 years old I had a cyst removed from my spine and I had an allergic reaction to the drug. My skin broke out and I began to itch everywhere.”\n“So, what’s the drug again and what is it for?” I asked the nurse.\nShe responded in an annoyed tone, “It’s Amoxicillin which is a form of penicillin, an antibiotic.”\n“But, she’s allergic to it. What are you giving it to her?”\n“Yes, she is allergic to it, but we’re only giving her a little bit to see if she’s no longer allergic.”\n“Okay, but isn’t there another drug you can give her? One that she’s not allergic to?”\n“Yeah, but we are going to give her this one. She doesn’t really need it any way.”\n“Okay, but if she doesn’t need it, then why are you giving it to to her?”\n“To see if she is still allergic!” She responded again in a tone of annoyance. “It was along time ago. The drugs have changed and improved, so we want to test it on her to see if she’s still allergic.”\n“Okay, but considering how run down and weak she is, I am not so sure I would want to risk it. Although it might only be an itchy sensation, with her immune system so run down I don’t think it’s a good idea to subject her to something that could reverse her progress and make her even worse,” I paused and looked toward my mother. “Mom, I am going to have them not give you the shot. Is that okay with you?” “Yes,” she replied. “I think that makes sense.”\n“Okay. We won’t give it to her,” the nurse commented in frustration.\nI immediately texted my wife and my nurse friend to get their thoughts. Once again, they both agreed. This was really strange, but not surprising. It seemed as though the doctors were using my mother as a guinea pig by administering a drug she did not need and was allergic to! Decades later and after dozens of visits to the hospital, she never needed Amoxicillin. Why in the world were they wanting to see if she was still allergic to the drug now? It did not make any sense!\nThe night before I had, what I thought was, a positive conversation with the Infectious Disease Specialist about the proper care for my mother. During that conversation, she clearly stated the hospital did not want to discharge my mother until her sodium levels improved, because they did not want the liability. That made sense to me and we agreed.\nSo, when I learned the Infectious Disease Specialist wanted to give my mother Amoxicillin, I was blown away! They were willing to take on the liability of injecting my mother with a drug that she did not need and was allergic to, just to test and see if was no longer allergic? Something is rotten in Denmark.\nOnce Saturday came around, I had accomplished the things I needed to ensure my mother’s safety; 1) stop the Remdesivir and 2) treat my mother for her real issues; dehydration and low sodium levels.\nThe following are comments from text message updates received from family members about my mother’s status in the days that followed:\nHer doctor commented that she is doing remarkably well considering everything. He is going to order an additional COVID test just confirm. Other patients he’s managing who have been vaccinated are not doing so well.\nHe said the CAT scan from Wednesday does look consistent with what you would see for someone with COVID.\nAllow me to repeat the aforementioned words: ’She is doing remarkably well..other patients who have been vaccinated ARE NOT DOING SO WELL.’ Hello! Really? ‘He is going to order an additional COVID test just to confirm.’\nThis reminds me of Anita Moorjani’s true story, Dying to Be Me . She was in complete remission from end-stage cancer and the doctors would not accept it. So, they continued poking, prodding and testing her determined to find the cancer so they could treat it.\nRead the following excerpt from the book:\nDying to Be Me , Anita Moorjani\nThe doctor came into my room with a whole team of hospital personnel, looking concerned. Then he spoke: “We have the results of the bone-marrow biopsy, but it’s a little disturbing.” For the first time in days, I felt some anxiety. “Why? What’s the problem?”\nMy family members were in the hospital room with me, and all of them looked worried.\n“We can’t find the cancer in your bone-marrow biopsy,” he said.\n“So how is that a problem?” Danny asked. “Doesn’t that just mean she doesn’t have cancer in her bone marrow?”\n“No, that’s not possible,” the doctor said. “She definitely has cancer in her body—it can’t disappear so quickly like that. We simply have to find it; and until we do, it’s a problem, because I’m unable to determine her drug dose.”\nSo, the doctors sent my bone-marrow sample to one of the most sophisticated pathology labs in the country. Four days later, the results returned negative—there was no trace of cancer. I felt an overwhelming sense of victory upon hearing the news.\nNot to be defeated, the doctors then wanted to conduct a lymph-node biopsy to find the cancer. Dying to Be Me , Moorjani 2014\nDoctors will neurotically poke, jab, test, re-test just to find a reason to administer a drug or treatment. People have instantaneously healed, leaving no trace of disease, and yet, the majority of doctors have a very difficult time accepting these miracles of healing. So, they will continue performing tests, scans or whatever it takes until they find the problem so they have something to treat. If you are looking for a definition of insanity, well this is it.\nEventually they discharged my mother on Monday, December 20th and she spent Christmas at home with family!\nDisaster was averted because her Advance Directive Medical POA prevented the hospital from intubating her.\nStopping the Remdesivir was another critical step taken to prevent a potential fatality. Because I was familiar with my mother’s health history, this helped me identify the trend in her recurring issues in order to get the right treatment for her and avert the all but guaranteed disaster with the ‘Kevorkian’ COVID Treatment Protocol.\nMy mother has COVID…and she’s had it for seven years or more. We all have some form of COVID or whatever the current label of fear they are using; flu, swine flu, bird flu, SARS, a cold, etc.\nWe can all heal, and will heal, the moment we understand, respect and embrace the miraculous healing powers of the human body and we reclaim our terrain!\nOf the dozen or more visits to the hospital and appointments my mother had with her primary care physician over the past decade, not once did they offered her a suggestion or way to prevent this from happening.\nNOT ONCE did they step back and look at her records to notice the pattern of recurring issues to offer an actual solution or, God forbid, a cure. Instead of cutting, removing, prescribing and injecting (which is not a cure but rather a band-aid to cover up the real issues), if the medical establishment reveals the truth by unveiling real healing, human existence will change as we know it, for the better.\nThrough proper nourishment, proper hydration, proper energetic levels (mindsets) and removal of toxins, which are too prevalent and the cause of all disease, the world as we know it can be transformed.\nWe are miracles of God. The cure to disease resides within each and everyone of us .\nSuggested reading, listening and viewing:\nThe pH Miracle Revised and Updated (2010), Dr. Robert O. Young\nSick and Tired, Dr. Robert O. Young\nALL DISEASE IS OUTFECTION NOT INFECTION–VACCINE NANO IS BIOWEAPON!\nhttps://www.bitchute.com/video/rdQhuY455VmK/\nPower vs. Force , David R. Hawkins M.D., Ph.D\nThe Eye of the I: From Which Nothing Is Hidden , David R. Hawkins M.D., Ph.D\nThe Biology of Belief, Bruce H. Lipton\nThe Blood and Its Third Element, Antoine Béchamp\nA Finger on the Magic of Life: Antoine Béchamp, Dr. Robert O. Young\nDR. YOUNG REVEALS GRAPHENE, ALUMINIUM, LNP CAPSIDS, PARASITE IN 4 VACCINES\nhttps://www.bitchute.com/video/Z2sAH0Woz38r/\nThe Origins of Cancer, Otto Warburg\nA Course in Miracles. Foundation for Inner Peace\nDying to Be Me , Moorjani 2014\nEvent 201, A Global Pandemic Exercise\nDR. YOUNG REVEALS COVID VACCINES ARE INTELLIGENT TARGETING BIOWEAPONS\nhttps://www.bitchute.com/video/ufDTR2WopE5p/', '[-0.07439494132995605, 0.09870904684066772, -0.01636957749724388, 0.06238747760653496, -0.0018138941377401352, 0.06146544590592384, -0.028157103806734085, 0.031621258705854416, 0.054568901658058167, 0.054819922894239426, -0.012161388993263245, 0.001725663198158145, -0.0245598703622818, -0.02455013059079647, -0.08934485167264938, 0.019077574834227562, -0.02173793874680996, -0.05738100782036781, -0.05678451806306839, 0.11929889768362045, 0.028440039604902267, 0.04406905919313431, 0.06194227188825607, 0.018352773040533066, -0.09905775636434555, 0.02026207186281681, -0.020963719114661217, -0.051631685346364975, 0.010288470424711704, -0.030299663543701172, 0.001558988238684833, -0.05717754364013672, -0.0460951142013073, 0.03654184937477112, -0.02911824733018875, 0.08756652474403381, 0.086797796189785, -0.0022506460081785917, -0.008777459152042866, 0.07111806422472, 0.027405302971601486, -0.04524880275130272, 0.02868170291185379, 0.0329083651304245, 0.04484951123595238, -0.03018255904316902, -0.09125629812479019, 0.051098089665174484, -0.010621581226587296, -0.08167149126529694, -0.11092039942741394, -0.04331010952591896, -0.01681596040725708, -0.016519727185368538, 0.012218545190989971, 0.010026447474956512, 0.015716610476374626, -0.03557462990283966, 0.03932313248515129, -0.04844561591744423, 0.04644874483346939, 0.012647459283471107, 0.035271141678094864, 0.0598796010017395, 0.030248524621129036, -0.12140915542840958, 0.15038463473320007, 0.029118018224835396, -0.016760706901550293, 0.021008586511015892, 0.022544842213392258, -0.054911110550165176, 0.0016869633691385388, 0.018672047182917595, -0.03611909598112106, 0.011654606088995934, -0.03114868700504303, -0.06664160639047623, 0.05977941304445267, -0.009627574123442173, 0.09714779257774353, 0.0626734048128128, 0.10101940482854843, 0.10506429523229599, -0.0048424010165035725, -0.04356849193572998, 0.036631111055612564, -0.04903162643313408, 0.03409329056739807, 0.01776728220283985, -0.08857209980487823, -0.05009538680315018, 0.03133171424269676, 0.03156473860144615, 0.01563522405922413, 0.011254115030169487, 0.015128142200410366, -0.02921571023762226, -0.06660911440849304, -0.008278300985693932, -0.0429825596511364, 0.013423985801637173, -0.02676057070493698, 0.05523039028048515, 0.004825310781598091, -0.07064823806285858, -0.11053566634654999, -0.013089217245578766, 0.008850492537021637, 0.057982198894023895, -0.013983428478240967, 0.01283261924982071, -0.12434840947389603, -0.0380089171230793, 0.05925943702459335, 0.04663189500570297, -0.06086411699652672, -0.07431408017873764, 0.020503468811511993, 0.011292380280792713, 0.03673996403813362, -0.02632295899093151, -0.05171223357319832, 0.0309061910957098, 0.052786216139793396, -0.0091955391690135, 0.08796980232000351, -7.770349988637042e-35, 0.04850579798221588, -0.033262401819229126, 0.0735563114285469, 0.014548788778483868, 0.05041220039129257, -0.008507893420755863, -0.029873423278331757, -0.029136380180716515, -0.029209725558757782, 0.029615748673677444, 0.0026504970155656338, 0.055181656032800674, 0.11444970965385437, 0.0013346450868993998, -0.14211109280586243, 0.009729251265525818, -0.12044642120599747, -0.0636182427406311, 0.028809014707803726, -0.0035660923458635807, 0.05151795223355293, 0.06499651819467545, -0.0200083926320076, -0.040253184735774994, -0.03447295352816582, -0.05166035518050194, -0.04275432974100113, 0.09620830416679382, 0.004598155617713928, -0.0008651559473946691, -0.02331683039665222, 0.039112791419029236, 0.04048395901918411, -0.10141780972480774, -0.07543764263391495, -0.024556901305913925, 0.006406228523701429, -0.08230975270271301, -0.0024548149667680264, 0.046993568539619446, -0.042912520468235016, 0.013809971511363983, -0.007551213726401329, -0.06955479085445404, 0.03425539657473564, -0.008964598178863525, 0.009011062793433666, -0.11878500133752823, -0.1451665312051773, 0.05294425040483475, -0.021021367982029915, 0.03909802809357643, -0.03768342733383179, 0.024008359760046005, -0.042879775166511536, 0.019372671842575073, -0.04118293151259422, 0.058071184903383255, 0.03535081818699837, -0.0632811039686203, 0.06699690967798233, -0.08613798022270203, 0.01810084469616413, 0.02867954596877098, 0.02840897999703884, -0.09695500135421753, 0.0020543194841593504, -0.09475183486938477, -0.030744733288884163, 0.015334461815655231, -0.094456247985363, -0.019137104973196983, -0.024931978434324265, -0.0514034666121006, -0.014359756372869015, 0.01379649993032217, -0.010672052390873432, -0.027675943449139595, -0.09579606354236603, -0.02409159392118454, -0.05394892767071724, 0.012197270058095455, 0.05418042466044426, 0.04301142692565918, 0.056683991104364395, -0.04011031240224838, -0.05076061189174652, -0.05415293574333191, -0.050721924751996994, -0.03052944876253605, -0.010206039063632488, 0.007728394120931625, 0.10462697595357895, -0.06492508947849274, -0.0012965050991624594, -4.479873623173033e-33, 0.05448037013411522, -0.031223764643073082, 0.008951056748628616, -0.01023409515619278, 0.07135647535324097, 0.019384507089853287, -0.15289081633090973, -0.032583072781562805, 0.04036577418446541, -0.0007975074113346636, 0.03322158008813858, 0.004625560250133276, 0.07824715226888657, 0.0349140539765358, -0.014354442246258259, 0.03929313272237778, -0.03215918689966202, 0.029231082648038864, -0.07227005809545517, -0.024341339245438576, 0.02708333171904087, 0.07248664647340775, -0.030504994094371796, -0.011022382415831089, 0.05002189800143242, 0.054135244339704514, 0.04271750897169113, -0.037440720945596695, 0.008118456229567528, -0.0062339226715266705, 0.0013270972995087504, -0.011988142505288124, -0.019722914323210716, 0.06340136379003525, -0.047720156610012054, 0.04573715105652809, 0.02590763568878174, -0.018801309168338776, 0.014936232008039951, -0.023115934804081917, 0.017425192520022392, 0.019618656486272812, 0.03414848446846008, -0.007177260704338551, -0.018808791413903236, 0.020915446802973747, 0.07314754277467728, 0.06410360336303711, 0.04711497947573662, -0.02615678869187832, 0.012923202477395535, -0.02000027894973755, -0.014100447297096252, 0.061725229024887085, -0.026374543085694313, -0.060402464121580124, 0.041108205914497375, -0.08581338822841644, 0.02357189543545246, -0.04284406453371048, -0.008003109134733677, 0.009653904475271702, -0.12220334261655807, 0.02524546906352043, 0.00922806654125452, 0.021005993708968163, 0.016446636989712715, -0.005526671186089516, 0.011351589113473892, -0.025744300335645676, -0.041283849626779556, -0.023158520460128784, -0.0931815430521965, -0.03096204437315464, 0.022133253514766693, 0.04172012582421303, -0.027180703356862068, -0.10196934640407562, -0.02203623205423355, -0.03301854059100151, 0.0453825518488884, -0.06287848204374313, 0.07355919480323792, -0.03875940293073654, 0.03545084223151207, -0.038415346294641495, 0.00313772214576602, -0.0093497009947896, 0.06285469979047775, 0.03318535163998604, -0.08557047694921494, -0.037586476653814316, 0.0015828367322683334, -0.054206281900405884, -0.03508007153868675, -6.712328826097291e-08, 0.11383255571126938, 0.030985713005065918, -0.04441557824611664, -0.003975330851972103, -0.004268857184797525, 0.0013040213380008936, -0.004763003438711166, -0.044866811484098434, -0.02506822533905506, 0.08746210485696793, 0.00830918550491333, 0.07255081087350845, 0.0910307839512825, 0.05076013505458832, 0.027098914608359337, -0.01245968323200941, -0.0035420150961726904, 0.0068501075729727745, -0.06172574311494827, -0.06131964549422264, -0.024491552263498306, -0.07757064700126648, 0.04505510628223419, -0.02580881118774414, 0.010518685914576054, 0.07196178287267685, 0.015622485429048538, -0.037410810589790344, -0.042253077030181885, -0.005384932737797499, -0.07877201586961746, 0.08403521031141281, -0.04132936894893646, 0.05371043086051941, -0.10614421218633652, -0.0050593712367117405, 0.12430784851312637, -0.001291152322664857, -0.022068103775382042, -0.02696378529071808, 0.06822988390922546, -0.016002988442778587, -0.044778723269701004, 0.011258182115852833, -0.016995491459965706, 0.016536211594939232, -0.010915431194007397, -0.050264135003089905, -0.007281175348907709, 0.038636233657598495, -0.007648068014532328, 0.011405039578676224, 0.04402974992990494, 0.06590748578310013, -0.06191376969218254, 0.04511221498250961, -0.0647527277469635, 0.022393230348825455, -0.06187330186367035, -0.024554578587412834, 0.08543678373098373, 0.026960372924804688, 0.12473146617412567, -0.003619051305577159]');
